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General introduction  










Spinal Cord Injury 
The spinal cord is a long, tubular bundle of nervous tissue within the vertebral 
column which builds the main pathway for information connecting the brain and 
peripheral nervous system (1-3). The human spinal cord is divided into 31 
different segments (8 cervical, 12 thoracic, 5 lumbar, 5 sacral, 1 coccygeal) (1-
3). At every segment, a pair of spinal nerves exits and supplies a respective part 
of the body (1, 2). Spinal nerves constitute a sensory, a motor or a mixed output 
from the spinal cord (2). An injury to the vertebral column can result in an injury 
to the spinal cord which can affect all of its functions below the level of injury 
(Figure 1) (1).  
 
Figure 1 






A loss of motor and/or sensory function in all four extremities, trunk, and pelvic 
organs due to damage to the cervical spinal cord is called a tetraplegia (1, 3, 4). 
Persons with tetraplegia have limited use of their arms and little or no use of their 
hands, while patients with the highest level of injury cannot breathe 
independently and rely on a ventilator (5).   
Paraplegia is defined as a functional loss of motor and/or sensory function within 
the trunk and/or lower extremities as a consequence of a damage to the spinal 
cord below the level of the first thoracic vertebra (1, 3, 4). 
The paralysis resulting from a damage to the spinal cord can be total or partial. 
A total paralysis is also referred to as complete spinal cord injury (SCI) where 
there is an absence of sensory and motor function in the lowest sacral segment 
(1, 3, 6). A SCI where partial preservation of sensory and/or motor functions is 
found below the neurological level and includes the lowest sacral segment is 
called a partial or incomplete SCI (1, 3, 6). Incomplete paraplegia and tetraplegia 
are currently the most frequent neurological categories followed by complete 
paraplegia and tetraplegia, as reported by a Dutch, a Swiss and an American 
Database (7-9).  
The neurological level of injury is generally the lowest segment of the spinal cord 
with normal sensory and motor function on both sides of the body (3, 10). Up to 
four different segments may be identified in determining the motor and sensory 
level (left and right) and each of these segments is recorded separately. The 
level of spinal column (bone) injury may not necessarily correlate with the 
neurological level of SCI (3, 10). 
The completeness of the injury is classified using the American Spinal Injury 
Association (ASIA) Impairment Scale (AIS), i.e. to determine whether there is an 
absence or presence of sacral sparing (Table 1) (3, 10). These are conducted 
on patients lying supine, and involve a qualitative grading of sensory responses 
to touch and pin-prick each of 28 dermatomes along both sides of the body and 
a qualitative grading of the strength of contraction of 10 representative (key) 














No sensory or motor function is preserved in the 






Sensory but not motor function is preserved below 







Motor function is preserved below the neurological 
level, and more than half of the key muscles below 







Motor function is preserved below the neurological 
level, and at least half of the key muscles below the 
neurological level have a muscle grade greater 






Motor and sensory function is preserved. 
 
The leading cause of traumatic injury are vehicle crashes, followed by falls, acts 
of violence and sports/ recreation activities (7, 11). Non-traumatic SCI can mainly 
be related to congenital reasons (e.g. skeletal malformations), genetic disorders 
(e.g. spino-cerebellar) or acquired abnormalities (e.g. vertebral column 
degenerative disorders, neoplastic, infection) (12).  
The mortality rate for persons with SCI are higher during the first year after injury 
than during subsequent years, particularly for persons with higher level of lesion 
and complete injuries (7). Life expectancy remains significantly below life 
expectancy of able-bodied persons (7). About one third of persons with SCI are 





from diseases of the genitourinary system and the skin, respiratory diseases are 
also common causes (7). Presently there is no cure for SCI and for the majority 
of patients paralysis is permanent (5). The overarching aim of rehabilitation is to 
assist persons with SCI, enabling independence and improving quality of life. 
 
Respiratory complications 
Community-acquired pneumonia is the fifth leading cause of mortality in the able-
bodied population in Europe (13) with Streptococcus pneumoniae being the most 
common pathogen (14, 15). Mortality ranges from <1% to 48% and is associated 
with advanced age, co-morbidities and severity of the pneumonia (15). The 
clinical and economic burden of pneumonia in Europe is high (15). Respiratory 
complications are also one of the main comorbidities after SCI, especially among 
persons with cervical and high thoracic injury (16). The underlying problem is 
paralysis of the respiratory muscles, which leads to poor mobilization of 
secretion, bacterial accumulation in the secretion and resultant respiratory 
infections (16-18). Pneumonia, atelectasis and other respiratory complications 
are reported to occur in 40-70% of persons with tetraplegia and are still the 
leading cause of death (17, 19-22). The higher the level of SCI, the greater the 
risk of respiratory complications (17). Due to the high rate of atelectasis and 
pneumonia among persons with tetraplegia, special attention needs to be given 
to monitoring the patient for these complications (17, 23). In the first hours and 
days after injury, the neurological level of injury can ascend, causing changes in 
respiratory function which requires urgent attention (16). In addition, respiratory 
muscles of persons with high-level cervical injuries may fatigue over the course 
of the first few days after their injury, especially since they are unable to 
expectorate their secretion (16). Persons with SCI are susceptible to respiratory 
complications that may not only occur immediately after injury but throughout the 
course of their lives (24). Chest roentgenograms provide useful diagnostic 
information but have also been shown to miss significant respiratory pathologies 
(16). It cannot be relied on as the sole evidence of normal function. A clinical 





contributes to the respiratory management following a SCI (16). For the 
screening of general respiratory health or the monitoring of therapy effectiveness 
a spirometry is invaluable (25). Spirometry is a physiological test that measures 
the inhalation and exhalation of volume of air as a function of time (25). For the 
interpretation of the lung function tests it is important to classify the derived 
values with respect to a reference population (26). The prediction of respiratory 
function based on able-bodied values has limitations in persons with SCI (Figure 
2). Ideally, reference values are calculated with models derived from 
measurements observed in a representative sample of a clearly defined and, as 
much as possible, corresponding population (27, 28).    
Figure 2 
Lung volume as % predicted of able-bodied persons for seven different lesion 
level groups (29). 
(Reprinted from Rehabilitation: Mobility, Exercise and Sports, L.H.V. van der Woude et al. (Eds.), 
Mueller G., Perret C., Michel F., Lung volumes in spinal cord injury – a distinct restrictive pattern, 
pages 199-201., Copyright (2010), with permission from IOS Press. 
The publication is available at IOS Press through http://dx.doi.org/[10.3233/978-1-60750-080-3-199]) 
 
Reducing the incidence of atelectasis should reduce the incidence of pneumonia 
because the bacteria will not have the secretion for their growth (16). If the 
patient develops respiratory infection and pneumonia, the result is likely to be a 
cascade effect of bacteria that are increasingly resistant to antibiotics (16). 





common treatments including assisted coughing, suctioning, percussion, 
respiratory muscle training and vibration should be instituted early (16, 30).  
 
Training specific aspects 
Respiratory muscle training involves specific training of inspiratory, expiratory, or 
both, muscles to yield improvements in strength and endurance (31). The 
principal intention of an expiratory and inspiratory muscle strength training is to 
increase the strength of the expiratory and inspiratory muscles respectively (32). 
The respiratory muscles can be trained following the basic training principles for 
skeletal muscles and with devices that increase the load on the muscles (31). 
There are two types of respiratory muscle strength training (31): Resistive 
training involves breathing through a small diameter hole, which limits the 
available airflow and threshold training involves breathing with sufficient force in 
order to overcome a spring-loaded valve to enable airflow (33, 34). A training 
session typically consists of a certain number of exercise repetitions or a 
particular length of time spent exercising (31). The reported training volumes and 
intensities vary greatly (31) and thus, the optimal training settings to achieve a 
clinically relevant improvement in respiratory muscle strength are still unknown. 
Less fit persons seem to benefit more from respiratory muscle training than 
athletes and improvements are greater with longer exercise duration (35). The 
current trend is high intensity training but the required high exercise intensities 
cannot be maintained for a prolonged period, and therefore, the training will 
mostly be performed in interval sessions (36). A high intensity training stimulus 
is also required for inducing respiratory muscle adaptations, i.e. increasing 
respiratory muscle strength (37). In able-bodied persons high intensity whole 
body interval training is an effective stimulus for the respiratory muscles (37). 
Another investigation in able-bodied persons showed that high intensity 
inspiratory training (80% of peak inspiratory pressure (PImax)) resulted in 
increased inspiratory muscle strength and lung volumes compared to lower 
training intensities (60% and 40% PImax) (38). Even though for persons with 





volume as well as on in- and expiratory muscle strength could recently be 
demonstrated (31), most persons in this population may not be able to reach a 
high enough stimulus for respiratory muscles through whole body exercise. 
However, isolated high intensity training of the respiratory muscles may be a 
promising alternative. In addition, high intensity training offers a time-efficient 
and probably also more motivating alternative compared to continuous training 
(37). For persons with SCI an individual respiratory muscle training may be a 
central aspect of maintaining health and quality of life. Additionally, respiratory 
function generally improves in line with spontaneous recovery during inpatient 
rehabilitation (39-42). However, it has not yet been established, whether and to 
what extent the spontaneous recovery of respiratory function can be increased 
by specific respiratory muscle strength training.  
 
Figure 3  
Group therapy for respiratory muscle training in a specialized rehabilitation 
center for SCI. 
 
Outline of the thesis 
Although respiratory complications are a common and well-known problem in 
SCI, there is little information about their management. Current practice is mainly 
based on clinical experience and expert opinion (33). The pathophysiology of the 
development and the occurrence of respiratory complications in SCI is well 
described in literature. However, there is still a gap in knowledge on how to 





characteristics that predispose persons to suffer from respiratory complications. 
Are respiratory muscle strength training programs effective to reduce respiratory 
complications and if so what kind of training program and what dose is indicated? 
It is important to understand the effect of respiratory muscle training in SCI so 
that interventions can be targeted at impacted patients to prevent respiratory 
complications, to reduce hospitalization and to improve quality of life. Therefore, 
recommendations for respiratory muscle training in hospital or community 
settings need to be developed and implemented in therapeutic practice. 
The overarching aim of this thesis is to understand the pathophysiologic 
principles of respiratory complications after a SCI as well as the potential to 
reduce them.  
 
Aim of the present studies 
The thesis is divided into nine chapters. 
 
After the introduction and problem formulation in Chapter 1, in Chapter 2 we 
survey the literature on numbers about the incidence of pneumonia in persons 
with SCI all over the world. Primarily goal is to introduce some principle elements 
of SCI as well as respiratory complications and secondly to systematically review 
the current literature about pneumonia as the leading cause of mortality after a 
SCI. Risk threshold values can be used to identify patients at increased risk of 
pneumonia. Patients with lung function values below the risk threshold values 
are recommended to train their respiratory muscle strength and lung volumes to 
prevent pneumonia.  
 
In Chapter 3 we investigate, whether respiratory function, measured at an 
arbitrary point in time after onset of the SCI, can be used as a discriminator for 
pneumonia. There are three studies on predictors of pneumonia in the SCI 
population (43-45). Two of these studies concentrated on factors of injury and 
hemorrhagic shock severity (44) or identified the level and completeness of injury 
as the fundamental clinical entity predicting respiratory complications (43). 





study focused on potentially modifiable factors, such as lung function but did not 
cover respiratory muscle strength and did not define the inclusion of respiratory 
complications precisely (45). In our study we identified modifiable predictors of 
pneumonia after SCI and also examined the difference of possible discriminators 
of pneumonia between the motor complete and motor incomplete group.  
 
In Chapter 4 we convey the protocol of the RESCOM study (RESpiratory 
COMplications). To the best of our knowledge, there is currently no 
comprehensive database available to improve the prediction and understanding 
of pneumonia risk with respect to impairment of lung function. The multicenter 
and multinational cohort study RESCOM aims to establish such an evidence 
base in SCI with the view to improve clinical practice by facilitating more specific 
interventions during the inpatient setting in high income countries. 
Prediction of respiratory function is essential to rate the respiratory status in daily 
clinical practice. The prediction of respiratory function in able-bodied persons 
cannot be transferred to persons with SCI. To provide reference values for 
respiratory function in persons with chronic SCI has led to the requirement for 
SCI-specific models to predict individual respiratory function values. Prediction 
models can help clinicians to identify patients whose respiratory function is below 
the norm. We do not know how accurate the available models are for persons 
several years post injury. Therefore, in Chapter 5 we test the accuracy of the 
available models for persons with chronic SCI and, if necessary, develop and 
validate new models to predict respiratory function. The overarching purpose of 
the prediction of individual respiratory function values is patient and clinical 
information with the ultimate intention of improving decision making about 
validated treatment (46). 
 
Studies regarding strength training mostly include training programs with a 
duration of eight to 12 weeks (47). The reported frequency of training sessions 
range from once (30min) to several times a day, four to five times a week (48, 
49). Thus, the reported training volumes and intensities vary greatly (31) and the 
optimal respiratory muscle training settings to achieve a clinically relevant 





investigate the effect of training intensity and -volume on improvements in 
respiratory muscle strength, taking the effects of the completeness and level of 
the lesion as well as the baseline respiratory muscle strength into consideration. 
 
In clinical practice, two main types of respiratory muscle strength training 
programs have been established, namely inspiratory and expiratory muscle 
strength training (32). The degree and severity of respiratory muscle paralysis 
caused by SCI is usually decisive in choosing either an in- or an expiratory 
training program or a combination of both (32). During clinical routine, the 
question about the more effective training regime is often raised. In Chapter 7 
we therefore evaluate the clinical implementation of a respiratory muscle training 
group during initial rehabilitation of persons with SCI. Our main hypothesis is that 
significant differences in the respiratory muscle strength and lung volume can be 
reached by different respiratory muscle training regimes. 
 
Since December 2019 the coronavirus disease (COVID-19) with clusters of 
pneumonia cases is identified as the cause of the most significant pandemics of 
the modern era. In Chapter 8 we provide the perspective and experiences from 
Switzerland for the SCI-population during the COVID-19 crisis. We hope that this 
letter can increase awareness of respiratory therapy for COVID-19 infected 
patients and provide support during these challenging times. 
 
The main findings of all projects described in this thesis are summarized and 
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Systematic review and meta-regression of 
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Objectives To assess formally the incidence rate of pneumonia in persons with 
spinal cord injury (SCI) and to use systematic and quantitative methods to 
examine reasons for variation in incidence estimates. 
 
Methods Systematic review of electronic databases (PubMed, EMBASE, 
MEDLINE, CENTRAL) and relevant reference lists. Search terms included 
“pneumonia”, “tetraplegia”, “paraplegia”, “spinal cord injuries”, “spinal diseases”, 
“prevalence” and “incidence”. Random effects Poisson regression was used to 
estimate incidence of pneumonia per 100 person days. Meta-regression was 
used to evaluate the influence of the clinical setting, the level of injury, the use 
of mechanical ventilation, the presence of tracheostomy, and dysphagia. 
 
Results For the meta-regression we included 25 studies. The incidence rates 
ranged from 0.03 to 7.21 patients with pneumonia per 100 days. In the 
multivariable meta-regression the incidence rate in the acute setting was more 
than twice as high (incidence rate ratio 2.49, 95% CI 0.73 to 8.45) as in the post-
rehabilitation setting, and the incidence rate for the ICU was almost 5 times as 
high as in the post-rehabilitation setting (incidence rate ratio 4.73, 95% CI 0.93 
to 23.98). 
 
Conclusions The main finding of this systematic review and meta-regression is, 
that we found large heterogeneity in the reporting of the incidence rates and we 
therefore should be cautious with interpreting the results. Large longitudinal 
studies with a standardized reporting on risk factors, pneumonia and detailed 
time under observation are needed.   




Pneumonia continues to complicate the course of spinal cord injury (SCI). 
Respiratory complications are the leading cause of morbidity and mortality in the 
acute phase of SCI with an incidence of 36- 38% (1-3). Pneumonia profoundly 
impacts the length of hospital stay and the neurological outcome (4). Male 
gender, motor complete injury, presence of chest trauma and the timing of 
intubation are key predictors for pneumonia in SCI (4). As a result of respiratory 
muscle paralysis, persons with tetraplegia are especially prone to respiratory 
complications (5-7). The higher the level of spinal cord damage the more severe 
the respiratory impairment (8). The respiratory dysfunction in SCI, that correlates 
with respiratory complications, may be related to three main factors (1). The first 
is the impairment of vital capacity caused by a reduction in inspiratory and 
expiratory muscle strength and faster fatigue. The other two factors are related 
to the retention of secretions and to the dysfunction of the autonomic system (1). 
Many persons with SCI, who survive acute hospitalization, die within 6.2 years 
after discharge (9) mainly as a result of cardiovascular (13-37%) and pulmonary 
diseases (9-30%) (9-11). Outside hospitals the case fatality rate for pneumonia 
(7.9% within 60 days) is considerably greater in persons with SCI compared to 
the general population and hospitalizations are more frequent with increasing 
age, tetraplegia and the occurrence of comorbidities (12). 
Pneumonia is defined as inflammation of the lung tissue and is usually caused 
by infection (5, 13) with Streptococcus pneumoniae the most common pathogen 
(14, 15). Diagnosis can be made by radiographic signs of parenchymal disease 
(5). Currently clinicians and policy-makers are faced with only single numbers of 
pneumonia incidence in the literature. A formal incidence of pneumonia in 
persons with SCI is still missing and to our knowledge this is the first systematic 
review of the incidence of pneumonia in the SCI-population. Incidence of a 
disease indicates the number of new cases within a time period in a population. 
Systematic reviews of prevalence and incidence data are becoming increasingly 
important as decision makers realize their usefulness in informing policy and 
practice (16). Accurate estimates of the true incidence of pneumonia are also of 





planning diagnostic and intervention services. We hypothesized that the risk of 
pneumonia may be influenced by various covariates such as clinical setting, the 
level of injury, use of mechanical ventilation, presence of tracheostomy, and 
dysphagia. Therefore, a systematic review of the literature was needed to 
provide an objective synthesis of the evidence about the incidence of pneumonia 
in persons with SCI under consideration of the five covariates clinical setting, the 
level of injury, use of mechanical ventilation, presence of tracheostomy, and 
dysphagia. 
Methods 
We conducted a systematic review and meta-regression of published incidence 
studies of pneumonia in SCI. The review was guided by the recommendations 
provided for Meta-analysis Of Observational Studies in Epidemiology (MOOSE) 
and guidelines for undertaking systematic reviews of incidence and prevalence 
studies (17, 18). The review was registered with the International Prospective 
Register of Systematic Reviews (PROSPERO 2019 CRD42019129048). 
 
Types of studies 
We considered all types of studies for inclusion, except case studies. 
 
Literature searches 
A variety of sources were used to find relevant publications including PubMed, 
EMBASE, MEDLINE (Ovid) and Cochrane Central Register of Controlled Trials 
(CENTRAL) databases. Search terms included “pneumonia”, “tetraplegia”, 
“paraplegia”, “spinal cord injuries”, “spinal diseases”, “prevalence” and 
“incidence” with a combination of exploded Medical Subject Heading/ Emtree 
terms using "or" and "and" per database specification. One review author (AMR) 
designed this search strategy in collaboration with an experienced health 
librarian. A systematic and comprehensive search was scheduled at the 20th of 
March 2019 with a last update at the 12th of May 2020. We hand-searched the 
reference lists of relevant papers and literature reviews. We contacted study 
authors to acquire information that was not included in their articles. Additionally, 
we contacted experts in the field to find all publications that match our inclusion 
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criteria. Initially we applied no date, language or publication restrictions. 
However, three papers in Chinese, Danish and Icelandic could not be translated 
and they were not included in the analysis. No other studies required translation 
into English.  
 
Eligibility criteria 
We included studies involving male and female patients with a primary diagnosis 
of traumatic or non-traumatic SCI, American Spinal Injury Association 
Impairment Scale (AIS) A-D, right and left motor level between C1-L5, both acute 
and chronic. The participants were 18 years of age and over. In those studies 
with missing information about the AIS impairments grade we contacted the 
authors of the study to obtain this information. In those with no answer we used 
the following definition; AIS A indicates a "complete" SCI in which no motor or 
sensory function is preserved, AIS B,C,D indicates an "incomplete" SCI in which 
sensory but no or partly preserved motor function (19). All types of pneumonia 
were included since we wanted to have a broad overview on all cases in SCI. 
Studies on patients with progressive neurological diseases such as multiple 
sclerosis, poliomyelitis or amyotrophic lateral sclerosis were excluded as well as 
studies on patients with mental disorders, patients taking bronchodilators or any 
other medication that influences respiration at the time of assessment. We also 
did not include studies which investigated pneumonia caused by the recently 
discovered coronavirus with the outbreak in China in December 2019 and the 
following pandemic affecting many countries globally. 
Fulltext, peer-reviewed studies were required to report data on incidence of 
pneumonia in persons with SCI. Studies could be conducted in the hospital or 
community setting.  
 
Study records 
The search results were collated in an EndNote X8 database (Clarivate 
Analytics, Philadelphia, USA). Duplicates were removed before search results 
were analyzed. Two review authors (AMR, SE) independently assessed the titles 





systematic review software (Veritas Health Innovation, Melbourne, Australia). 
After initial screening, the two review authors independently assessed the full 
texts of the retrieved articles for compliance with the eligibility criteria. 
Disagreement was resolved by discussion. In case when no decision could be 
made by consensus a third author (GM) was consulted for discussion until 
agreement could be reached. A PRISMA flow chart of the study selection 
procedure was created (Figure 1). 




PRISMA flow diagram. Systematic review of incidence studies of pneumonia in 







Methods and population characteristics reported across most studies were 
selected for data extraction. One review author (AMR) extracted and coded data 
from included studies by using a predefined form. A second review author (RH) 
checked the extracted data. The second review author consulted the first one in 
case where there was disagreement to find a consensus. The following items 
were extracted: year of publication, country, type of study, sample size, setting, 
age, sex, AIS grade, level of injury, length of hospital stay, mechanical 
ventilation, length of observation, and the incidence of pneumonia.   
 
Risk-of-bias assessment  
Risks of bias were assessed for all included studies using a "Quality assessment 
checklist for prevalence studies developed from Hoy et al." (20). In principal the 
tool consists of 10 questions and each question can be answered as "yes", 
defined as low risk of bias level or "no", defined as high risk of bias level. At the 
end a summary on the overall risk of study bias can be rated as low risk (0-3 
points scored), as moderate risk (4-6 points scored) or as high risk (7-9 points 
scored). The quality assessment checklist addressing external validity (item 1-4) 
and internal validity (item 5-10). We subjectively selected the five most important 
items (item 2, 4, 6, 7, 10) regarding our study question. We decided for a 
conservative procedure that the worst item out of these five items were decisive 
for the rating of the whole study. Uncertainties in the rating of the risk of bias 
were resolved by discussion with two further authors (RH, GM). The full risk-of-
bias assessment is shown in Table 4. We planned to perform a sensitivity 
analyses comparing results from studies with a high risk of bias compared to 
studies with low risk of bias within the subgroups.   
 
Data synthesis 
We calculated incidence rates per 100 person days based on events divided by 
the total exposure time in days. Because most of the studies did not report exact 
time at risk, we estimated the time at risk by taking the mean follow-up time in 
days for patients without pneumonia and by taking half of the mean follow-up 
time in days for the patients with pneumonia to adjust for the reduced exposure 
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time in cases. In a sensitivity analysis we calculated a minimal follow-up time by 
using 0 days for the cases, and a maximal follow-up time by using the full follow-
up time for all patients.  
The incidence rates were pooled with a Poisson’s regression with a logarithmic 
link-function and total exposure time per study as an offset variable and a 
random intercept (21). Analyses were performed in subgroups for clinical setting, 
the level of injury, use of mechanical ventilation, presence of tracheostomy, and 
dysphagia. We assumed that these five covariates may influence the risk of 
pneumonia. Setting was divided into ICU, acute phase, rehabilitation phase, 
post-rehabilitation phase and mixed setting, in which the first three settings are 
linked to hospital-acquired pneumonia and post-rehabilitation belongs to 
community-acquired pneumonia. Mechanical ventilation means a ventilation 
through tracheostomy or endotracheal intubation (22). Tracheostomy is 
preferred if mechanical ventilation is required longer than 21 days (23, 24). It 
improves pulmonary toilet and reduces the length of breathing pathway, i.e. the 
anatomical dead space, and airway resistance (24). Dysphagia is commonly 
diagnosed by a bedside swallow evaluation, a flexible fiberoptic endoscopy 
evaluation of swallowing or a videofluoroscopic swallow study (25). Statistical 
heterogeneity was evaluated using tau, tau2 and the I² statistic. I2 describes the 
proportion of variation in incidence estimates that is due to genuine variation 
rather than sampling error. Values for I² of 50% or greater were considered as 
showing substantial heterogeneity (26, 27). Multilevel mixed-effects Poisson 
regression was used for the meta-regression to calculate univariable and 
multivariable incidence rate ratios with corresponding 95% confidence intervals. 
Five categorical variables were included in the multivariable regression model: 
Setting (Acute, ICU, Rehabilitation, Post-Rehabilitation, Long-Term Ventilated, 
and Mixed), Level of Injury (Paraplegic, Tetraplegic, > 50% Paraplegic, > 50% 
Tetraplegic (for studies where the actual number of paraplegic and tetraplegic 
was not reported), and Mixed), Ventilated (Not Ventilated or No Information, 
Ventilated, and Mixed), Tracheostomy (No, Yes, Mixed), Dysphagia (Not 
Mentioned, No, Yes). The categorical variable dysphagia was not entered in the 
multivariable meta-regression, because of the low number of studies with 





Analyses were performed with Stata, version 16.1 and R (R Foundation for 




Literature searches identified 713 records including duplicates. Figure 1 displays 
the flow of the inclusion. After exclusion through comparisons of titles and 
abstracts against inclusion criteria, 97 records were identified for detailed 
examination. In total, 70 records were excluded with the reasons listed in Figure 
1. The main reason was that in 54 studies the wrong patient population was 
examined (Figure 1). Mainly data for the sub-analyses for the SCI population 
were missing and therefore the numbers for incidence of pneumonia could not 
be used for our analyses. No studies have separated moderate and severe 
pneumonia from mild infections.  
Finally, 27 records met inclusion criteria, 25 studies could be included in the 
analyses for the incidence rates and incidence rate ratios. Of the 27 studies, 25 
provided estimates of pneumonia and two of respiratory complications. Of the 25 
included studies, only two designed their study specifically to report on incidence 
rates of pneumonia. The study sample sizes ranged from 14 to 18,693 
(median=145) and the studies were published between 2001 and 2020 and 
carried out in Europe (n=9), Asia (n=4) and America (n=14). Of these 27 studies, 
11 studies were prospective. Table 1 describes the study characteristics. 
 
Risk of bias  
Table 4 is a tabular display of the overall risk-of-bias assessment. Of the 27 
included papers all studies were rated as high risk of bias, therefore, we refrained 
from the risk of bias sensitivity analysis. 





Characteristics of 27 included studies. 
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ASIA=American Spinal Injury Association; CI=Confidence Interval; n.m.=not mentioned in study; Para=Paraplegia; SCI=Spinal Cord Injury; 
Tetra=Tetraplegia 
All numbers are rounded up or down to a full turn-out; 
*we included injury level between C1-L5, Joseph et al. included injury level C1-S5, but prevalence of pneumonia was divided into cervical, 





Incidence rates per 100 person days and incidence rate ratios 
Meta-regression of 25 studies reporting on 42 study samples were conducted. 
Setting  
In the univariable meta-regression, the incidence rate ratio was 6.37 (95% CI 
1.96 to 20.72) for the acute setting, and 17.13 (95% CI 5.11 to 57.36) for the 
ICU, compared to the post-rehabilitation setting. The incidence rate ratio for the 
long-term ventilation setting, the mixed and the rehab setting were not 
statistically significant (Table 2). In the multivariable meta-regression (adjusted 
for setting, level of injury, ventilation, and tracheostomy), the incidence rate in 
the acute setting was more than twice as high (incidence rate ratio 2.49, 95% CI 
0.73 to 8.45) as in the post-rehabilitation setting, and the incidence rate for the 
ICU was almost 5 times as high as in the post-rehabilitation setting (incidence 
rate ratio 4.73, 95% CI 0.93 to 23.98). However, all confidence intervals, with the 
exception of mixed rehabilitation, were too wide to reject the null hypothesis that 
the incidence rates were the same for all settings. 
Level of Injury 
Tetraplegic patients showed higher incidence rates compared to the paraplegic, 
however the confidence intervals were too wide to exclude the null hypothesis 
that there is no difference (see univariable and multivariable incidence rate ratios 
in Table 2).  
Mechanical ventilation 
Mechanically ventilated patients showed higher incidence rates than non-
ventilated patients, but the confidence intervals of the univariable and 
multivariable incidence rate ratios were too wide to exclude the Null hypothesis 
that there is no difference (Table 2).  
Tracheostomy 
Patients with a tracheostomy showed higher incidence rates than patients 
without tracheostomy, but the univariable and multivariable incidence rate ratios 
were not statistically significant (Table 2). 
Dysphagia 
Patients with dysphagia showed higher incidence rates than those without 
dysphagia in the univariable regression, but the incidence rate ratios were not 
statistically significant (Table 2). Because there were only three studies with 




information on dysphagia, we decided not to include dysphagia in the 
multivariable meta-regression.  
Figure 2 shows the subgroups regarding the five risk factors, the number of 
persons with pneumonia, the total number of persons, the follow-up time in days 
per person, as well as the incidence rate per 100 person days. The most 
important findings were the high heterogeneity overall and within the subgroups. 
The incidence rates ranged from 0.03 pneumonias per 100 days to 7.21 
pneumonias per 100 days. Because of the small numbers of studies in the 









Univariable and Multivariable Meta-Regression including Setting, Level of 
Injury, Mechanical Ventilation, Tracheostomy, and Dysphagia.  
 
 
n.a.: Too few studies with information on dysphagia (only two studies reported on 
dysphagia), therefore, we did not include dysphagia in the multivariable model.  
Incidence Rate Ratio: exp(coefficient): how many times the incidence per 100 days is 
higher compared to the reference category (in multivariable analysis: controlled for all 
other variables).  
CI=confidence interval; ICU=Intensive Care Unit; Para=paraplegia; 
Rehab=rehabilitation; Tetra=tetraplegia 
 




The mean incidence estimates of pneumonia varied between 0.03 and 7.21 
patients with pneumonia per 100 days (Figure 2). All included studies provided 
useful data about the covariate clinical setting (Figure 2) (24, 25, 30-54). Ten 
studies with 631 participants provided data for persons with tetraplegia (Figure 
2) (24, 25, 30, 32-37, 52). Thirteen studies with 1,326 participants included 
mechanically ventilated patients (24, 25, 30, 31, 34-37, 39, 40, 52, 54, 55) of 
which six studies with 827 participants provided useful data (Figure 2) (24, 31, 
36, 37, 40, 55). Fourteen studies with 1,681 participants measured tracheostomy 
(24, 25, 30, 31, 34-40, 44, 48, 54) of which six studies with 539 participants 
provided useful data (24, 30, 31, 37, 40, 54). Four studies with 176 participants 
measured dysphagia (25, 34, 35, 44) of which three studies with 156 participants 
provided useful data (25, 34, 35).  
 
Sensitivity analyses 
The sensitivity analyses (Table 3a and 3b) with the two alternative calculations 


























Sensitivity analyses where the time under risk for the patients with pneumonia 
was set to 0 (i.e. as if they had the pneumonia all at the first day).  
 
n.a.: Too few studies with information on dysphagia (only two studies reported on  
dysphagia), therefore, we did not include dysphagia in the multivariable model. 
Incidence Rate Ratio: exp(coefficient): how many times the incidence per 100 days is 
higher compared to the reference category, (in multivariable analysis: controlled for all 









Sensitivity analyses where the time under risk for the patients with pneumonia 
was set to the same time as for those patients without pneumonia (i.e. as if they 
had the pneumonia all at the last day).  
 
n.a.: Too few studies with information on dysphagia (only two studies reported on 




Forest Plot of all included study samples, without pooled results. 
CI=confidence interval; Fup=Follow up; G-Csf= granulocyte colonystimulating 
factor; ICU=Intensive Care Unit; LT-Ventilated=long-term ventilated; 
MPSS=high-dose methylprednisolone sodium succinate; n.m.=not mentioned; 









Summary of risk of Bias assessment. 





























































































































et al. (24) 
- + - - - - - + + + high 
Citak  
et al. (38) 
- + - - + - - + - + high 
Evans  
et al. (39) 
+ + - - - + - + - - high 
Fusse-
nich  
et al. (40)  
- - - + - + + + + + high 
Garcia-
Leoni  
et al. (31) 
- + - - + + + + + + high 
Hatton 
et.al. (37) 
- + - - - - - + + + high 
Ito  
et al. (32) 

































































































































et al. (41) 
- + + + + + - + + + high 
Kamiya  
et al. (33) 
- + - - - + + + + + high 
McKinley  
et al. (42) 
+ + - - - - - + + + high 
McKinley  
et al. (43) 
- + + - - - - + + + high 
Medee  
et al. (30) 
- + - - + - + + + + high 
Patel  
et al. (44) 
- - - - + - - + + + high 
Raab  
et al. (45) 
- + - + + - - + - + high 
Shem  
et al. (34) 
- + - + - - - + + + high 

































































































































et al. (35) 
- + - - - - - + + + high 
Smith  
et al. (46) 
+ + + - - - - + + + high 
Stillman  
et al. (47) 
- + - - + - - - + + high 
Stolz-
mann  
et al. (48) 
- + - + - - - - + + high 
Street  
et al. (49)  




et al. (50) 
- + + + - - - + + - high 
 
 



































































































































- + + + + - - + + + high 
Wahman 
et al. (52) 
- + + + + - - + + + high 
Younan  
et al. (53) 
- + - + - + + + + + high 
Yu  
et al. (36) 
- + - - - - - + + + high 
Vitaz  
et al. (54) 
- + - - - - - - + + high 
Two questions were modified concerning the aim of the study. The question in item 1 was rephrased to "Was the study population 
representative of the target population?" because our systematic review included the clinical SCI population. The question in item 7 was 
changed into "Was there a description of the study instrument that measured the parameter of interest (incidence of pneumonia)?". 
We focused on the five most important items regarding our study question, namely item 2,4,6,7,10. The worst item out of these five items 
were decisive for the rating of the whole study.






This systematic review and meta-regression of 25 studies analyzed the 
incidence rate of pneumonia in SCI. All studies had a high risk of bias with high 
heterogeneity, which remained even in the subgroup analysis. Pooled estimates 
of incidence rates would be useful to indicate the public health burden of 
pneumonia in SCI. However, we have only very low confidence in the pooled 
estimates of the incidence rates. This low confidence results mainly because of 
i) the design of the studies, which were not specifically designed to analyze 
incidence rates of pneumonia, ii) the reporting of the follow-up time (time at risk), 
iii) the low sample sizes, iv) the heterogenous and non-standardized reporting of 
the outcome variables and the risk factors (i.e. setting, level of injury, mechanical 
ventilation, tracheostomy, dysphagia), the high risk of bias, that not all studies 
were longitudinal studies.   
 
Overall completeness of evidence 
The overall completeness of evidence with 25 identified studies appears to be 
sufficient to address the incidence of pneumonia in SCI taking into account wide 
95% confidence intervals. Most studies reported the incidence of pneumonia in 
SCI and a minority reported the point prevalence or the period prevalence of 
pneumonia. We therefore decided to focus on incidence estimates. The analyses 
of incidence rates had the limitation that the time under risk was not reported. 
For a correct follow-up time, the follow-up days should only be counted up to the 
diagnoses of a pneumonia, and most studies reported the overall follow-up time, 
i.e. including the days where a patient was already diagnosed with a pneumonia. 
Therefore, we had to estimate the follow-up time by adjusting the days for 












Hospital-acquired pneumonia is defined as a pneumonia not incubating at the 
time of hospital admission and occurring 48 hours or more after admission (56, 
57). Community acquired pneumonia is seen more frequently in patients who 
have not been in hospital recently (58). The setting seems to have an influence 
on the incidence of pneumonia. Rates of pneumonia are considerably higher 
among patients hospitalized in ICUs compared with those in hospital wards (22, 
59). These findings are confirmed in this systematic review, the incidence of 
pneumonia in SCI is also highest in ICU and decreases with longer time post 
injury (Figure 2). The clinical setting varied between the included studies. For 
example, in some studies pneumonia was identified at ICU during acute phase 
of SCI and in other studies pneumonia was identified in the rehabilitation phase 
or already in the outpatient setting. Details about the setting were insufficient in 
two studies. In one study we only found a description that the diagnosis of 
pneumonia in an ICU setting is difficult because the clinical presentation varies 
and therefore, we assigned the setting to ICU (53). In the other study pneumonia 
events occurred before admission to the hospital unit and we assume, that the 
period before admission is the time in ICU (30).  
Level of injury  
We investigated the incidence of pneumonia according to the covariate level of 
injury. We divided the level of injury into tetraplegia and paraplegia because the 
degree of respiratory impairment depends on the level of injury, with higher levels 
of injury causing greater impairment (8, 60). Generally, the incidence of 
pneumonia seems to be higher in high-level tetraplegia in comparison to low-
level tetraplegia and paraplegia (5). One study in this systematic review directly 
compared patients with tetraplegia and paraplegia with comparable 
personal/baseline characteristics (52) and could not confirm this statement. The 
incidence rate per 100 person days of pneumonia in the group with tetraplegia 
was higher compared to patients with paraplegia, but the results were not 
statistically significant (Table 2). These results rely on a small sample size with 
45 participants and an unequal proportion of tetra- and paraplegics and 
therefore, this evidence was not strong. 




Mechanical ventilation  
For patients receiving mechanical ventilation the risk of pneumonia is increased 
3- to 10-fold (22, 59, 61). The incidence of ventilator associated pneumonia 
ranges from 8% to 28% (59, 62). Ventilator associated pneumonia is defined as 
pneumonia occurring >48 hours after endotracheal intubation (56). Some using 
the term hospital-acquired pneumonia to denote any pneumonia developing in 
the hospital (including ventilator associated pneumonia) and others excluding 
ventilator associated pneumonia from the hospital acquired pneumonia 
designation (56). So the comparability of the literature is complicated by 
inconsistent usage of the terms. Four of the studies in this systematic review 
used the term ventilator-associated pneumonia (31, 37, 40, 53) and one study 
used the term hospital-acquired infection as generic term (39). The difference 
between successful or unsuccessful weaning from mechanical ventilation 
showed marked differences in the incidences of pneumonia but rely only on one 
study and hence no conclusion can be drawn. From all pneumonia events in 
hospital, about 60% occur in non-ventilated patients with SCI (63). The incidence 
of hospital-acquired pneumonia is low (1.6%) in the non-ventilated general 
population (57). These 1.6% correspond to about 22% of all hospital-acquired 
infections. For this group we did not have information about dysphagia. 
Therefore, the incidence of pneumonia in non-ventilated SCI seems to be much 
higher than in the general population. 
Tracheostomy 
The results of the meta-regression showed higher incidence rates for patients 
with tracheostomy, however, these results were not statistically significant. 
Tracheostomy seems to influence the incidence of pneumonia at first sight, but 
this relies only on one single study (24). In this single study no statistical 
significance for the timing of tracheostomy and pneumonia was found. Further 
literature also states, that the rates of pneumonia in SCI cannot be reduced by 
timing of tracheostomy (1, 64). However, the timing of the tracheostomy within 7 
days of entry to ICU is associated with a shorter duration of mechanical 
ventilation and shorter length of ICU stay (1, 64, 65). A literature review of 




pneumonia reported that some studies found reduction in pneumonia but some 
did not (66). 
Dysphagia 
Dysphagia seems to be an important variable linked to the incidence of 
pneumonia, but only a limited number of studies provided data that could be 
included in this systematic review. The most common cause of death in patients 
with dysphagia due to neurological disorders is aspiration pneumonia (58, 67). 
The term aspiration pneumonia is often used in clinical practice. Aspiration 
pneumonia is defined as an infectious process caused by the inhalation of 
oropharyngeal secretions that are colonized by pathogenic bacteria (68). 
Generally, 5% to 15% of cases with community-acquired pneumonia are 
aspiration pneumonia (68, 69). The included studies in this systematic review did 
not consider aspiration pneumonia. 
General aspects 
Due to the different compositions of setting, level of injury, mechanical 
ventilation, tracheostomy and dysphagia in our sub-analyses, a direct 
comparison with the general population is difficult. 
Generally for reduction of pneumonia incidence a rapid identification of infected 
patients and an appropriate antimicrobial treatment is required (59).  
Generally, it was only possible to assess the impact of reported covariates. 
Qualitative influence on incidence such as time since injury, type of bacterial 
pneumonia or smoking could not be included due to missing details in the 
studies. In future, it would be valuable to have even more thorough recording of 
study characteristics with a clear definition of pneumonia type, setting and 
description of ventilation or dysphagia to facilitate meta-analyses. 
 
Strengths and Limitations 
Our search strategy was planned to comprise extensive literature searches of 
several major electronic databases as well as contact with experts in the field. 
Despite these searches, we might miss eligible studies, in particular if they are 
not published in indexed peer-reviewed journals. This might lead to a reporting 
bias (70). Our literature search revealed three papers which were published in 
Chinese, Danish and Icelandic, languages we were not able to translate. This 




may also constitute a reporting bias. Generally, the included studies were 
conducted in high-income countries and therefore, the incidence of pneumonia 
after SCI in low-income countries could not be reflected in this systematic review. 
Due to the specific patient group and the strictly defined research question we 
did not expect large number of studies for inclusion. The number of included 
studies in each single sub-analysis was low (Figure 2). Overall, we concede that 
it is possible that some cases may have appeared in multiple reports, but we 
think this unlikely given the temporal and geographical spread of the cases. We 
are aware that many of the included studies were interventional studies with 
multiple in- and exclusion criteria and therefore increased potential risk for 
pneumonia that could bias our outcomes as well, but in this way all types of 
pneumonia were included to get a broad overview on all cases in SCI. The 
inclusion of two studies with focus on respiratory complications and not only on 
pneumonia bears the risk of bias. For the covariate setting the acute phase is 
not a standardized term and therefore, the time period was defined differently in 
the included studies or was not defined at all, this can lead to a mixture of 
different times post injury. Even if we already tried to specify potential sources of 
clinical diversity by defining strict inclusion criteria in the protocol we still had high 
heterogeneity according to the statistical I2 test (Figure 2). For the correct 
interpretation of the cumulative incidences, the exact time-period for the 
incidence should be available because cumulative incidences depend on the 
duration of observation. This was not the case for most studies. Therefore, the 
incidences should only be compared within studies with similar observation 
periods. Incidence rates (cases with pneumonia divided by the observed person-
time) would be a better statistic but few studies reported the observed person-
time. A further important source of clinical heterogeneity can be the insufficient 
definition of diagnostic criteria for pneumonia in quite a number of the included 
studies (Table 4). Generally, with high diversity in a systematic review, reliable 
conclusions need to be interpreted with caution or, to be on the safe side, seen 
as hypotheses. Finally, we rely on the quality and quantity of available published 
information. To our knowledge, this is the first systematic review on the incidence 
of pneumonia in SCI, and therefore, we are not able to make a comparison with 





The main finding of this systematic review and meta-regression is, that we found 
large heterogeneity in the reporting of the incidence rates and we therefore 
should be cautious with interpreting the results. Large longitudinal studies with a 
standardized reporting on risk factors, pneumonia and detailed time under 
observation are needed. Nevertheless, this review showed, that pneumonia is 
still a clinically relevant complication and special attention concerning 
pneumonia prevention should focus on the ICU setting and patients with 
complete tetraplegia. 
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 Maximum inspiratory pressure  
is a discriminator of pneumonia  
in individuals with spinal cord injury 
 

















Objectives The present study investigated whether respiratory function is a 
discriminator of pneumonia in individuals with spinal cord injury and to determine 
the best predictive parameter.  
 
Methods Retrospective cohort study. Individuals with traumatic spinal cord 
injury, level C3-T12, complete and incomplete lesions were included. Data of 
respiratory function were extracted from medical records. The receiver operating 
characteristic curve was calculated for each parameter (forced vital capacity, 
forced expiratory volume in one second, peak expiratory flow, maximal 
inspiratory and expiratory pressure) to determine the discriminator with the 
largest area under the curve between individuals with and without pneumonia.  
 
Results Data of 307 subjects were analyzed. Maximal inspiratory pressure was 
identified as best discriminator between individuals with and without pneumonia, 
both in motor complete (area under the curve: 0.86; 95% confidence interval: 
0.78-0.93; p-value < 0.001) and incomplete individuals (area under the curve: 
1.0; 95% confidence interval: 1.00-1.00; p-value < 0.001). In individuals with 
motor complete lesions, the threshold value for maximal inspiratory pressure 
was 115% of the lesion specific reference value (sensitivity 74.4%; specificity 
83.4%). In motor incomplete individuals, the maximal inspiratory pressure 
threshold value was 93.5cmH2O (sensitivity 100%, specificity 100%). 
 
Conclusions Maximal inspiratory pressure is the best discriminator between 
spinal cord injured individuals with versus those without pneumonia. Individuals 










As a result of respiratory muscle paralysis, tetraplegic individuals are prone to 
respiratory complications, which remain a major cause of mortality among 
individuals with chronic spinal cord injury (SCI) (1). In acute SCI, up to 80% of 
patients are affected by respiratory complications (2) and in 51% of these cases 
pneumonia occurs (3). Many individuals with SCI who survive the acute 
hospitalization phase die within 6.2 years after discharge mainly as a result of 
cardiovascular and pulmonary diseases (65%) (4-6). The case fatality rate for 
pneumonia (7.9% within 60 days) is considerably greater in individuals with SCI 
compared to the able-bodied population and hospitalizations are more frequent 
with increasing age, tetraplegia and the occurrence of comorbidities (7).  
From an economic point of view, individuals with SCI and respiratory 
complications have a significantly longer length of hospital stay compared to 
patients without respiratory complications (40.7 vs 12.8 days) (8). The number 
of respiratory complications experienced during the initial acute-care 
hospitalization is a more important determinant for length of stay and hospital 
costs than the level of injury in individuals with tetraplegia (9). 
To our knowledge, there are three studies on predictors of pneumonia in the SCI 
population (8, 10, 11). Two of these studies concentrated on factors of injury and 
shock severity (10) or identified the level and completeness of injury as the 
fundamental clinical entity predicting respiratory complications (8). However, 
both studies did not investigate potentially modifiable factors. The third study 
focused on potentially modifiable factors, such as lung function but did not cover 
respiratory muscle strength and did not define the inclusion of respiratory 
complications precisely (11). The purpose of this study was therefore to 
investigate, if respiratory function, measured at an arbitrary point in time after 
onset of the SCI, can be used as a discriminator for pneumonia. We hypothesize, 
that respiratory function parameters are able to discriminate between individuals 








Design and setting 
A retrospective cohort study was performed in a single SCI rehabilitation center.  
The study had been approved by the competent ethics committee. We certify 
that all applicable institutional and governmental regulations concerning the 
ethical use of data of human volunteers were followed during the course of this 
research. 
All patients in our center get informed about the potential retrospective use of 
their medical or personal data for research purposes in written form. All patients 
who reject the use of their medical or personal data for research purposes have 
been excluded for this research project. 
 
Study population 
Male and female patients with a primary diagnosis of traumatic SCI, American 
Spinal Injury Association Impairment Scale (AIS) A-D, motor level between C3-
T12 and aged 18 years or older were included. All  
data on pneumonia events, respiratory function and personal or lesion 
characteristics were collected from the medical records.  
Patients with progressive neurological diseases such as multiple sclerosis or 
amyotrophic lateral sclerosis were excluded as well as patients with mental 
disorders, acute or chronic respiratory diseases (except pneumonia), respiratory 
co-morbidities like sleep apnea and atelectasis, bronchodilators or any other 
medication that could have influenced respiration at the time of assessment. If 
patients in our center suffer from respiratory problems like atelectasis or 
increased secretion, mechanical in-/exsufflation and chest physiotherapy will be 













Individuals who had suffered pneumonia from January 2010 to July 2014 were 
identified using the ICD-10 database of our center (Chapter X, Code J09 to 
J18.9). The following respiratory function data of subjects fulfilling the inclusion 
criteria were collected from the personal medical records: forced vital capacity 
(FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), 
maximal inspiratory and expiratory muscle pressures (PImax, PEmax). Since we 
hypothesize that pneumonia can influence the respiratory function parameters, 
no data were collected during the existence of pneumonia. The respiratory 
function data for subjects without pneumonia were extracted from the encrypted 
lung function database of our center. These data were filtered according to the 
inclusion and exclusion criteria.  
 
Statistical analysis 
Demographic data are presented as mean (standard deviation) and median 
(25% and 75% quartile) or frequency (12). Respiratory function parameters were 
calculated as mean (standard deviation). Normal distribution of the demographic 
data was tested using QQ-plots. Depending on the distribution of the data, an 
independent t-test or a Mann-Whitney U test was used to investigate group 
differences. 
Subjects were divided into two groups: 1) SCI subjects with no diagnosis of 
pneumonia and 2) SCI subjects with the diagnosis of pneumonia. The cohort 
was further sub-divided into subjects with motor complete (AIS A/B) and subjects 
with motor incomplete lesions (AIS C/D). Receiver operating characteristic 
(ROC) curves were calculated for evaluating the classification accuracy of the 
respiratory function variables for pneumonia. Individuals with motor complete 
and incomplete SCI were analyzed separately. For the individuals with motor 
complete SCI, all analyses were performed using the relative respiratory function 
values (percent predicted according to personal and lesion characteristics) (13). 
Using lesion specific relative values of respiratory function is much more 
sensitive in this population. The lower the lesion level the more respiratory 





function than gender, age etc. in individuals with motor complete SCI (14). For 
the individuals with motor incomplete SCI, the absolute values were used for 
analysis because no lesion specific prediction equations are available for this 
group of subjects. 
The odds ratios, the likelihood ratios (LR+/LR-) and the positive and negative 
predictive values (PPV/NPV) regarding the presence or absence of pneumonia 
were calculated for the discriminators with the largest AUC. The ‘pneumonia risk 
threshold’ values for the best discriminators were determined by choosing the 
point with the lowest false positive and negative rate on the ROC.  
Statistical significance was set at alpha ≤ 0.050. All statistical analyses were 
performed using SPSS (Version 18.0.3, IBM, Somers, NY, USA).   
 
Results 
Overall, 110 subjects with pneumonia and 237 without pneumonia were 
identified. From those subjects with pneumonia 40 were excluded due to the 
following reasons: In 11 cases invalid respiratory function measurements were 
available, 17 were diagnosed with progressive neurological diseases or chronic 
respiratory diseases, 10 did not fulfill the inclusion criteria (age and lesion level) 
and 2 had refused the retrospective use of their data. In total, 307 subjects were 
analyzed, 70 subjects (23%) with pneumonia and 237 (77%) without pneumonia. 
The demographic data are presented in Table 1.  





Characteristics of participants 
  
Characteristics Individuals with 
Pneumonia (n= 70) 
Individuals without 
Pneumonia (n= 237) 
p-
value 
Male, n (%) 







Age AIS A/B, mean ± 
SD  
52.8 ± 15.2 46.0 ± 13.9 .01† 
Age AIS A/B, median 
(IQR)  
Age AIS C/D, mean ± 
SD  
















Time post-injury AIS 
A/B, mean ± SD  
Time post-injury AIS 
A/B, median (IQR)  
Time post-injury AIS 
C/D, mean ± SD  
Time post-injury AIS 
C/D, median (IQR)  





Height, mean ± SD cm 
Height, median (IQR) 
cm 
Weight, mean ± SD kg 
Weight, median (IQR) 
kg 













175.3 ± 9.0 
174.5 (170.0-182.0) 
 
72.2 ± 14.7 
68.0 (64.0-83.3) 













175.1 ± 9.2 
175.0 (169.0-180.0) 
 




















All data belong to the date of the lung function measurement. n= 307. 
† Independent t test; ‡ Mann-Whitney U test; AIS= American Spinal Injury 







Subjects with motor complete lesions (AIS A/B) 
In the motor complete sub-group (AIS A/B), the relative PImax was the best 
discriminator between individuals with and without pneumonia (AUC 0.86; 95% 
CI: 0.78-0.93; p-value < 0.001) (Figure 1, Table 2). For the relative PImax, a 
pneumonia risk threshold value of 115% of the lesion specific reference value 
was identified with a sensitivity of 74.4% and a specificity of 83.4% (indicated as 
arrow in Figure 1). This means that the inspiratory strength needs to be 15% 
higher than the lesion specific reference value. The odds of pneumonia in 
individuals with motor complete SCI and a relative PImax value below 115% were 
16.1 (95% CI: 7.2-36.0; p-value < 0.001) times the odds in individuals with 
relative PImax values equal and above 115%. In subjects with a PImax value below 
115%, the probability to suffer a pneumonia is 50% (PPV). In contrast to subjects 
with a PImax value above 115%, the probability not to suffer a pneumonia is 94% 
(NPV). The PPV represents the proportion of patients with positive test results 
who were correctly diagnosed (true positives divided by all positives), and the 
NPV represents the proportion of patients with negative test results who were 
correctly diagnosed (true negatives divided by all negatives (15). The likelihood 
ratio includes both sensitivity and specificity and provides an estimate of how 
much a test result will change the odds of having a condition (15). The likelihood 
of the patients having a pneumonia has increased 4.6-fold given a PImax below 
115%. Conversely, the likelihood of having a pneumonia is decreased 0.29-fold 
given a PImax above 115% (15). The ROC curves and AUC results for all other 

















Results of the receiver operating characteristics analysis for all assessed 














AIS A/B (n= 232)    
FVC (%) 0.71 <.001 0.62-0.80 
FEV1 (%) 0.64 .006 0.53-0.75 
PEF (%) 0.58 .13 0.46-0.69 
PImax (%) 0.86 <.001 0.78-0.93 
PEmax (%) 0.49 .90 0.38-0.61 
AIS C/D (n= 63)    
FVC (L) 0.74 .002 0.61-0.87 
FEV1 (L) 0.99 <.001 0.98-1.00 
PEF (L/s) 0.93 <.001 0.83-1.00 
PImax (cmH2O) 1.00 <.001 1.00-1.00 
PEmax (cmH2O) 0.97 <.001 0.92-1.00 
AIS= American Spinal Injury Association Impairment Scale 
FVC= forced vital capacity; FEV1= forced expiratory volume on one second; PEF= peak 
expiratory flow 







Figure 1  
Receiver operating characteristics curves for respiratory function parameters as 
discriminators for pneumonia in individuals with motor complete SCI (AIS A/B). 
 
The comparison between individuals with and without pneumonia concerning 
lung function and respiratory muscle strength are presented in Figure 3a and 3b, 
respectively. A significant difference between motor complete SCI individuals 
with and those without pneumonia was observed for relative FVC (p < 0.001), 
relative FEV1 (p = 0.02) and relative PImax (p < 0.001). 
 
Subjects with motor incomplete lesions (AIS C/D) 
For individuals with motor incomplete SCI (AIS C/D), PImax was also the best 
discriminator between individuals with and without pneumonia (AUC 1.00; 95% 
CI: 1.00-1.00; p-value < 0.001) (Figure 2, Table 2). A PImax risk threshold value 
of 93.5cmH2O was identified for individuals with AIS C/D lesions (sensitivity of 





100%, specificity of 100%). The perfect discrimination between subjects with and 
those without pneumonia and consequently, the false negative rate of 0, made 
the odds ratio calculation for PImax impossible. The ROC curves and AUC results 
for all other analyzed parameters are presented in Figure 1 and Table 2. 
Additionally to the PImax also the expiratory parameters FEV1, PEF and PEmax 
were excellent discriminators between individuals with and without pneumonia. 
The risk threshold values were 3.1L for FEV1 (sensitivity of 96%, specificity of 
100%), 7.0L/s for PEF (sensitivity of 86%, specificity of 100%) and 83.5cmH2O 
for PEmax (sensitivity of 91%, specificity of 100%). The comparison between 
individuals with and those without pneumonia concerning lung function and 
respiratory muscle strength are presented in Figure 3c and 3d, respectively. A 
significant difference between individuals with and those without pneumonia was 
observed for all respiratory function parameters, namely FVC (p < 0.001), FEV1 


























A: Comparison of relative (% predicted for SCI) respiratory function parameter 
values (FVC, FEV1, PEF) between motor complete SCI (AIS A/B) individuals with 
and those without pneumonia. 
B: Comparison of relative (% predicted for SCI) respiratory muscle strength 
parameter values (PImax and PEmax) between motor complete SCI (AIS A/B) 
individuals with and those without pneumonia. 





C: Comparison of absolute respiratory function parameter values (FVC, FEV1, 
PEF) between motor incomplete SCI (AIS C/D) individuals with and those without 
pneumonia. 
D: Comparison of absolute respiratory muscle strength parameter values (PImax 
and PEmax) between motor incomplete SCI (AIS C/D) individuals with and those 
without pneumonia. 
Bottoms and tops of boxes are the first and third quartiles, and the horizontal line 
represents the median. Whiskers denote the lowest and the highest data points 
that are still within 1.5x the interquartile range from the lower and the upper 










Figure 3  
Receiver operating characteristics curves for respiratory function parameters as 
discriminators pneumonia in individuals with motor incomplete SCI (AIS C/D). 
 
Discussion 
Maximal inspiratory pressure was found to be the best parameter to discriminate 
between SCI individuals with and those without pneumonia independent of injury 
severity. A PImax threshold value of 115% of the lesion specific reference value 
in motor complete individuals and 93.5cmH2O in motor incomplete individuals 
were identified. 
In individuals with AIS C/D lesions, also the expiratory parameters FEV1, PEF 
and PEmax were excellent discriminators between individuals with and those 
without pneumonia. 





Characteristics of participants  
The 23% pneumonia rate in our representative sample lies in the middle of the 
reported range of 3%-50% in the literature (8, 10, 16-19). In the motor complete 
sub-group, individuals without pneumonia were significantly younger than those 
with pneumonia. This confirms the findings of earlier studies, that the younger 
the patients are, the less prone they are to respiratory complications (20, 21). 
Individuals with motor incomplete SCI seem to suffer a pneumonia significantly 
earlier after injury compared to individuals with motor complete SCI (Table 1). 
However, the respiratory function tests in individuals with motor incomplete 
lesions were mainly performed during inpatient rehabilitation and therefore 
results of this group are only valid for subjects up to 6 months post injury. In 
individuals with motor complete SCI the respiratory functions tests ranged from 
the acute phase till years after inpatient rehabilitation. In the chronic phase of 
SCI, time post injury does not seem to have a significant association with 
respiratory complications (22, 23). 
 
Subjects with motor complete lesions (AIS A/B) 
As an example, the calculated absolute PImax value of an average motor 
complete subject from our sample (Table 1) with a lesion level C6-C8 is about 
78cmH2O (13). Therefore, the relative PImax risk threshold value of 115% of the 
lesion specific reference value in individuals with motor complete SCI seems to 
be greater in comparison to the values in preceding investigations (51cmH2O – 
66cmH2O) (23-25). In subjects who suffered from pneumonia, inspiratory 
strength was significantly lower than in individuals without pneumonia (Figure 
3b). However, expiratory strength did not differ between individuals with motor 
complete SCI and pneumonia and those without pneumonia (Figure 3b). 
Complete lesions of the spinal cord are accompanied by paralysis of the 
abdominal muscles and therefore the mainly passive process of expiration 
cannot be augmented by a forceful contraction of the abdominal muscles (26). 
However, inspiratory muscle strength may be even more important for an 
effective cough than expiratory muscle strength because stronger inspiratory 
muscles can cause a greater pre-cough inspiratory capacity (25). Weak 





restricted production and distribution of the substance `surfactant` in the lungs. 
Consequently, the peripheral airways can collapse (27). Therefore, inspiratory 
muscle pressure may be an important factor in the development of pneumonia. 
 
Subjects with motor incomplete lesions (AIS C/D) 
In the group with motor incomplete SCI, PImax was also identified as the best 
discriminator between individuals with and those without pneumonia with a 
sensitivity and specificity of 100%. This means that all subjects who suffered 
from pneumonia had a PImax value below 93.5cmH2O. Furthermore, FEV1, PEF 
and PEmax seem to be excellent discriminators between individuals with and 
those without pneumonia in individuals with motor incomplete SCI. Merely, FVC 
was a poor discriminator. This may have resulted from including subjects with 
decreased abdominal muscle and pelvic floor muscle tone, in whom the effect of 
gravity on the diaphragm cannot be compensated in the sitting position. The 
abdominal muscles in general are regarded as expiratory muscles although they 
also mechanically support the movement of inspiration by the diaphragm (28). 
The inspiratory and the expiratory muscle strength was significantly higher in 
subjects who had no pneumonia compared to those with pneumonia (Figure 3d). 
The constant expiratory strength in those with pneumonia is in contrast to the 
results of the motor complete SCI individuals and may be explained by the 
maintained coordinated action of innervated expiratory muscles (14). 
In contrast to the motor complete SCI individuals, PEF was a good discriminator 
in motor incomplete SCI individuals. The absolute PEF values in incomplete SCI 
individuals with no pneumonia and those with pneumonia were 8.3L/s and 
4.7L/s, respectively (p < 0.001) (Figure 3c). At least 5-6L for PEF are necessary 
to produce an effective cough (29) and a minimum flow of 2.7L/s is essential to 
clear secretions (30) and to prevent from respiratory complications (31). 
 
Clinical Relevance 
The risk threshold values reported in this paper can be used to identify patients 
at increased risk of pneumonia. Patients with PImax values below the risk 
threshold values are recommended to train their inspiratory muscle strength to 
prevent pneumonia. Inspiratory muscle training is effective and is able to 





increase PImax by 10-25% (32). At the beginning of an active rehabilitation, 
individuals with motor complete tetraplegia only achieve approximately 
50cmH2O PImax on average whereas those with motor complete paraplegia can 
achieve approximately 70cmH2O PImax on average (33). Over time PImax can 
increase by approximately 20cmH2O until one year after starting inpatient 
rehabilitation (33). This training potential should be utilized to attain the high 
threshold values for PImax in order to reduce the risk of pneumonia. An intensive 
respiratory muscle training should start early after the injury and be a routine part 
of the initial rehabilitation program and also during lifelong follow-up care in 
individuals with SCI.  
Based on our results, inspiratory muscle training for SCI patients with PImax 
values above the risk threshold values does not seem to be necessary for 
pulmonary rehabilitation. Maximal inspiratory pressure can be measured easily, 
quickly and at low costs. Unfortunately, no guidelines exist regarding the 
frequency of lung function tests. Nonetheless, respiratory function should be 
assessed regularly for clinical monitoring (19), which may also motivate patients 
for respiratory muscle training. In addition to PImax measurements also PEF, 
FEV1 or PEmax can be used as reliable discriminators for individuals with 
incomplete SCI.  
 
Limitations 
This study was performed retrospectively. As a result, timing of respiratory 
function tests varied widely. Even with this temporal variation, the PImax 
parameter stands out as best discriminator between those with and those without 
pneumonia. 
Further, we do not have any details on the type of pneumonia as well as 
hospitalizations due to pneumonia and mortality. Using the ICD-10 code to 
identify patients with pneumonia may introduce selection bias. In our study, an 
independent person identified individuals with pneumonia using the ICD-10 
database of our center. 
Future research is needed to strengthen our current results from this 
retrospective analysis or to identify other modifiable predictors of pneumonia 





performed to confirm or precise the results of this analysis and also to assess 
the type of pneumonia as well as hospitalizations and mortality.  
Conclusion 
Maximal inspiratory pressure is the best discriminator between SCI individuals 
with and those without pneumonia. Therefore, individuals with PImax values below 
the reported threshold values may be at increased risk of pneumonia. In patients 
with motor complete lesions and PImax values below the threshold values, 
inspiratory muscle training should be promoted in clinical practice to reduce the 
risk of pneumonia. In patients with motor incomplete lesions and accordingly 
completely or partly maintained expiratory muscle innervation, inspiratory as well 
as expiratory muscle training is recommended.  
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Objectives Pneumonia is one of the leading complications and causes of death 
after a spinal cord injury (SCI). After a cervical or thoracic lesion, impairment of 
the respiratory muscles decreases respiratory function, which increases the risk 
of respiratory complications. Pneumonia substantially reduces patient’s quality 
of life, prolong inpatient rehabilitation time, increase health care costs, or at 
worse, lead to early death. Respiratory function and coughing can be improved 
through various interventions after SCI, but the available evidence as to which 
as aspect of respiratory care should be optimized is inconclusive. Further, ability 
of respiratory function parameters to predict pneumonia risk is insufficiently 
established. This paper details the protocol for a large-scale, multicenter 
research project that aims to evaluate the ability of parameters of respiratory 
function to predict and understand variation in inpatient risk of pneumonia in SCI. 
 
Methods RESCOM (for RESpiratory COMplications), a prospective cohort 
study, began recruitment in October 2016 across 10 SCI rehabilitation centers 
from Australia, Austria, Germany, the Netherlands and Switzerland. In-patients 
with acute SCI, with complete or incomplete cervical or thoracic lesions, 18 years 
or older and not/no more dependent on 24-hour mechanical ventilation within the 
first three months post injury are eligible for inclusion. The target sample size is 
500 participants. The primary outcome is an occurance of pneumonia; 
secondary outcomes include pneumonia-related mortality and quality of life. We 
will use the longitudinal data for prognostic models on inpatient pneumonia risk-
factors. 
 
Conclusions RESCOM is the first multinational study to prospectively evaluate 
predictors of pneumonia from a representative sample of persons with SCI 
receiving inpatient rehabilitation in a high-income setting. This study will provide 
insight whether the improvement of respiratory muscle strength and respiratory 
function represent promising targets for intervention to reduce pneumonia risk 
following spinal cord injury. 
 






Strengths and limitations of this study 
 
• RESCOM (for RESpiratory COMplications) is the first multinational study 
to prospectively evaluate predictors of pneumonia from a representative 
sample of persons with spinal cord injury (SCI) receiving inpatient 
rehabilitation in a high-income setting.  
 
• The RESCOM cohort will enroll 500 persons with SCI to develop 
generalizable prognostic models as well as to validate causal risk 
factors, specifically impaired respiratory function, of pneumonia risk. 
 
• Because respiratory function following SCI may be improved through 
respiratory muscle training, study results may inform and improve 
current clinical practice and patient management through the better 
targeting of interventions. 
 
• Generalizability of the study with respect to pneumonia risk is limited to 
patients with less than 24 hours of mechanical ventilation within the first 
three months post injury, because respiratory function cannot be 
measured using standard techniques in those who are intubated.  
 
• This study will provide insight whether the improvement of respiratory 
muscle strength and respiratory function represent promising targets for 







Pneumonia is a leading complication and cause of death after a spinal cord injury 
(SCI), even in high income countries (1, 2). In newly injured patients, pneumonia 
may substantially complicate and lengthen the period of first rehabilitation, while 
community dwelling persons living with SCI are commonly re-hospitalized for 
pneumonia over extended periods that frequently involve intensive care (3, 4). 
Contemporary health care policy and patient management aims to improve 
health-related quality of life and life expectancy in the SCI community as well as 
to reduce infection-related health care costs. Reducing the incidence of 
pneumonia is therefore a major objective. Critical to this goal is that 1) persons 
with an elevated risk of pneumonia can be identified early (prediction), 2) 
modifiable risk factors are known (causality) and readily measurable, and 3) 
effective interventions targeting key risk factors are established. Unfortunately, 
however, the contemporary evidence base regarding risk groups and modifiable 
risk factors of pneumonia in SCI, and subsequent effective intervention 
strategies, remain scant (5-8). Most existing studies evaluating between-person 
differences in risk of pulmonary complications assessed non-modifiable factors 
only; demographics (sex, age), injury severity (level, completeness) or spinal 
shock severity (5, 6, 8). Only one recent study investigated modifiable risk factors 
for pneumonia, i.e. steroid administration, which may be helpful to maintain 
muscle mass and strength but may also cause other relevant side-effects (9). 
Impairment of respiratory function represents the most promising target for 
clinically relevant research on pneumonia in SCI, as these measures are directly 
linked to the neurological impairment and appear to be modifiable through 
targeted respiratory training (10-12). Respiratory muscles below the level of 
injury may become paralyzed or impaired (13) and respiratory function is 
compromised with higher levels of injury causing greater impairment (10, 14). 
Cough impairment is also considered critically important, as insufficient removal 
of airway secretions may result in the development of mucus plugging and 
complications such as atelectasis or pneumonia (15, 16). Effective coughing 
comprises an inspiration, compression and expulsion phase. Cough impairment 




following SCI may affect each phase due to the weakening of inspiratory and 
expiratory muscle function, which may decrease the maximum volume of 
expelled air by restricting both the maximum inspiratory volume prior to 
contraction as well as a reduction in the amount able to be expelled (15, 17). The 
limited evidence in SCI suggests that inspiratory (using maximal inspiratory 
muscle pressure; PImax) rather than expiratory function (maximal expiratory 
muscle pressure; PEmax) is the prime determinant of cough capacity (peak flow), 
particularly in patients with a motor-complete cervical SCI (18). Postma et al. 
found that impaired pulmonary function may increase respiratory infections at 
one year after SCI, but their study did incorporate respiratory muscle 
strengthening and respiratory complications were incompletely assessed (7). 
To the best of our knowledge, there is currently no comprehensive database 
available for the further development of generalizable prognostic models, nor to 
improve causal inference of pneumonia risk in light of impairment in respiratory 
function. The multicenter and multinational cohort study RESCOM aims to 
establish such an evidence base in SCI. We believe RESCOM will thereby 
improve clinical practice through better targeting of interventions during the 
inpatient setting in high-income countries. 
 
Methods 
Design and setting 
RESCOM is a prospective international, multi-center cohort study in high-income 
countries. Data collection commenced in October 2016 across 10 specialized 
rehabilitation centers for SCI from Austria (2 centers), Australia (1 center), 
Germany (1 center), The Netherlands (2 centers) and Switzerland (4 centers) 










Newly injured persons who are aged 18 years or older, admitted for inpatient 
rehabilitation in the participating centers, with complete or incomplete lesions 
(grades A-D on the American Spinal Injury Association Impairment Scale (AIS) 
(19) and cervical or thoracic lesion levels (right and left motor level between C1- 
T12). Persons with severe pre-existing scoliosis, progressive neurological 
diseases, 24h mechanical ventilation dependency until more than 3 months post 
injury or severe mental disorders are excluded. 
 
Sample Size 
For the analysis of pneumonia risk we estimated, over a conservative range of 
pneumonia event probabilities from 0.1 to 0.2, the minimal sample size needed 
to detect a plausible hazard ratio (effect size of interest) of 1.7 or more for 
inspiratory muscle strength (principal predictor variable) (20). Using a 
conventional power of 0.8 and significance level of 0.05, this analysis indicated 
a sample size of 500 as adequate for the purpose of the present study. 
 
Procedures 
The measurement schedule of RESCOM includes up to four measurement time-
points (T1-T4) during the inpatient rehabilitation period (Figure 1). Following start 
of rehabilitation, newly injured patients are contacted for recruitment at about 4 
weeks (T1) or at 12 weeks (T2) if the first six or more weeks following injury were 
spend on the ICU or in a general hospital for acute care. Subsequent 
assessments are planned at 24 weeks (T3) and at discharge to the community 
(T4). The T4 timepoint may precede and replace T2 and/or T3 in patients with a 
shorter length of inpatient rehabilitation stay. Temporal start and length of 
inpatient stay for rehabilitation varies with injury severity, general health status 
of patients and between countries and clinics. As such, between two and four 
measurement time-points are anticipated across patients, with those with more 
severe lesions and the longest length of stay providing more time points. In the 
four Swiss centers RESCOM is run as a “nested project” of the Swiss Spinal 
Cord Injury (SwiSCI) cohort study (www.swisci.ch) (20). The temporal schedule 
of data collection of RESCOM is aligned to that of SwiSCI and the relevant data 




for RESCOM will be extracted from the SwiSCI database additionally to 





Time frames for measurements (T1 toT4) during inpatient rehabilitation.  
 
Quality control 
Each of the participating centers has one or two responsible study nurses. Before 
the start of recruitment, a study nurse meeting in the Swiss Paraplegic Centre 
Nottwil was performed to train all study nurses for the procedures and the 
assessments of the study. A study manual has been established to give an 
overview of the procedures and all assessed variables. A frequently asked 
question sheet is available in the study specific database (secuTrial®, iAS, Berlin, 
Germany) with all relevant questions the study nurses asked during data 
collection. For quality control of data assessment, regular central (database 
secuTrial®) and one local monitoring visit in each of the participating centers are 
performed. The coordinating study center supports one central study coordinator 
who is responsible for central and local monitoring as well as for support of the 
local study nurses for questions concerning patient inclusion, data collection and 
entry into the database. 
 
Parameters assessed 
Primary outcome  
The occurrence of pneumonia is the primary outcome of RESCOM, observed 
continuously during the whole risk period of interest from time of injury until the 
end of inpatient rehabilitation. Medical records of inpatients are screened for 





admission to the rehabilitation center. Pneumonia is classified by type and 
cause, and the date of onset and duration of each event is recorded. Pneumonia 
is clinically diagnosed using the criteria described in the pneumonia flow diagram 
as endorsed by the Center for Disease Control and Prevention (CDC) (21). 
Mortality is defined as pneumonia-related, if pneumonia was clinically recorded 
as the initiating cause of events leading to death. Other causes of death are 
similarly classified.  
 
Participant characteristics 
All participant characteristics are obtained from medical records. Basic 
characteristics that are collected at T1 include gender, age, height, cause of SCI 
(traumatic or non-traumatic) and smoking history. Parameters that may 
temporally vary, including body weight, motor lesion level and American Spinal 
Injury Association Impairment Scale (AIS), medication, frequency of defecation 
as well as medical complications are assessed on all available measurement 
time-points. At T4, the actual smoking status and ICD-10 coded co-morbidities 
are recorded additionally. 
 
Additional parameters 
Additional parameters assessed at all measurement time-points, i.e. up to four 
times per participant (further details on these measurements and questionnaires 
are given below): 
- Measurement of respiratory muscle strength and lung function 
- ISCoS Pulmonary function data set (22)  
- Quantitative questionnaire on physical exercise training 
- Quantitative questionnaire on respiratory therapy and respiratory muscle 
training 
- Bogenhausener Dysphagia score (BODS) 
- ISCoS Quality of Life questionnaire (23)  
- COVID-19 assessment form 
 
 




Measurement of respiratory function 
Measurement of respiratory function consists of respiratory muscle strength 
(maximal inspiratory pressure (PImax) and maximal expiratory pressure (PEmax)) 
and lung function with forced vital capacity (FVC), forced expiratory volume in 1s 
(FEV1), peak expiratory flow (PEF) and peak cough flow (PCF). All 
measurements are performed at the same day according to the ATS/ERS 
guidelines (24) in a sitting position either in the participant’s own wheelchair or 
on a chair in participants that are able to walk. To derive a reliable estimate of 
the highest value for each parameter, each measurement is repeated until the 
three highest values of a given parameter are within a 20% range. The highest 
value of each parameter is retained for further analysis (25). 
 
Measurement of respiratory muscle strength and lung function have been 
harmonized across the 10 centers using identical equipment. PImax and PEmax 
are measured using a hand-held respiratory pressure meter (Micro RPM, Micro 
Medical, Hoechberg, Germany). The PImax measurement is derived from residual 
volume and PEmax from total lung capacity, against the occluded one-way valve 
of the respiratory pressure meter with the pressure maintained for at least one 
second. To derive the maximum pressure over a one second period, the patient 
is instructed to maintain in- and expiratory pressure for at least 1.5 seconds (26). 
Abdominal binders are removed prior to any measurement of respiratory function 
(27). 
  
The FVC is the total volume of air the participant is able to exhale after a maximal 
inspiration. The FEV1 is the total volume of air that has been exhaled at the end 
of the first second of maximal forced expiration. PEF is the maximum flow of air 
achieved during the maximum expiratory flow manoeuver (28). During the PCF 
manoeuver the maximum flow of air is measured by having the participant cough 
as forcefully as possible through a peak flow meter. Participants breathe through 
a mouthpiece while wearing a nose clip. Across study centers, lung function 
parameters are measured accordingly, but using three different brands of 
portable spirometer, including Micro Loop® (Care Fusion, Basingstoke, UK; all 





Melbourne, Australia; Australian center), Masterscreen PFT Pro® (Care Fusion, 
Hoechberg Germany; one Austrian center) and  Vitalograph® (Ennis, Ireland; one 
Austrian center).  
 
ISCoS Pulmonary function data set  
The ISCoS Pulmonary function data set (22) consists of questions on pulmonary 
complications (asthma, chronic obstructive pulmonary disease, sleep apnea and 
others) before and after SCI, smoking history, current utilization of pulmonary 
assistance and lung function measurement.  
 
Questionnaires on physical exercise and respiratory muscle training as well as 
on respiratory therapy  
The questionnaires on individual respiratory muscle training, regular physical 
exercise and therapy are kept as simple as possible. Only quantitative or yes/no 
questions on physical activities performed during the last seven days are asked. 
Physical activity, duration of sport activities as well as number of physiotherapy 
sessions per week are recorded. Respiratory therapies such as mobilisation of 
secretions, manual blowing or air stacking and in-/exsufflation are assessed on 
a yes/no basis and if yes, whether with or without manual cough assistance. 
Respiratory muscle training is assessed separately for in- and expiratory muscle 
strength training as well as respiratory muscle endurance training (i.e. isocapnic 
hyperpnoea). In case of training, the name of the device, the number of training 
sessions per week, the number of repetitions per session as well as the 
resistance is noted. 
 
Bogenhausener Dysphagia score (BODS) 
Dysphagia is assessed using the Bogenhausener Dysphagia score (BODS), 
which consist of two scales, each with a score from 1 to 8, resulting in a sum-
score of 2 to 16. The first scale quantifies swallowing of saliva and whether the 
patient has a tracheal cannula. For patients with tracheal cannula, the degree of 
blocking is quantified as fully, partly or mainly not blocked. The second scale 
quantifies problems with oral ingestion including four of the eight scores for 




parenteral nutrition. The BODS is assessed by a speech therapist or a 
physiotherapist, in close coordination with the RESCOM study nurse.  
 
ISCoS quality of life questionnaire 
Quality of Life (QoL) is evaluated using the ISCoS QoL questionnaire (23). This 
measurement instrument accepts a multi-facetted concept and includes three 
questions that capture general QoL (overall well-being), rating of physical health, 
and satisfaction with psychological health.  
 
COVID-19 assessment form 
At the start of the COVID-19 pandemic (March 2020) we implemented an 
additional form into the study database and instructed all study nurses of each 
participating center to additionally fill in this form for the already included and 
future patients. Since COVID-19 infections are often leading to severe 
pneumonia and probably also death, we identified this as a potential confounder 
of our study results and therefore have to include this infection into our analysis. 
The COVID-19 form includes information on diagnosis, date of diagnosis, 
symptoms and death due to COVID-19. 
 
Database secuTrial® 
To enable secure capture and management of RESCOM data, the professional 
and web-browser based database system secuTrial® is used. SecuTrial® fulfills 
the minimal requirements for data storage and management indicated in the 
ICG-GCP guidelines and also supports the central monitoring of data collection 
across all participating centers. Database set-up, personal accounts with pre-
defined roles for all study collaborators as well as support, data export and 
archiving is provided by a study-independent database manager from the study-
center in Nottwil, Switzerland. 
 
Methods of minimizing bias 
Study participants receive an introduction for the study procedure by the local 





study specific tasks. A standardized study protocol was defined to minimize 
attrition bias. 
The coding of the participants is conducted by the study nurses of each site in 
order to keep the data management and the biostatistician blinded (de-identified 
at source). The coding list remains with the study nurses of each site for the 
whole duration of the study and archiving period. Thus, coding is conducted 
without any influence of the principal investigator, the data manager or 
biostatistician. The study investigators strive for complete separation of the 
persons involved in the steps of enrolment and data collection from those 
involved in the data management and analysis. 
All assessments are conducted and entered into the study database by the 
trained study nurse(s) of each participating center.  
 
Patient and Public Involvement 
No patients or public have been directly involved in the planning or conduct of 
this study. Study results will be disseminated to the scientific community through 
peer-reviewed journals and conference presentations, to the SCI community, 
other stakeholders and via social media, newsletters and engagement activities. 
 
Statistics 
Statistical analysis will involve basic descriptive statistics and multivariable 
regression analyses that take into account the longitudinal and multilevel 
structure of the data. A global overview of the multivariable data analysis plan 
for investigating the association between respiratory function and pneumonia is 
given in Figure 2. To evaluate variation in pneumonia risk, time-to-event analysis 
techniques (e.g., flexible parametric survival modeling) will be employed, taking 
date of injury as the starting point of the risk period. Regression models targeting 
causal inference will make use of time-updated information for all variables in 
accordance with the repeated measurement schedule of RESCOM, while 
controlling for between-person and between-center sources of variance using 
random and fixed effects. The exposure 'respiratory function' will be 
operationalized using parameters of respiratory muscle strength and parameters 
of lung function, as a latent construct within generalized latent variable modeling 




or as individual parameters in selected analysis as required (29). Critical 
confounders that have been defined using evidence from the literature and 
expert opinion of RESCOM collaborators include age, lesion severity, time since 
injury (structurally captured in time-to-event modelling), artificial ventilation and 
medication. Models targeting prognosis of pneumonia during first rehabilitation 
will only include parameters of respiratory function that have been collected at 






Global scheme of the planned data analysis investigating the dynamic 
association between respiratory function and pneumonia. In regression 
modelling all variables will be time-updated in accordance with the repeated 
measurement schedule of RESCOM and controlling for between-person and 
between-center sources of variance. Respiratory function is operationalized 








Strengths and limitations 
RESCOM is the first prospective, international study that reports modifiable 
predictors of pneumonia from a representative sample of persons with SCI 
during inpatient rehabilitation. Its comprehensive evidence base facilitates the 
systematic evaluation of the discriminatory power of respiratory function 
parameters for pneumonia risk in high-income countries.    
The RESCOM study is effective in recruiting a representative sample of 
inpatients with a motor complete or incomplete SCI in Austria, Australia, 
Germany, The Netherlands and Switzerland. The anticipated minimal sample 
size of 500 should provide project sufficient statistical power to answer the key 
hypothesis that respiratory function, and PImax in particular, is a strong prognostic 
parameter that quantifies clinical pneumonia risk in SCI. The longitudinal, 
international design of this project is considered a further strength; participants 
can be observed during the whole period of inpatient rehabilitation in different 
countries. Various factors like a central web-based  database, a study nurse 
meeting, a comprehensive study manual and regular monitoring were 
implemented to ensure the standardization of the measurements and data and 
thus to keep quality of the project in the 10 centers as high as possible. 
 
For data collection we used the International SCI Core Data Set, (32, 33) the 
International SCI QoL Basic Data Set (23) and the International SCI Pulmonary 
Function Data Set (22) which are developed to provide global data standards for 
SCI clinical research. The advantage of using these standardized data sets is to 
increase the data quality and to facilitate data sharing. 
Potential limitations include the observational nature of the project which limits 
causal inference even within a prospective study design. Although the RESCOM 
sample reflects the composition of the source population quite well, we cannot 
exclude potential selection bias and therefore, the results of the RESCOM 
project may not be transferable to all persons with SCI. There is a risk that the 
study inclusion and exclusion criteria may miss those patients with a potential 
high risk of pneumonia because those with more severe lesions or more 




complications may not consent to participate in an observational study that may 
not directly increase their outcome. Similarly, patients with a very long stay in the 
intensive care unit (e.g. due to polytrauma) or a very late admission to the 
rehabilitation unit, may miss T2 and therefore no more qualify for study 
participation. Those patients with 24h of mechanical ventilation are excluded 
since respiratory function cannot be measured and also those with other 
languages than used in our study centers are excluded. Another limitation of this 
project is that we do not have a follow-up period after the participants complete 
inpatient rehabilitation.  
 
Conclusion 
In summary, using discriminatory parameters of respiratory function, clinicians 
may identify persons with SCI who are at heightened risk of developing 
pneumonia during inpatient rehabilitation. Thus, interventions can be targeted at 
these persons to reduce pneumonia risk. The RESCOM study is well-positioned 
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Objectives To validate previously developed respiratory function prediction 
models for persons with long-term spinal cord injury (SCI) and if necessary 
develop and validate new models. 
 
Methods Five respiratory function parameters were measured in adults with 
chronic, traumatic, motor complete SCI (C4-T12). First, the models published in 
2012 were validated using Bland-Altman plots. Then, new models were 
calculated using 80% of the dataset by multiple regression analysis with the 
candidate predictors gender, age, height, weight, time post injury (TPI), lesion 
level and smoking. In a third step, the new models were validated using the other 
20% of the dataset by Bland-Altman plots. 
  
Results 613 participants were included. For persons with long-term SCI, the 
2012 models were poorly predictive, especially for respiratory muscle strength 
(R2=0.4). Significant predictors for all respiratory function parameters in the new 
models (R2=0.7-0.8) were lesion level, gender and weight. Small effects on 
single outcome parameters were observed for TPI and age whereas smoking 
had no effect. For the new models the mean differences between measured and 
predicted values for respiratory muscle strength were 4.0±36.0cmH2O and for 
lung function parameters -0.3L (FVC), -0.5L (FEV1)  and 0.5L/s (PEF). 
 
Conclusions We did not find better models for lung function in long-term SCI 
but those for respiratory muscle strength showed better accuracy. 
  





Prediction of respiratory function is an essential component of understanding 
respiratory status in daily clinical practice, but the prediction of respiratory 
function based on able-bodied values has limitations in persons with spinal cord 
injury (SCI). The respiratory function in SCI is reduced due to the partly or 
complete impairment of the respiratory muscles (1, 2). This impairment is 
dependent on the completeness and level of the lesion (3, 4). Immediately after 
the onset of the injury the respiratory function is reduced but during inpatient 
rehabilitation and the first year thereafter the respiratory function can partly 
recover (1, 5-9). At some point this initial improvement turns into a decline (5) 
which exceeds the normal age-related decline (10). This age-related decline in 
able-bodied persons is mainly related to gender and height (11-13). In persons 
with SCI the decline in respiratory function in the first years after rehabilitation 
also appears associated with higher body mass index, lower inspiratory muscle 
strength and declined physical fitness (6, 10, 14). In general, large interpersonal 
differences in changes of respiratory function might be possible (10). The 
intention of this study is to promote regular measurements of the respiratory 
function by spirometry but also give the clinicians an additional tool for better 
individualized interpretation of the measured values. SCI-specific prediction 
models can help identify patients whose respiratory function is below the norm 
(i.e. predicted values) and thus, clinicians can deliver targeted interventions to 
this group of patients. Individual pulmonary diagnostics and therapy are 
therefore central treatment targets to maintain health and quality of life (15).  
In 2012 a reference value calculator was developed to obtain an overview of 
respiratory function status whilst taking into account the spinal cord lesion level 
(15). To develop these initial models, 440 persons were tested of whom 150 
were between six months and two years post injury; a period when lung function 
is known to improve after a SCI. As such, it is unclear whether these models are 
accurate for persons several years post injury. 
Therefore, the aim of this study was to test the accuracy of the 2012 models in 
persons with long-term SCI and if necessary develop and validate new prediction 





models published in 2012 (15) are not sufficiently accurate for long-term injured 




Design and setting 
A multicenter, cross-sectional study with 10 SCI rehabilitation centers was 
performed (The Netherlands (n=8), Australia (n=1), Switzerland (n=1)).  
In the Netherlands, data from the research program “Active Lifestyle 
Rehabilitation Interventions in aging Spinal Cord Injury” (ALLRISC) have been 
used (17). Reporting follows the TRIPOD checklist (18). 
 
Study population 
Inclusion criteria for this study were: long-term SCI (>2 years after injury, median 
20 years) due to trauma, at least 18 years of age, motor complete injury 
(American Spinal Injury Association Impairment Scale (AIS) A and B), right and 
left motor level between C4-T12. Only data from motor complete injured persons 
were analyzed to increase the homogeneity of the sample. 
Persons with acute or chronic respiratory diseases were excluded as well as 
persons with severe scoliosis, progressive neurological diseases, 
bronchodilators or any other medication that could have adversely affected 
respiratory function at the time of assessment. Persons with respiratory failure, 
ventilator or tracheostomy dependency, traumatic brain injury or mental 




The outcome measures were forced vital capacity (FVC), forced expiratory 
volume in one second (FEV1), peak expiratory flow (PEF), maximal inspiratory  
(PImax) and maximal expiratory pressure (PEmax). Gender, age, height (measured 
or asked and not arm span as a surrogate), weight and time post injury (TPI) at 
the time of the respiratory function measurement were recorded. Information on 




smoking history was also collected. Each center entered their anonymized data 
in a centralized study database. In the Swiss center the data were collected from 
November 2002 to June 2018, in the Dutch centers from November 2011 to 
February 2014 and in the Australian center from April 1996 to May 2014. The 
lung function measurements in the Netherlands and in Australia were performed 
for research purposes (19, 20). The lung function measurements in Switzerland 
were performed during clinical practice. Measurements of respiratory function 
were performed only once per participant in all centers by appropriately trained 
personnel according to the ATS/ERS guidelines (21). Participants were sitting 
upright in their own wheelchair and breathed through a mouthpiece while 
wearing a nose clip. Each measurement was repeated until three reproducible 
measurements were registered and the highest value was quoted for further 
analysis. The spirometers for measurement of FVC, FEV1 and PEF were 
calibrated daily. To measure FVC and FEV1, the participants were instructed to 
exhale fully from total lung capacity. The maximum airflow during this forced 
expiration was measured to assess PEF. PImax and PEmax were measured using 
a respiratory pressure meter (Micro RPM, Micro Medical, Hoechberg, Germany). 
For the measurements the participants carried out their maximal in- and 
expiratory maneuvers from residual volume and total lung capacity, respectively 
(22). Abdominal binders were removed for all measurements.  
 
Statistical analyses 
Demographic data are presented as frequency or as median (25% and 75% 
quartile). Depending on the distribution of the data, an independent t-test or a 
Mann-Whitney U test was used to investigate differences between the model- 
and validation sample for all numerical data. Differences between the model- 
and the validation sample of categorical data were compared using chi-square 
tests. Lesion level was treated as a categorical variable with four different lesion  
groups, two for tetraplegia grouped in lesion level C4-C5 and C6-C8 and two for 
paraplegia grouped in lesion level T1-T6 and T6-T12. These lesion level groups 
were built based on the level of innervation of the main respiratory muscles. 





All analysis except the multilevel regression analysis were performed using 
SPSS (Version 18.0.3, IBM, Somers, NY, USA). Statistical significance was set 
at alpha ≤0.05. The multilevel regression analysis were done with the multi-level 
modelling program MLwin (MLwin, version 1.1; Center for Multilevel Modelling, 
Institute for Education, London, UK) (23, 24). 




Flow-chart of the project. 
 
Phase 1– Accuracy of the statistical models published in 2012 
Bland-Altman plots were used (25) to quantify the agreement and to evaluate a 
bias between the predicted values (calculated with the lesion-specific reference 
values published in 2012 (15)) and measured respiratory function values. The 
mean differences between measured and predicted values were assessed 
against their mean and the limits of agreement (mean ± 1.96 standard deviations  
(SD) of the difference). A visual examination of the plot allowed us to evaluate 
the global agreement between the two different methods (25). Adding a 
regression line of the difference and confidence interval limits into the Bland-
Altman plots assisted with describing any proportional difference (25). To test 
how much the measured test scores are spread around the “true” score the 




standard error of measurement (SEM) was calculated. T-tests were performed 
to test for proportional bias in the old models (measured values versus predicted 
values). The ICCs (two-way random, absolute agreement) were calculated to 
determine the correlation between the predicted and measured respiratory 
function value. Values for ICCs indicate the following reliability: less than 0.5 
poor, between 0.5 and 0.75 moderate, between 0.75 and 0.9 good, greater than 
0.9 excellent (26). The ICCs and Bland-Altman tests are appropriate for reliability 
analysis and it is recommended that both are used (27).  
 
Data splitting procedure (preparation for phase 2 and 3) 
The data were split into two samples: (1) a sample to develop the new statistical 
models, the ‘model sample’ (80%) (phase 2) and (2) a sample to cross-validate 
the reliability of the models, the ‘validation sample’ (20%) (phase 3). Random 
numbers were generated and the data split on basis of the order of these 
numbers (model 80% and validation 20%) (28, 29). 
 
Phase 2 - Development of lesion-specific reference models 
For the development of the new lesion-specific reference models we principally 
followed the 2012 statistical procedure but now added the parameter country as 
level. For each of the respiratory function parameters FVC, FEV1, PEF, PImax and 
PEmax one model was developed to determine the relationship of personal and 
lesion characteristics with respiratory function. The hierarchy in the data was as 
follows: individual participants (level 1) who were grouped in the participating 
centers (level 2) and the participating countries (level 3). In order to calculate the 
influence of the lesion level, three dummy variables were used and the lesion 
group T1-T6 with the most participants was defined as reference group. Further 
factors potentially influencing respiratory function, such as gender (male=1,  
female=0), age (years), height (cm), weight (kg), TPI (years) were added to a 
basic univariate multilevel regression equation. Information about smoking 
history (pack-years (years), ever (0=never smoker, 1=ever smoker), former 
(0=no former smoker, 1=former smoker) or current smoker (0=no current 
smoker, 1=current smoker)) were added to the basic univariate multilevel 





included in a subsequent multivariable equation. Model fit was assessed with the 
-2 Log likelihood for the equations. A backward selection procedure was then 
carried out, excluding non-significant determinants (p ≥ 0.05) in order to create 
a final multivariable equation. 
The predictive ability of each of the five models was judged based on the 
adjusted R2 (explained variance) as a statistical measure of accuracy.  
 
Phase 3 - Accuracy of the lesion-specific reference models 
The validation sample was used to test the predictive value of the developed 
models. As in phase 1 of the project the predicted respiratory function values 
(calculated with the new models) were compared with the measured respiratory 
function values. Adding a regression line of the difference and confidence 
interval limits into the Bland-Altman plots assisted with describing any 
proportional difference (25). T-tests were performed to test for proportional bias 
in the new models (measured values versus predicted values). For the graphical 
illustration of the validation also residual plots were used. The SEM and ICCs 
were calculated.  
 
Results 
A total of 613 participants were analyzed; 346 participants (56%) with tetraplegia 
and 267 (44%) with paraplegia. The Swiss rehabilitation center provided data 
from 304 persons, the Dutch 215, and the Australian center 94 persons with long-
term SCI. Demographic data are presented in Table 1. No differences in personal 
and lesion characteristics were found between the model- and the validation 
sample (Table 1). No measurements of respiratory muscle pressures from the 











Characteristics of participants of the whole sample (n= 613), divided into a 




















CH = 247 (50%) 
AUS = 77 (16%) 
NL = 166 (34%) 
CH = 57 (46%) 
AUS = 17 (14%) 






400 / 90 (82% / 18%) 
 








C4-C5 = 155 (32%) 
C6-C8 = 125 (26%) 
T1-T6 = 140 (29%) 
T7-T12 = 70 (14%) 
 
C4-C5 = 29 (24%) 
C6-C8 = 37 (30%) 
T1-T6 = 42 (34%) 










48 (40 to 58) 
 




Time post injury 
(years)  
 
    20 (11 to 29) 
 







178 (172 to 184)  
 







77 (67 to 89)  
 




Ever smoker  
[n] / % 
 
216 out of 431 (50%) 
 







0.00 (0.00 to 8.5) 
 




All data are reported as median (with 25% & 75% quartiles) unless otherwise indicated. 
CH=Switzerland; AUS= Australia; NL= The Netherlands 












Phase 1 - Accuracy of the statistical models published in 2012 
The predictions of the models published in 2012 did not match the measured 
data of persons with long-term SCI well. The t-tests to test for proportional bias 
(measured versus predicted values) are significant for FEV1 (p=0.033), PEF 
(p<0.000), PImax (p<0.000), PEmax (p<0.000) and almost for FVC (p=0.053), that 
means that the measured values are significantly lower or higher than the 
predicted values. Thus, there is a systematic difference in the old models for all 
five respiratory function parameters and the models give an over- or 
underestimation. Figure 2 demonstrates this proportional bias for all of the 
variables examined. The 2012 equations underestimated the actual values in the 
lower range and overestimated in the upper range for all five parameters. The 
ICCs for the lung volumes (0.62-0.64) were moderate but the ICCs for the 
respiratory muscle strength values were only poor to moderate with 0.41 for PImax 
and 0.40 for PEmax, respectively (Table 2) (26).  
 
Phase 2 - Development of lesion-specific reference models 
Due to the poor accuracy of the models published in 2012 for long-term SCI, new 
statistical models to predict respiratory reference values were developed with the 
model sample (80% of the total sample) (Table 3). The remaining candidate 
predictors after the backward regression models for all five respiratory function 
parameters were lesion level and gender. Age, height, weight and TPI had an 
additional significant influence on a sub-set of parameters only. We explored 
different forms of TPI in advance (observed, linear, logarithmic, exponential 
fittings) and did not find substantial differences between the four fittings. Based 
on those plots we decided that other fittings than the linear fitting did not improve 
the models. All significant predictors can be seen in Table 3.  
The predictors included in the new models explained 69-78% of the variance 











Figure 2 (phase 1) 
Bland-Altman plots of differences between the measured respiratory function 
values (FVC, FEV1, PEF, PImax and PEmax) of each participant and the calculated 
respiratory function values using the lesion-specific reference models published 
in 2012. The bold line represents the proportional bias and dashed lines show 
the limits of agreement. 
Dotted, diagonal line represents the regression line and confidence interval limits 





FVC regression line (95% CI): y=-2.27 + (4.545 to 4.717) + 0.48 (0.832 to 0.997) 
*x 
FEV1 regression line (95% CI): y=-1.81 + (3.786 to 3.928) + 0.46 (0.810 to 0.981) 
*x 
PEF regression line (95% CI): y=-3.76 (7.537 to 7.856) + 0.52 (0.959 to1.128) *x 
PImax regression line (95% CI): y=-59.5 (93.529 to 98.852) + 0.67 (0.838 to 0.995) 
*x 









Phase 1: Accuracy for prediction of lung function and respiratory muscle strength 
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CI= confidence interval; ICC= intraclass correlation coefficient; SCI= spinal cord injury; 
SD= standard deviation; FVC: forced vital capacity (L); FEV1: forced expiratory volume 
in 1 second (L); PEF: peak expiratory flow (L/s); PImax: peak inspiratory pressure 






Phase 2: Regression coefficients (β) and 95% CI of the new models from the 





















R2 0.78 0.74 0.69 0.69 0.69 


























































































































Smoking n.s. n.s. n.s. n.s. n.s. 
*Significant influencing factor (p ≤ 0.05); n.s.: not significant and removed from the final 
model; TPI= time post injury; FVC: forced vital capacity (L); FEV1: forced expiratory 
volume in 1 second (L); PEF: peak expiratory flow; (L/s); PImax: peak inspiratory 
pressure (cmH2O); PEmax: peak expiratory pressure (cmH2O);  
β: regression coefficient for each independent variable; CI: confidence interval;  
Δ: lesion group dummies with lesion group T1-T6 as reference;  
Smoking history includes the variables pack-years, ever smoker, former smoker, current 
smoker  
 




Phase 3 - Accuracy of the lesion-specific reference models 
The reliability of the new models were tested with the ‘validation sample’ (20% 
of the total sample) (Figure 1). The t-tests to test for proportional bias (measured 
versus predicted values) are significant for FVC (p<0.000), FEV1 (p<0.000), PEF 
(p<0.000) that means that the measured values are significantly lower or higher 
than the predicted values but not significant for PImax (p=0.43) or PEmax (p=0.41). 
Thus, there is a systematic difference with an over- or underestimation in the 
new models for all three lung function parameters but not for the respiratory 
muscle strength parameters. Figure 3 shows the predicted and measured 
respiratory function values in Bland-Altman plots. The ICCs between the 
measured and predicted lung function values for the new models ranged from 
0.28 (PImax) to 0.55 (PEF),  








Phase 3: Accuracy for prediction of lung function and respiratory muscle 



































































































































































































 to 32) 
 
CI= confidence interval; ICC= intraclass correlation coefficient;  
SD= standard deviation; 
FVC: forced vital capacity (L); FEV1: forced expiratory volume in 1 second (L);  
PEF: peak expiratory flow (L/s); PImax: peak inspiratory pressure (cmH2O);  
PEmax: peak expiratory pressure (cmH2O) 






Figure 3 (phase 3)  
Bland-Altman plots of differences between the measured respiratory function 
values (FVC, FEV1, PEF, PImax and PEmax) of each participant and the calculated 
respiratory function values using the new developed models with the 
representation of the limits of agreement (dashed, horizontal lines). 






Dotted, diagonal line represents the regression line and confidence interval limits 
are presented as continuous, diagonal lines. 
FVC regression line (95% CI): y=-4.57 (-5.08 to -4.06) + 1.22 (1.07 to 1.37) *x 
FEV1 regression line (95% CI): y=-3.29 (-3.70 to -2.87) + 1.08 (0.94 to 1.23) *x 
PEF regression line (95% CI): y=-6.54 (-7.60 to -5.47) + 1.02 (0.85 to 1.20) *x 
PImax regression line (95% CI): y=-99.05 (-125.42 to -72.67) + 1.26 (0.95 to 1.57) 
*x 




The prediction models published in 2012 showed to be not accurate enough for 
persons with long-term SCI and new models needed to be developed. The 
reason is that the 2012 equations underestimated the actual values in the lower 
range and overestimated them in the upper range for all five respiratory function 
parameters. For clinical practice, comparison of measured values with 
population specific reference values is important in order to prescribe preventive 
treatment. One possible treatment could be the increase of inspiratory muscle 
strength by respiratory muscle training as shown in a previous publication of our 
research group where we also used reference values (30). Using lesion-specific 
relative values of respiratory function is much more sensitive in the SCI-
population than just absolute values or reference values from able-bodied 
persons (30). For lung function we did not find better models for persons with 
long-term SCI but the models for respiratory muscle strength improved. 
 
Phase 1 - Accuracy of the statistical models published in 2012 
There was a need to test the accuracy of the first published models for persons 
with more than two years TPI. The ICCs for the lung volumes were good and 
also the Bland-Altman plots only showed small differences between the 
measured and the predicted values (Table 2). According to the ATS/ERS 
documents the acceptable difference between the measured and the predicted 
value should be below 0.150L for FVC, should not exceed 20% for FEV1 and 




should be below 0.67L/s for PEF (31). In our results these differences between 
measured and predicted values are within these acceptable differences, 
however, the 95% limits of agreement for FVC are between 2.12L and 1.96L 
which represents a wide range (Table 2). For PImax and PEmax the ICCs were 
poor, the differences and limits of agreement between the measured and the 
predicted values relatively wide (Table 2). Normal ranges for respiratory muscle 
strength are wide and the inter-individual differences between measurements in 
muscle strength is considerably greater than for lung function (32). Due to these 
findings we judged the old models not accurate, especially for respiratory muscle 
strength for a long-term SCI population.  
 
Phase 2 - Development of lesion-specific reference models 
New models to predict respiratory function values in long-term SCI were 
developed with lesion level, gender and weight as the main candidate predictors. 
There are some parallels between the “old” and the newly developed models but 
also some fundamental differences. Lesion level, as a SCI-specific parameter is 
important for all models and similar to able-bodied persons, also gender had an 
influence on all models (Table 3) (15). Typically, women have smaller vital 
capacities and maximal expiratory flow rates, reduced airway-diameters and 
smaller diffusion surfaces than age- and height-matched men (11). Height is 
similar between both models (15) (Table 3), only in PEF there was no additional 
increase with increasing height (Table 3). In able-bodied persons a 1% increase 
in height corresponds to a 2.5% increase in FVC and FEV1 (13).  
In the “old” models, increasing age had a negative effect on all five respiratory 
function parameters (15). In the newly developed models age had only a 
negative effect on FEV1 with a decrease of 15ml per year (Table 3). This is about 
half the age-related decline shown in the old models and in able-bodied persons  
where FEV1 declines by up to 30ml per year (12, 33). The aging lung is likely to 
have experienced exposures to environmental toxins and reductions in 
physiological capacity (12), and the chest-wall compliance is reduced due to 
stiffening of the rib cage (1). In the “old” models TPI was positively associated 
with PEmax (15). The newly developed models with the long-term SCI population 





was even a stronger predictor than age. Large interpersonal differences in 
change of FVC can happen in the first five years after rehabilitation (10). If a 
clinician is interested to see what the influence is of 10 years aging or TPI instead 
of 1 year aging or TPI one can multiply the beta of age or TPI by 10 (Table 3). 
Smoking history conferred no predictive power even though it is well known that 
starting smoking is related to a rapid decline of lung function while quitting 
smoking has a beneficial effect on lung function (34). Our findings are supported 
by literature where smoking history did also not show differences over time for 
FVC and FEV1 in males with traumatic tetraplegia and in persons with either 
tetra- or paraplegia with AIS A-D (10, 35). In our study all those participants with 
chronic lung diseases have been excluded and thus, an underrepresentation of 
the average population-based respiratory function status may occur. When 
estimating smoking history, recall bias may be an issue due to the retrospective 
design among ex-smokers (36). Recall bias means when persons remember 
past events, they do not usually have a complete or accurate picture of what 
happened. However, in another investigation self-reports of regular, former or 
never smoking were found to be usually accurate and the validity of self-reporting 
smoking seemed to be similar among persons from different ages and 
socioeconomic groups (37). 
 
Phase 3 - Accuracy of the lesion-specific reference models 
An important aspect of prediction is to consider if a regression model can be 
used reliably in persons with comparable characteristics. The ICCs for the lung 
volume parameters were poor and the Bland-Altman plots for FVC and FEV1 
showed relatively wide differences and limits of agreement between the 
measured and the predicted values (Table 4). According to the ATS/ERS 
documents the acceptable difference between the measured and the predicted 
value should be below 0.15L for FVC, should not exceed 20% for FEV1 and 
should be below 0.67L/s for PEF (31). In our study the difference between the 
measured and the predicted values for FVC (-0.45L) is higher than the 
acceptable difference of 0.15L and for FEV1 (-0.31L) and PEF (-0.53L/s) they 
are within the acceptable range but the differences are higher than in the 
validation of the old models (Table 4). A positive trend appeared evident in all 




five Bland-Altman plots, as illustrated with the regression line of the difference 
and confidence interval limits (25) (Figure 3). We conclude that for lung volume 
models in long-term SCI, other possible candidate predictors need to be 
evaluated in future research. The list of further predictors is long, ranging from 
clinical (e.g. co-morbidities) and laboratory (e.g. Chest X-ray) predictors to 
social/ psychological (e.g. ethnicity, motivation) predictors (38). With the 
currently available candidate predictors, lung function cannot be well predicted. 
As such, the “old” models appeared to be more accurate for predicting FVC and 
FEV1.  
The use of different prediction equations can lead to different interpretation with 
results differing on models and geographical site of assessment (39). The Global 
Lung function Initiative (GLI) provide standardized spirometry reference 
equations for able-bodied aged from 3 to 95 years to improve comparability and 
accuracy (40). After comparing the GLI and another two commonly used 
spirometry prediction equations in a group of healthy Kenyan volunteers one can 
see that no equation consistently provides accurate estimates of normal lung 
function (41). Even if the exposure to environmental pollutants in the Kenyan 
population is not comparable with the reference population the study brings into 
question the validity of these major published spirometry prediction equations 
(41). The best accuracy is given with detailed information about age and height. 
A few months age difference can affect the predicted values by up to 8.5% (42). 
Also a 1 cm error in height can lead to an error in the predicted value of 6% (40).  
 
Clinical relevance 
Prediction models for respiratory function are useful to individually assess the 
respiratory function in persons with different levels of injury. By yearly measuring 
the respiratory function and comparing them to the predicted values, we can 
potentially identify lung dysfunction and deterioration with aging, posture, obesity 
or ascension of neurological level.  
 
Strengths and limitations 
The strengths of this study are the appropriate set of respiratory function values 





Data of several laboratories are combined in which the techniques are performed 
in the same way as in daily routine so that sources of variability are minimized 
(43). 
The development of these new models involved some compromise as data of 
respiratory muscle strength and PEF were only available in two of three 
countries. Ideally, reference values are calculated with models derived from 
measurements observed in a representative sample of a clearly defined and, as 
much as possible, corresponding population (44, 45). With our study size of 276 
and 393 participants for respiratory muscle strength and PEF (Table 3), 
respectively, these criteria can still be fulfilled.  
The lung function measurements in the Netherlands and in Australia were 
especially performed for research purposes which bears the risk of a selection 
bias, but had the advantage of standardized measurement protocols.  
The period of inclusion of participants from 1996-2018 is long and changes in 
treatment regime happened, e.g. new respiratory muscle training devices are 
used in clinical practice and more is known about the effect of in- and expiratory 
muscle strength training. However, since this is not a training- or longitudinal 
study (one measurement per participant only) this may only have a marginal 
influence on the results. 
Differences in TPIs may have contributed to the heterogeneity of the results. In 
the Australian and Swiss centers the TPI started at two years in contrast to the 
Dutch centers where the TPI was defined with 10 years. Since TPI had been 
included as continuous parameter into the analysis, this fact should not be a 
limitation. 
Our focus was on the most obvious and easy to assess candidate predictors for 
feasibility reasons in the daily clinical practice. The research team selected the 
candidate variables based on the available literature in the same population (15, 
20) and with able-bodied persons (45). In future, the Delphi method as a 
structured communication technique could help to update and reach consensus 
on candidate predictors (38). Despite the fact that our models do still not contain 
all potential candidate predictors of relevance (38), our large sample size in 
general reflects a wide range of various levels of, e.g. activity and sports among 
the participants. 




For the graphical illustration of the validation, Bland-Altman plots (Fig. 2 and 3) 
were used. There is a discussion about the difference between these two 
statistical methods with the argument that in Bland-Altman plots a systematic 
proportional bias can occur (46). When looking at Fig. 2 and 3, in fact this type 
of bias is obvious. At lower respiratory function values the predicted values are 
higher than the measured values while at higher respiratory function values the 
predicted values are lower than the measured values.  
Conclusion 
The respiratory function prediction models published in 2012 showed to be not 
accurate enough for persons with long-term SCI. Thus, new statistical models 
have been developed to predict the respiratory function in persons with injuries 
more than two years ago. In summary, we did not find better models for lung 
function in long-term SCI but those for respiratory muscle strength showed better 
accuracy. 
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Evaluation of a clinical implementation of a 
respiratory muscle training group during 
spinal cord injury rehabilitation 
 

















Objectives To evaluate the clinical implementation of a respiratory muscle 
training group during rehabilitation of individuals with spinal cord injury.  
 
Methods Individuals with complete or incomplete lesions during inpatient 
rehabilitation, level C4-T12. 
Ten or more training sessions of either an inspiratory or a combined in- and 
expiratory muscle training were performed in a group-setting with respiratory 
function measurements before and after the training period. 
 
Results Analysis of 79 persons. Inspiratory muscle training was performed for 7 
weeks with a median of 3.1 training sessions/week. Median training intensity was 
at 33% of baseline PImax and 58 repetitions were performed per training session. 
Respiratory mucle strength parameters improved by 18-68% of baseline values 
and lung function parameters by 11-31% after inspiratory muscle training.  
The combined respiratory muscle training was performed for 13 weeks with a 
median of 2.8 sessions/week and 88 repetitions per training session. Median 
inspiratory training resistance was at 39% of baseline PImax and median 
expiratory training resistance was at 27% of baseline PEmax. Respiratory muscle 
strength parameters improved by 14-51% of baseline values and lung function 
parameters improved by 15-34% after the combined in- and expiratory muscle 
training. 
 
Conclusions Respiratory resistance training improved respiratory function of 
individuals with acute spinal cord injury. Even if the combined respiratory muscle 
training was performed with more repetitions per training and nearly twice as 
long, relative improvements of respiratory function parameters were comparable 











After a spinal cord injury (SCI), respiratory function is impaired and the degree 
of impairment depends upon the lesion level (1). Due to the complete or partial 
paralysis of the respiratory muscles, the effectiveness of coughing is reduced 
and the clearance of airway secretions is insufficient (2, 3). This retention of 
secretions may increase the airway resistance (4) and may cause respiratory 
complications such as atelectasis or pneumonia (2, 5) As a result of high airway 
resistance, respiratory work increases and may cause respiratory failure and 
subsequent complications in SCI individuals (6). Respiratory complications are 
still among the leading causes of death in individuals with complete SCI (7) with 
only a slight decrease in mortality over the past 40 years (8). In chronic SCI, a 
progressive decrease of respiratory function has been reported (6). This 
observed decline in respiratory function exceeds the normal age-related decline 
(9). The weakness of respiratory muscles and the inefficiency of breathing 
predispose individuals with tetraplegia to fatigue of the respiratory muscles (10, 
11). In able-bodied individuals, it has been demonstrated that, like other skeletal 
muscles, the respiratory muscles can be trained for both strength and endurance 
(12, 13). In clinical practice, two main types of respiratory muscle strength 
training programs have been established, namely inspiratory and expiratory 
muscle strength training (13). The degree and severity of respiratory muscle 
paralysis caused by SCI is usually decisive in choosing either an in- or an 
expiratory training program or a combination of both (13).  
Individual respiratory muscle training may be a central aspect of maintaining 
health and quality of life in this group of individuals with SCI. Additionally 
respiratory function improves during inpatient rehabilitation due to spontaneous 
recovery (4, 14-16). However, it has not yet been established, whether and to 
what extent the spontaneous recovery of respiratory function can be increased 
by specific respiratory muscle strength training. A statistically significant effect of 
respiratory muscle training on lung volume as well as on in- and expiratory 
muscle strength has recently been demonstrated for individuals with cervical SCI 
(3). Unfortunately, no specific analyses regarding the efficacy of in- or expiratory 





the clinical routine, the question about the more effective training regime is often 
raised. 
The purpose of this project was to evaluate the clinical implementation of a 
respiratory muscle training group during initial rehabilitation of individuals with 
SCI. Our main hypothesis was that significant differences in the respiratory 
muscle strength and lung volume can be reached by different respiratory muscle 
training regimes.  
 
Methods 
Design and setting 
A retrospective cohort study was performed in a single SCI rehabilitation center. 
The study had been approved by the ethics committee. We certify that all 
applicable institutional and governmental regulations concerning the ethical use 
of data of human volunteers were followed during the course of this research. 
 
Study population 
Male and female inpatients with a primary diagnosis of traumatic or non-
traumatic SCI, American Spinal Injury Association Impairment Scale (AIS) A-D, 
lesion level between C4-T12, aged 18 years or older who had participated in the 
respiratory muscle training group of the clinic from October 2010 to August 2015 
and who had completed a minimum of 10 training sessions were included.  
Persons with progressive neurological diseases such as multiple sclerosis or 
amyotrophic lateral sclerosis were excluded as well as persons with time post 
injury ≥ one year, tracheostomy, mental disorders, acute or progressive 
respiratory diseases, bronchodilators or any other medication that could have 
influenced respiratory function at the time of assessment.  
 
Respiratory training and measurements 
Respiratory training: 
The respiratory muscle training group is part of our clinical routine since 2010. 
The individuals performed the respiratory muscle training in a sitting position in 
their own wheelchair or on a chair (persons with the ability to walk). Up to five 




training sessions per week were performed in the group-setting, supervised by 
a physiotherapist. The repetitions per training were defined individually with a 
target of 80-90 repetitions. After each training session, the training resistance 
and count of training repetitions were recorded for each person. The “Borg 
Rating of Perceived Exertion” (RPE) was used to document the person`s self-
rated exertion during each training session. The exertion is rated on a scale of 
6-20, where 6 represents "no exertion at all" and 20 "maximal exertion". Four 
different training devices (IMT®, PEP®, Powerlung BreatheAir® and Powerlung 
Trainer®) were used for the training. The training device for isolated inspiration 
(Threshold IMT®, Philips Respironics, Parsippany, USA) is a small handheld 
device which includes a mouthpiece and a spring loaded valve. The valve 
provides a constant inspiratory pressure training load, and the persons must 
generate a sufficiently negative pressure in order to open the inspiratory valve 
and inhale air. The valve is calibrated and can be adjusted (9 to 41cmH2O) 
according to the individuals maximal inspiratory pressure (PImax). The training 
device for expiration (Threshold PEP®, Philips Respironics, Parsippany, USA) 
has the identical principle as the IMT®. The difference is that the persons must 
generate a positive pressure (5 to 20cmH2O) in order to open the expiratory valve 
and exhale air. The Powerlung BreatheAir® (PowerLung, Inc., Houston, TX, 
USA) is a small handheld device with a mouthpiece and two control dials with 
which the inspiratory and the expiratory resistance can be adjusted 
independently. THE Powerlung Trainer® (PowerLung, Inc., Houston, TX, USA) 
has the same principle but offers slightly higher levels of resistance. Therefore, 
the individuals who were using the Powerlung® devices did in- and expiratory 
muscle training together, with an inspiratory resistance during inspiration and an 
expiratory resistance during expiration. 
The respiratory muscle training were planned to start with the device set at 80% 
of the assessed PImax and maximal expiratory pressure (PEmax) at best. Once a 
person was able to perform the training session with less effort (RPE) than the 








Respiratory function measurements: 
Measurements of lung function and respiratory muscle strength were performed 
as part of the clinical routine. Respiratory function measurements were 
performed before the start of the respiratory muscle training (t1) and after the 
end of participation in the respiratory muscle training group (t2). Lung function 
parameters were measured according to the ATS/ERS guidelines (17). The 
following parameters were measured by bodyplethysmography (Master Screen® 
Body, Viasys Healthcare GmbH, Hoechberg, Germany): forced vital capacity 
(FVC), forced expiratory volume in 1 second (FEV1) and peak expiratory flow 
(PEF). Maximal inspiratory pressure and PEmax were measured using a 
respiratory pressure meter (Micro RPM, Micro Medical, Hoechberg, Germany). 
For all respiratory function measurements the individuals had to breathe through 
a mouthpiece while wearing a nose clip. Sniff nasal inspiratory pressure (SNIP), 
as a simple and reliable method of measuring diaphragmatic muscle strength, 
was additionally measured with a hand-held meter (Micro RPM, Micro Medical, 
Hoechberg, Germany). Each lung function measurement was performed at least 
three times. The highest value of each parameter was used for analyses.  
                     
Statistical analysis 
The data of a person were included for analysis if lung function measurements 
before (t1) and after participation in the respiratory muscle training group (t2) 
were available and if at least 10 respiratory resistance training sessions had 
been performed. The differences between the respiratory function values 
measured before and those after respiratory muscle training were calculated for 
each individual. 
Two training types were analyzed: 1) inspiratory muscle training 2) combined in- 
and expiratory muscle training. Persons who were assigned to the inspiratory 
group performed the training only with the IMT® device and those who were 
assigned to the combined group trained with a combination of the IMT® or the 
PEP® device and one of the Powerlung® devices. The data were further analyzed 
for individuals with motor complete lesions (AIS A/B) and with motor incomplete 
lesions (AIS C/D). Normal distribution of the data was tested using QQ-plots. 




Normal distributed data are presented as mean (standard deviation) and not 
normal distributed data as median (25% and 75% quartiles). Depending on the 
distribution of the data, paired T-tests or Mann-Whitney U tests were used to 
compare the training-specific parameters (between-group differences) and 
paired T-tests or Wilcoxon tests were used to investigate differences in 
respiratory function between the t1 and t2 measurements (within-group 
differences). Statistical significance was set at alpha ≤ 0.05. Benjamini Hochberg 
correction with a defined false-positive rate of 5% was used to adjust for multiple 
testing. All statistical analyses were performed using SPSS (Version 24.0, IBM, 
Somers, NY, USA).   
 
Results 
In total, 303 persons participated in the respiratory muscle training group. 
Overall, 224 individuals were excluded due to various reasons (Figure 1). Thus, 
the data of 79 persons were analyzed (Figure 1). The demographic data of the 
individuals are presented in Table 1, and their training-specific data are 
presented in Table 2. 
 
Figure 1 






Characteristics of participants. 











Combined in- and expiratory 

















Male/female [n]  
(%) 
 
10 / 5 
33.3 / 66.7 
 
22 / 5 
81.5 / 18.5 
 
14 / 2 
87.5 / 12.5 
 
18 / 3 





(30.0 to 58.0) 
 
63.0  
(37.0 to 73.0) 
 
44.5  
(30.0 to 52.5) 
 
60.0  
(41.0 to 72.5) 
 




(0.1 to 0.3) 
 
0.1  
(0.1 to 0.2) 
 
0.1  
(0.1 to 0.2) 
 
0.2  
(0.1 to 0.2) 
 


















Weight [kg]  
 
67.0  
(61.0 to 82.0) 
 
70.0  
(64.0 to 80.0) 
 
76.0  
(64.3 to 88.5) 
 
75.0  
(66.5 to 84.0) 
 
Traumatic/non-
traumatic [n] (%) 
 
13 / 2 
86.7 / 13.3 
 
21 / 6 
77.8 / 22.2 
 
15 / 1 
93.8 / 6.2 
 
15 / 6 




[n] (%)  
 
7 / 8 
46.7 / 53.3 
 
 
22 / 5 
81.5 / 18.5 
 
7 / 9 
43.8 / 56.2 
 
18 / 3 
85.7 / 14.3 
AIS= American Spinal Injury Association Impairment Scale  
A/B: motor complete lesion; C/D: motor incomplete lesion 
 
  























per week [Nr.] 








57.7 (53.6 to 72.7) 
 
 









7.0 (5.0 to 9.0) 
 






% of basis 
PImaxvalue 
 
26.5 (21.8 to 33.0)  
33.4 (11.0 to 66.9) 
 
 
32.0 (28.1 to 35.2)  













51.2 (48.3 to 53.6) 
26.7 (2.5 to 68.7)  
 
n.a. 
AIS: American Spinal Injury Association Impairment Scale  
A/B: motor complete lesion; C/D: motor incomplete lesion 
n.a.: not applicable 
* Significant difference p≤0.05  
 
Inspiratory muscle training 
The respiratory function parameters before and after inspiratory muscle training 
are presented in Table 3. The pre-post training differences in percent 
improvement from pre-training values of respiratory parameters in individuals 
with motor complete and incomplete lesions are presented in Figure 2 and 3. 
The exertion during inspiratory training was classified as a mean of 13±1 
(maximum 20) on the RPE scale. The value 13 on the RPE scale is defined as 







Comparison of the respiratory function parameters pre and post inspiratory 
muscle training in individuals with motor complete SCI (AIS A/B) and motor 
incomplete SCI (AIS C/D). 
All data are reported as mean ± SD (for normal distributed data) or median 
(with 25% & 75% quartiles) for not normal distributed data. 
  
Motor complete SCI (AIS A/B) 
 
 
























































46.5 ± 29.4 
 





45.3 ± 16.7  
 










46.7 ± 18.4  
 




44.6 ± 19.7  
 









1.8 ± 0.6 
 
 





2.0 ± 0.7 
 
 










1.5 ± 0.5  
 
 





1.7 ± 0.6  
 
 










4.0 ± 2.0  
 
 





4.6 ± 1.7  
 
 




PImax=maximal inspiratory pressure (cmH2O); PEmax=maximal expiratory pressure (cmH2O); 
SNIP=sniff nasal inspiratory pressure (cmH2O); FVC=forced vital capacity (L);  
FEV1=forced expiratory volume in 1 second (L); PEF=peak expiratory flow (L/s); 
*Significant difference p≤0.05 (Benjamini Hochberg correction with a false-positive rate of 5%) 




Combined in- and expiratory muscle training 
The respiratory function parameters before and after combined in- and expiratory 
muscle training are presented in Table 4. The pre-post training differences in 
percent improvement from pre-training values of respiratory parameters in 
individuals with motor complete and incomplete lesions are presented in Figure 
2 and 3. The exertion during combined in- and expiratory training was classified 




The pre-post training differences in % (median ± 95% confidence interval) of 
respiratory muscle strength parameters before and after the inspiratory and the 
combined in- and expiratory muscle training in individuals with motor complete 
(AIS A/B) and incomplete (AIS C/D) lesions.  
PImax= maximal inspiratory pressure; PEmax= maximal expiratory pressure; 







The pre-post training differences in % (median ± 95% confidence interval) of 
respiratory lung function parameters before and after the inspiratory and the 
combined in- and expiratory muscle training in individuals with motor complete 
(AIS A/B) and incomplete (AIS C/D) lesions.  
FVC= forced vital capacity; FEV1= forced expiratory volume in one second; PEF= 
peak expiratory flow.  





Comparison of the respiratory function parameters pre and post combined in- 
and expiratory muscle training in individuals with motor complete SCI (AIS A/B) 
and motor incomplete SCI (AIS C/D). 
All data are reported as mean ± SD (for normal distributed data) or median 
(with 25% & 75% quartiles) for not normal distributed data. 
  
Motor complete SCI (AIS A/B) 
 
 































58.7 ± 19.5  
 
 




58.7 ± 19.7  
 
 









46.5 ± 22.1  
 





69.5 ± 31.6  
 










45.7 ± 18.1 
 




51.2 ± 18.5  
 









2.1 (1.8 to 
2.5) 
 





















2.0 (1.7 to 
2.3)  
 





















4.5 ± 1.8  
 
 





4.7 ± 1.4  
 
 




PImax=maximal inspiratory pressure (cmH2O); PEmax=maximal expiratory pressure (cmH2O); 
SNIP=sniff nasal inspiratory pressure (cmH2O); FVC=forced vital capacity (L);  
FEV1=forced expiratory volume in 1 second (L); PEF=peak expiratory flow (L/s) 






Both in- and combined in- and expiratory muscle training increased lung function 
and respiratory muscle strength on median by 27% (Figure 1 and 2). An increase 
of about 30% (Figure 2) in the respiratory muscle strength parameters after the 
inspiratory muscle training and in the lung function parameters of about 17% 
(Figure 3) could be achieved. The combined in- and expiratory muscle training 
improved the respiratory muscle strength parameters on average by 34% (Figure 
2) and the lung function parameters by about 27% (Figure 3). Even if the 
combined training regime was conducted with much higher training volumes 
(repetitions per training session and number of weeks) compared to the 
inspiratory muscle training, relative improvements did not differ substantially 
between the two training regimes. On the other hand, relative training 
resistances (intensity) was quite similar in both training regimes. 
 
Respiratory muscle strength 
Generally, PImax as well as PEmax were increased by both respiratory training 
regimes (Figure 2) with a statistically significant improvement in PImax in 
individuals with motor complete and those with motor incomplete lesions (Table 
3 and 4). The principal intention of an expiratory muscle strength training is to 
boost the strength of the expiratory muscles (13) and the identical intention for 
the inspiratory muscle training and the inspiratory muscles. The greatest 
expansion after the respiratory resistance training is especially remarkable with 
PEmax after the inspiratory muscle training in individuals with motor incomplete 
lesions (Figure 2).   
However, it is difficult to explain the differences in improvements between the 
four groups, since various influences as e.g. differences in training volume, 
distribution of individuals with para- and tetraplegia as well as spontaneous 
recovery may all have influenced the improvements and overlay isolated training 
effects. Interestingly, the SNIP values which mirror the force of the diaphragm 
and therefore should be stimulated mainly by inspiratory efforts, improved 
significantly after the combined in- and expiratory training in the motor complete 
and incomplete group, but not after isolated inspiratory muscle training (Table 




4). Since the diaphragm contains more aerobic muscle fibres, probably the 
higher training volume in the combined training regime may have caused this 
difference. The PImax at baseline was greater than the PEmax in all individuals 
regardless of the lesion group and the type of training, with the exception of 
individuals with motor incomplete lesions receiving combined training (Table 3 
and 4). This is the logical consequence of the innervation of the respiratory 
muscles depending on the grade and level of lesion. Generally, with higher lesion 
levels, the expiratory muscles are more impaired than the inspiratory muscles 
and therefore, inspiratory muscle strength is higher compared to expiratory 
muscle strength in individuals with SCI and particularly in those with tetraplegia 
(6, 18).  
In any case, maximal respiratory pressure appears to be a more useful marker 
to detect weakness in respiratory muscles compared to lung volumes (19).  
 
Lung volumes 
We could demonstrate a statistically significant improvement in FVC of 14-34% 
from baseline values in the motor complete as well as in the motor incomplete 
group, both after the isolated inspiratory as well as after the combined in- and 
expiratory muscle training (Figure 3). Improvements in lung volumes after 
respiratory muscle strength training are apparently the consequences of higher 
in- and expiratory muscle strength since respiratory muscles are able to expand 
and compress the lungs to a higher extent which leads to increases in lung 
volumes. The FVC is defined as the total volume of air a person is able to exhale 
for the total duration of the test during maximal effort.(20) After a complete 
cervical lesion, individuals can only breathe with the movement of the diaphragm 
and accessory muscles around the neck. Therefore, individuals with tetraplegia 
reach much smaller values of FVC compared to paraplegics or able-bodied with 
a reduction of FVC to 30-50% of normal values (1). Thus, the improvements in 
lung volumes found in this study are clinically relevant and may also justify the 
efforts to implement regular respiratory strength training.  
The FEV1 is the total volume of air that has been exhaled at the end of the first 
second of maximal forced expiration (20). A recent Cochrane Review (3) 





results show a statistically significant increase of 11-28% in FEV1 in all groups 
independent of the training regime (Figure 3). This finding may be also important 
for secretions clearance, as FEV1 represents the ability to forcefully exhale air. 
Thus, a higher FEV1 and FVC seem to be protective against respiratory illness 
(21), and therefore respiratory muscle training should be an integral part of the 
clinical practice. 
Furthermore, PEF, an even more important parameter for coughing (22), 
increased between 13% and 25% (Figure 3). For an effective cough, an 85-90% 
lung insufflation is required to achieve the maximum expiratory flow (2). The 
inspiratory muscle weakness after a SCI restricts the pre-cough volumes and an 
effective cough for secretions clearance cannot be produced (2). That’s why our 
improvements in PEF after respiratory resistance training may also have a high 
clinical relevance for prevention of respiratory complications.  
However, it has to be taken into account that improvements of 21% and 25% in 
the motor complete group did not reach statistical significance. This can be 
explained by the very low sample size, since PEF has not been measured in all 
individuals of these groups (Table 3 and 4).  
 
Training parameters  
Regarding training-specific parameters our training duration was approximately 
15 minutes, 3 days per week during 7-13 weeks (Table 2). These parameters lie 
in the middle of the reported values of a recent Cochrane review which reported 
a daily training duration from 10 to 60 minutes, 3 to 7 days per week for a period 
of 4 to 12 weeks (3). Interestingly, training volume of the group who performed 
the combined in- and expiratory muscle training was much higher i.e. more 
repetitions per training session and nearly twice of total training weeks, 
compared to the group who performed isolated inspiratory muscle training. 
Nevertheless, relative improvements compared to baseline values (Figure 2 and 
3) were quite comparable between the two groups. Considering relative training 
intensity, the two groups were comparable with an inspiratory training resistance 
of 33% and 39% of baseline PImax, respectively (Table 2). This may create the 
hypothesis that training intensity may have a higher impact on improvements in 
respiratory function than training volume. This should be addressed in a future 




study and may be of high clinical impact. Independent of our training stimuli 
which may have been below the optimal intensity (23), an improvement in 
respiratory function could be achieved, but on the other hand we do not yet know 
how high the improvement could have been with higher training intensities.  
 
Limitations 
Respiratory muscle strength is affected by both in- and expiratory muscle training 
and therefore, there might have been an interaction of effects in the combined 
in- and expiratory muscle training group (24). However, the evaluated data 
clearly demonstrated the positive effect of isolated inspiratory as well as 
combined in- and expiratory muscle training on respiratory function parameters 
in individuals with SCI.  
Due to the retrospective analysis of a clinical implementation of respiratory 
muscle training, no control group was included and no systematic group 
allocation was performed.  
Spontaneous improvement of the respiratory function parameters occurs (4, 14, 
25, 26), however, the training effect on respiratory muscle strength is more 
pronounced (27). The improvement in lung function in our study was similar to 
the magnitude reported for natural recovery but lung function also depends on 
other factors (e.g. gender, age, height) apart from respiratory muscle training. 
Respiratory muscle training mainly aims to improve respiratory muscle strength. 
There is a preponderance of motor incomplete individuals with tetraplegia in our 
sample (Table 1), as a result of the higher proportion of incomplete individuals 
with tetraplegia in the SCI population (28). This study mirrors the clinical situation 
without the potential influence of over-motivation generated by the participation 
in a study (29).  
 
Clinical Relevance 
Independent of the training regime, from our point of view respiratory muscle 
training should be an integral part of the therapy. In order to assess and adapt 
the individual respiratory muscle training, repeated measurements of the 
respiratory function are needed. Recommendations for respiratory muscle 





in therapeutic practice. Furthermore, respiratory muscle training may be an 
useful way to reduce the rate of pneumonia due to the improvement of PImax (30). 
Conclusion 
In conclusion, respiratory muscle training revealed a great effect on 
improvements in respiratory function parameters and especially in respiratory 
muscle strength with improvements of up to 70% from baseline values. Even if 
the combined respiratory muscle training was performed with more repetitions 
per training and nearly twice as long, relative improvements of respiratory 
function parameters were comparable with isolated inspiratory muscle training. 
Therefore, future research should focus on the effects of training intensity. The 
clinical implementation of a respiratory muscle training group during initial 
rehabilitation for individuals with SCI seems to be worthwhile.  
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Respiratory muscle training  
in individuals with spinal cord injury:  
Effect of training intensity and -volume on 
improvements in respiratory muscle strength 
 
















Objectives To investigate the effect of training intensity and -volume on 
improvements in respiratory muscle strength in individuals with spinal cord injury. 
 
Methods Inpatients with spinal cord injury, lesion level C4-T12, who had at least 
10 individualized inspiratory muscle training sessions with respiratory function 
measurements before and after the training period. Multiple regression analysis 
with natural logarithmic (ln) transformation of the outcome values was used to 
examine the effect of training intensity and –volume, lesion level and 
completeness and baseline respiratory muscle strength on improvements in 
respiratory muscle strength. 
 
Results Overall 67 individuals were analyzed. Variation in PImax was explained 
by PImax at baseline and training intensity. This adjusted effect size suggested a 
7% (95%CI 2.8%-11.6%) increase in PImax per 10 units of increase in training 
intensity. Controlling for the variation in baseline PEmax, the effect of training 
intensity on PEmax was conditional on AIS (p<0.021). While individuals with motor 
complete lesions showed a 6.8% (95%CI 2.1%-11.7%) increase in PEmax per 10 
units of increase in training intensity, the corresponding adjusted effect size in 
those with motor incomplete lesions was 0.1% (95%CI -4.3%-4.5%). The full 
models explained 57% and 60% of the variance of lnPImax and lnPEmax, 
respectively. 
 
Conclusions The intensity of inspiratory muscle training was more relevant than 
training volume for the improvement of respiratory muscle strength in individuals 
with spinal cord injury. Thus, training intensity should be chosen as high as 
possible. 
  






The dysfunction of respiration after a spinal cord injury (SCI) is characterized by 
respiratory muscle weakness (1-3). Weak respiratory muscles may lead to 
complications such as atelectasis or pneumonia (1, 4, 5), which are still among 
the leading causes of death in individuals with complete SCI (6). An increased 
PImax may be a crucial factor in the prevention of respiratory complications such 
as pneumonia (7). The most sensitive indicators for respiratory muscle 
weakness and function are peak in- (PImax) and expiratory pressure (PEmax) (4, 
8). According to a recent Cochrane review, both PImax and PEmax can be 
improved by respiratory muscle training in individuals with SCI (2). An increase 
in PImax and PEmax is associated with an improved cough capacity (9), resulting 
in a more effective secretion clearance (4). Therefore, respiratory muscle training 
may be useful to reduce the rate of pneumonia (7). 
There are two types of respiratory muscle strength training (2): Resistive training 
involves breathing through a small diameter hole, which limits the available 
airflow and threshold training involves breathing with sufficient force in order to 
overcome a spring-loaded valve to enable airflow (10). The reported training 
volumes and intensities vary greatly (2) and thus, the optimal training respiratory 
muscle training settings to achieve a clinically relevant improvement in 
respiratory muscle strength are still unknown. The current practice of respiratory 
management is mainly based on clinical experience and expert opinion (10). 
It is important to understand the effect of training intensity and -volume in SCI 
that interventions can be targeted at these individuals to prevent respiratory 
complications, to reduce hospitalization and to improve quality of life. The aim of 
this study was to investigate the effect of training intensity and -volume on 
improvements in respiratory muscle strength, taking the effects of the 
completeness and level of the lesion as well as and the baseline respiratory 
muscle strength into consideration. This assumption was tested in a specialized 
rehabilitation center for SCI in Switzerland with specification in the management 
of patients with respiratory issues. We hypothesized that an increase in training 
intensity and -volume is associated with an improvement in respiratory muscle 






Design and setting 
The data were collected retrospectively in a single specialized center for SCI in 
Switzerland from October 2010 to August 2015.  
 
Study population 
Male and female inpatients (not intensiv care unit), 18 years and older, with a 
traumatic or non-traumatic SCI, a motor lesion level from C4 to T12 and an 
American Spinal Injury Association Impairment Scale (AIS) A to D (11) were 
included, if they had participated in the respiratory muscle training group and had 
undergone at least two respiratory muscle strength measurements with at least 
10 respiratory muscle training sessions in between. Individuals suffering from 
neurological diseases such as multiple sclerosis (MS), amyotrophic lateral 
sclerosis (ALS), mental disorders or acute or progressive respiratory diseases 
were excluded. Additionally, individuals with bronchodilators or any other 
medication that could have influenced respiration at the time of measurement, 
those in the intensive care unit or those who rejected the retrospective use of 
personal medical data were excluded.  
 
Demographic data 
All baseline demographic data (gender, age, level and completeness of the 
lesion, weight, height, time post injury and cause of lesion) were collected from 
the medical records and entered into the study specific web-based database 
(secuTrial®, interActive Systems GmbH, Berlin, Germany). 
 
Respiratory muscle strength measurement 
Respiratory muscle strength (PImax, PEmax) was measured using a respiratory 
pressure meter (Micro RPM, Micro Medical, Hoechberg, Germany) which was 
part of the clinical routine (12). These measurements were performed once 
before and once after the respiratory muscle training period. All measurements 





were carried out whilst the training participants were seated and wearing a a 
nose-clip. Abdominal binders were removed for the measurements.  
The respiratory muscle strength measurements were performed according to the 
ATS/ERS guidelines (13). Each maneuver was repeated until three reproducible 
measurements were registered and the highest value of the measurements were 
entered into the study specific database and used for analysis.       
For the PImax measurement, the training participants carried out their maximal 
inspiratory maneuvers at residual lung volume against an one-way valve of the 
respiratory pressure meter maintaining with the pressure for at least one second. 
Accordingly, PEmax was measured at total lung capacity with maximal expiratory 
maneuvers.  
 
Respiratory muscle training 
The respiratory muscle training group has been a part of the clinical routine in 
our centre since 2010 and is supervised by an experienced and trained 
physiotherapist (maximum patient:physiotherapist ratio of 8:1). An in-house 
instruction protocol was used for the standardization of the respiratory muscle 
training. The training was performed in a sitting position either in the participant’s 
own wheelchair or on a chair for those who are able to walk. The inspiratory 
muscle training was conducted with the Threshold IMT® (Philips Respironics, 
Parsippany, USA), a training device for isolated inspiratory resistance. It is a 
small handheld device which includes a mouthpiece and a spring loaded valve. 
The valve provides a constant inspiratory pressure training load, and the 
participant has to generate a negative pressure great enough to open the 
inspiratory valve and inhale air. The valve is calibrated and can be adjusted (9 
to 41cmH2O) according to the participant’s PImax.  
According to a Cochrane Review, training intensity is set at a percentage of the 
maximum measured respiratory pressure and training volume consists of the 
number of exercise repetitions (2). Our respiratory muscle training was usually 
started about six weeks after injury and lasted for a period of about six 
consecutive weeks with three to five training sessions per week and with up to 
90 repetitions per training session. The number of repetitions per training varied 





responsible physiotherapist. The target intensity (resistance) during the 
respiratory muscle trainings was adapted individually to the maximum 
achievable intensity by the responsible physiotherapist. The responsible 
physiotherapist made sure that the valvular opening sound of the training device 
was heard during each breath. In order to evaluate the self-rated exertion, the 
“Borg Rating of Perceived Exertion” (RPE), scaled from six (no exertion at all) to 
20 (maximal exertion), was used after each training (14). Once a participant was 
able to perform the training session on a lower self-rated level of intensity 
compared to the previous session, the resistance was increased by the 
responsible physiotherapist. The physiotherapist made sure that the participant 
was able to just complete a training session at the new load. After each training 
session, all training-specific details were documented in an individual training log 
by the responsible physiotherapist. Based on these data, the repetitions per 
session, the number of training sessions and the training intensity (% resistance 
of the individual baseline value of PImax) of each participant were determined for 
the whole training period and entered into the study database. All participants 
received standard physiotherapy as part of the comprehensive in-patient 




Normal distribution of the data were tested using QQ-plots separately for 
individuals with motor complete and motor incomplete lesions. The data were 
presented as mean/median and quartiles or count and percentage. 
The Mann-Whitney U Test and Pearson`s Chi-squared or Fisher's Exact Test 
were used to investigate differences in the demographic and the training-specific 
parameters between individuals with motor complete and those with incomplete 
lesions. 
We checked for non-linearity in the association of the predictor variables training 
intensity and training volume with the dependend variables PImax and PEmax by 
using fractional polynomial transformations (15). There was no support for any 
non-linear effects of the predictor variables. 





Natural log (ln) transformation (16) was used for the dependend variables PImax 
and PEmax and for the predictor variables baseline PImax and PEmax in order to 
achieve normal distribution. Linear regression analysis was used to investigate 
the effect of the chosen predictor variables (baseline PImax or PEmax, training 
intensity, training volume, lesion level and lesion completeness) as well as 
interactions between training intensity and lesion level (para/tetraplegia) or 
lesion completeness (AIS) on PImax and PEmax, with paraplegia and AIS C/D as 
reference groups respectively. All predictor variables, irrespective of significance 
level, were included in the model a priori. The interactions between training 
intensity and lesion level or lesion completeness were included when significant. 
The significance of the interaction effects was investigated using likelihood ratio 
tests.  
Training intensity, multiplied by 100, can be interpreted as percentage difference 
per 10 units increase in training intensity. A unit describes the increase in training 
intensity in cmH2O (1 unit= 1 cmH2O). Training volume, multiplied by 100, is the 
percentage difference per 100 training repetitions (17). 
QQ-plots and Mann-Whitney U tests were performed using the SPSS software 
(Version 24.0, IBM, Somers, NY, USA) and all other statistical analyses 
described above were done using the STATA software (Version 14.2, StataCorp, 
Texas, USA). Statistical significance was set at alpha ≤ 0.05. 
 
Results 
In total, 145 individuals fulfilled the inclusion criteria. The data of 78 individuals 
were excluded due to various reasons: neurological disease (n=33) (MS, ALS, 
etc.), respiratory disease (n=44) (severe asthma or COPD, chronic cough, etc.) 
or rejection of the retrospective use of personal medical data (n=1). Thus, 67 
data sets were analyzed. The demographic data of the analyzed individuals are 
presented in Table 1, and their training-specific data are presented in Table 2. 
The results of the multiple linear regression analyses are shown in Table 3 (PImax) 







Characteristics of participants of the total group and sub-groups according to 
completeness of the lesion. 








Completeness of SCI 
 








Sample size [n] 67 41 26  
 
Male/female [n]  
(%) 
 
55 / 12 
82.1 / 17.9 
 
33 / 8 
80.5 / 19.5 
 
22 / 4 







(35 to 66) 
 
42  
(28 to 55) 
 
64  








(1.2 to 2.9) 
 
2.0  
(1.3 to 2.7) 
 
1.9  




Height [cm]  
 
175  
(171 to 181) 
 
175  
(171 to 182) 
 
177  




Weight [kg]  
 
70 (64 to 82) 
 
70 (63 to 82) 
 





traumatic [n] (%) 
 
59 / 8 
88.1 / 11.9 
 
38 / 3 
92.7 / 7.3 
 
21 / 5 






[n] (%)  
 
47 / 20 
70.1 / 29.9 
 
23 / 18 
56.1 / 43.9 
 
 
24 / 2 
92.3 / 7.7 
 
.002* 
AIS= American Spinal Injury Association Impairment Scale;  
AIS A/B= motor complete spinal cord injury;  
AIS C/D= motor incomplete spinal cord injury;  
SCI= spinal cord injury 










Training specific data of the total group and sub-groups according to 
completeness of the lesion. 
All data are based on average levels per individual over the whole training 






      Completeness of SCI  
 
















(40 to 70) 
 
56  
(42 to 70) 
 
58  









(24 to 33) 
 
31  
(24 to 34) 
 
29  









(5 to 8) 
 
6  
(4 to 8) 
 
7  










(2 to 3) 
 
3  
(3 to 4) 
 
3  









(13 to 24) 
 
17  
(13 to 23) 
 
23  








(54 to 73) 
 
62  
(55 to 74) 
 
58  




RPE (Borg) 13 (12 to 14) 13 (12 to 14) 13 (13 to 14) .391 
AIS= American Spinal Injury Association Impairment Scale;  
AIS A/B= motor complete spinal cord injury;  
AIS C/D= motor incomplete spinal cord injury 
RPE= Borg Rating of Perceived Exertion; SCI= spinal cord injury 








Variation in PImax was explained by PImax at baseline (ln-transformed) and training 
intensity (Table 3). This adjusted effect size is suggestive of a 7% (95%CI 2.8%-
11.6%) increase in PImax per 10 units (cmH2O) of increase in training intensity. 
Completeness and level of lesion were not associated to PImax. The full model 
explained 57% (adjusted R2) of the variance of lnPImax. The association of PImax 
with training intensity was independent of AIS (test of interaction: chi2=0.18, 
d.f.=1, p=0.67) and lesion level (chi2=0.00, d.f.=1, p=0.99). 




















ln_PImax_baseline 0.977 0.129 <0.000* 0.718 to 1.235 
 
Training intensity 








0.028 to 0.116 
 
Training volume 






































-1.225 to 1.299 
 
AIS= American Spinal Injury Association Impairment Scale; Coef β= regression 
coefficient; ln= natural log;  
lnPImax= maximal inspiratory pressure ln transformed; Std.Error= Standard Error; 
Tetraplegia= reference group for lesion level; 
Training intensity per 10 units= training intensity multiplied by 100, results can be 
interpreted as percentage difference; 
Training volume per 100 repetitions= training volume multiplied by 100, results can be 
interpreted as percentage difference; 
*Significant difference p≤0.05 (based on likelihood-ratio tests) 
 






Controlling for the variation in baseline PEmax (ln-transformed; p<0.0001), there 
was statistical support that the effect of training intensity on PEmax was 
conditional on AIS (test of interaction: p<0.021; Table 4). While individuals with 
motor complete lesions (AIS A/B) showed a 6.8% (95%CI 2.1%-11.7%) increase 
in PEmax per 10 units (cmH2O) of increase in training intensity, the corresponding 
adjusted effect size in the group with motor incomplete lesions (AIS C/D) was 
0.1% (95%CI -4.3%-4.5%). The full model explained 60% (adjusted R2) of the 










Multivariable linear regression model for lnPEmax. 
AIS= American Spinal Injury Association Impairment Scale; Coef β= regression 
coefficient; ln= natural log;  
lnPEmax= maximal inspiratory pressure ln transformed; Std.Error= Standard Error; 
Tetraplegia= reference group for lesion level; 
Training intensity per 10 units= training intensity multiplied by 100, results can be 
interpreted as percentage difference; 
Training volume per 100 repetitions= training volume multiplied by 100, results can be 
interpreted as percentage difference; 
















Ln_PEmax_baseline 0.576 0.082 <0.000* 0.412 to 0.739 
 









-0.043 to 0.045 
 






























-0.320 to 0.032 
 
Interaction  
AIS A/B + training 












0.021 to 0.117 
 
Interaction  
AIS C/D + training 






















1.236 to 2.991 
 






The aim of the multiple regression analysis was to investigate the effect of 
inspiratory muscle training intensity and training volume on improvements in 
respiratory muscle strength. 
The training intensity seems to be more relevant for a successful improvement 
of the respiratory muscle strength than the training volume (Tables 3 and 4).  
 
PImax 
Training intensity has a significant effect on PImax by inspiratory muscle training 
(Table 3). This increase in PImax does not depend on training volume, lesion 
completeness or level. An increase in training intensity of 10 units results in a 
7% increase in PImax. Given a median training intensity of 57% and a baseline 
PImax of 40cmH2O, we can expect an improvement of 16cmH20 (7 x 0.4cmH2O 
=2.8cmH2O; 2.8cmH2O x 5.7 =16cmH2O), resulting in an inspiratory pressure of 
56cmH2O after a period of inspiratory muscle training If training intensity was at 
80%, improvements of 22cmH2O could be expected (2.8cmH2O x 8 
=22.4cmH2O). Of course, training volume is not completely irrelevant for 
improvements in respiratory muscle strength, but based on the results of our 
models, about 1000 repetitions of inspiratory muscle strength training would be 
necessary to achieve an increase of 1% in PImax (Table 3). Our results support 
the current trend of high intensity training, which is performed above 80-85% of 
peak oxygen uptake (18). Such high exercise intensities cannot be maintained 
for a prolonged period, and therefore, the training will mostly be performed in 
interval sessions (18). A high intensity training stimulus is also required for 
inducing respiratory muscle adaptations, i.e. increasing respiratory muscle 
strength (19). In able-bodied individuals high intensity whole body interval 
training was an effective stimulus for the the respiratory muscles (19). Another 
investigation in able-bodied individuals showed that high intensity inspiratory 
training (80% PImax) resulted in increased inspiratory muscle strength and lung 
volumes compared to lower training intensities (60% and 40% PImax) (20). Most 
individuals with SCI may not be able to reach a high enough stimulus for 





intensity training of the respiratory muscles may be a promising alternative. In 
addition, high intensity training offers a time-efficient and probably also more 
motivating alternative compared to continuous endurance training (19). 
 
PEmax 
The improvement of PEmax depends on the interaction between training intensity 
and motor complete SCI (Table 4). The completeness of the lesion was crucial 
for the improvement of PEmax, but not for PImax. For motor complete injured 
individuals, an increase in PEmax can be achieved by inspiratory muscle training. 
For motor incomplete injured individuals, the inspiratory muscle training did not 
show a significant effect on PEmax (Table 4). This is due to the smaller respiratory 
muscle function impairment in individuals with motor incomplete lesions 
compared to those with motor complete lesions (10, 21) including abdominal and 
pelvic floor muscle function. The abdominal muscles are expiratory muscles and 
contract to increase the intra-abdominal pressure that elevates the diaphragm 
during forceful exhalation or cough (1). Thus, patients with innervated abdominal 
and pelvic floor muscles, i.e. individuals with incomplete SCI, have less potential 
for an improvement in expiratory muscle function by inspiratory muscle training 
and need it to a lesser extent. Inspiratory muscle training does not seem to be a 
main therapy goal in individuals with motor incomplete lesions and no respiratory 
complications.  
Based on our results, an increase of 10 units in training intensity results in an 
increase in PEmax of almost 7% in individuals with motor complete lesions and 
absent abdominal and pelvic floor muscles. Thus, given a median training 
intensity of 57% (Table 2) and a baseline PEmax of 31cmH2O, we could expect 
an improvement of 12cmH20 (7 x 0.3cmH2O =2.1cmH2O; 2.1cmH2O x 5.7 
=12cmH2O), resulting in a PEmax of 43cmH2O after a period of inspiratory muscle 
training. In clinical practice, there is a considerable debate regarding the optimal 
training volume for improving muscle strength during a respiratory muscle 
training program. Our results indicate that training volume does not significantly 
affect PEmax. Thus, patients should be motivated to reach a high training intensity 
rather than to do hundreds of repetitions with a low training intensity during a 
training session. The median training period in our study was six to seven weeks, 





with three training sessions per week, and a median of 60 repetitions per 
session. Recommendations regarding the minimum training volume vary largely. 
In a recent systematic review, four to 12 weeks of respiratory training were found 
to be sufficient to reach significant changes in PImax and PEmax (22). In another 
systematic review, a training duration of less than eight weeks did not show any 
significant effect on PImax and PEmax (2). However, studies regarding strength 
training mostly include training programs with a duration of eight to 12 weeks 
(23). The reported frequency of training sessions range from once (30min) to 
several times a day, four to five times a week (24, 25). Our finding that training 
volume has a neglectable effect on improvements in respiratory muscle strength 
compared to training intensity may explain these diverging results. 
 
Clinical relevance 
Based on our results an increase in training intensity of 10 units is followed by a 
7% increase in PImax and for individuals with complete lesions also in PEmax. In 
contrast, per 1000 repetitions (training volume) of inspiratory muscle training, 
PImax will only increase about 1%. Our recommendation is therefore, to keep the 
training intensity as high as possible with a self-reported rating of at least 15 on 
the RPE scale (defined as “hard”). Once an individual is able to perform the 
training session on a lower self-rated level of intensity (RPE) compared to the 
previous session, the resistance should be increased. In order to assess and 
adapt the individual respiratory muscle training and to continuously motivate 
individuals to perform this training, repeated measurements of the respiratory 
function are needed (26). Furthermore, respiratory muscle training should be 
started as early as possible after SCI, and longterm respiratory muscle training 
is considered to be beneficial (27). 
 
Study Limitation 
Only individuals with at least 10 respiratory muscle training sessions and two 
measurements of respiratory muscle strength (pre- and post measurement) were 
considered for this analysis. This bears the risk of a selection bias. Our goal was 





muscle training which are known to occur after about four weeks of regular 
training (2).  
We decided to investigate training intensity and –volume as the main factors 
affecting respiratory muscle strength improvements. Training intensity was a 
main predictor of improvements in respiratory muscle strength after inspiratory 
muscle strength training (Tables 3 and 4). Of course, there are also other factors 
such as gender, age, height, time post injury, spontaneous recovery, physical 
activity or smoking which can affect lung function parameters (28). However, the 
size of our sample was not large enough to include these factors as predictors 
in our models.  
The maximum training intensity of the Threshold IMT® device ends at 41cmH2O 
and thus, may restrict the maximum training intensity possible. In clinical 
practice, those individuals with higher respiratory muscle strength values 
generally change to another training device, which offers higher levels of 
resistance, e.g. the Powerlung® (PowerLung, Inc., Houston, TX, USA).  
There is a minority of motor incomplete individuals with paraplegia in our sample 
(Table 1). Therefore, our models may not be very accurate for this sub-group of 
individuals with SCI. However, individuals with motor incomplete paraplegia 
often have no respiratory problems and other rehabilitation goals such as e.g. 




The training intensity was more relevant than the training volume for a successful 
improvement in respiratory muscle strength in individuals with SCI. Thus, training 
intensity should be chosen as high as possible. Per 10 units of increase in 
training intensity, PImax will improve by 7%. For individuals with motor complete 
lesions also PEmax will increase by almost 7% per 10 units of increase in 
inspiratory muscle training.  
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Significant demands on healthcare resources  
during the COVID crisis 
 


















We read with interest the letter by Torres-Castro and colleagues (1). This has 
prompted us to provide our perspective and experiences from Switzerland. We 
hope it helps others around the world that are facing similar challenges.  
No country on earth has escaped the coronavirus disease (COVID-19). As we 
all know it is an infectious disease which is highly contagious (WHO). At the time 
of writing, most hospitals are currently experiencing the calm before the storm, 
but for others they in the midst of a hurricane. Hospitals have to plan for an 
increased demand of their services. This requires identifying staff with 
specialized knowledge, skills and decision making to work with patients with 
respiratory complications. 
We cannot flee from this dangerous virus; we are all filled with consternation. 
Even more concerned are people with spinal cord injuries (SCI) who are at 
increased risk from the COVID-19 disease. People with tetraplegia or high-level 
paraplegia and reduced lung function may be at higher risk of having more 
severe problems with COVID-19. However, we still do not know how much 
greater that risk is. Most people infected with COVID-19 virus will experience 
mild to moderate respiratory illness and recover without requiring special 
treatment (2). The WHO states that older people and those with underlying 
medical problems are more likely to develop serious illness (2). We assume that 
the rate of pneumonia will now, congruent to the general population, also 
increase in the SCI population due to COVID-19. Nevertheless, the incidence of 
death in those with SCI from pneumonia and influenza, are significantly higher 
than in the general population (3). 
The respiratory infection associated with COVID-19 is mostly associated with 
fever and dry, non-productive cough as mild symptoms. With increasingly severe 
symptoms following additional increasing oxygen requirement, difficulty in 
breathing, severe productive coughing and changes in lung tissue consistent 
with consolidation (4). Some patients subjectively describe the experience of 
breathing with COVID-19 as shards of glass in the lungs.   
Who takes care of all these “Post-COVID-19” patients after they have struggled 
in ICUs, been intubated for a long time and sedated against the disease and 
have luckily survived after weeks of mechanical ventilation? 




A few days ago, at the front line in the REHAB-center in Basel, Switzerland, the 
first patient arrived in our institution. A middle-aged man, tetra paretic, 
tracheotomized, only able to breathe by himself without the aid of the ventilator 
1 hour 3 times a day, unable to speak for more than a month, and not able to 
swallow. Fear was in his eyes. The second and third patient followed soon after. 
Many more of these patients will follow. Also at the Swiss Paraplegic Centre 
Nottwil, Switzerland there are currently a handful of patients with COVID-19 at 
the ICU for mechanical ventilation and weaning purposes. 
Currently, the treatment for COVID-19 is by symptoms and not diagnosis. 
Therefore, the treatment strategy does not differ from the treatment of other 
respiratory complications but most importantly, hygiene and personal safety 
have to be an absolute priority. It is imperative to make sure respiratory 
techniques do not generate high levels of aerosolized droplets that spread widely 
and increase the risk of transmission of respiratory viruses to health 
professionals (5). Therapists providing respiratory care to patients need to use 
appropriate personal protective equipment including N95/P2 masks, fluid 
resistant long-sleeved gowns, googles/face shields and gloves as (4). 
 
Respiratory therapy interventions include (5) 
• airway clearance techniques (e.g. positioning, percussion and 
vibrations, positive expiratory pressure therapy, mechanical insufflation-
exsufflation) 
• secretion clearance removal (e.g. assisted or stimulated cough 
manoeuvres, airway suctioning with closed inline suction catheters) 
• mobilization and exercise prescription which may trigger a cough and/or 
sputum expectoration 
 
Positioning and mobilization are effective methods of respiratory therapy. Prone 
ventilation for example is an effective strategy in mechanically ventilated patients 
(6). For patients with SCI it however requires a lot of human resources and 
expertise to perform safely and to ensure patients do not develop pressure 





into a seated or if possible, standing position is encouraged and is an effective 
method to lower the prevalence of plugging (7). The mobilization of SCI patients 
with high lesions or with co-morbidities/secondary complications is challenging 
even without a highly contagious disease. Now the therapy will be more 
complicated due to very strict hygienic precautions. 
There are various methods and devices for respiratory therapy with different 
objectives. Now the therapists need to weigh up the pros and cons, the possible 
positive effect against the hygienic measures. In general, re-usable respiratory 
equipment should be avoided. Use only the maximal needed equipment for 
single-patient use or material which can be properly decontaminated (4). 
Generally, a well-considered plan for mobilization and exercises is essential.  
 
Are we spinal cord rehabilitation units not predestined to look after these 
numerous patients similarly concerned with all these handicaps after intensive 
care? To rehabilitate these tetra paretic and ventilated patients is now our task 
regardless as to whether he or she was paraplegic, tetraplegic or healthy before. 
It is time to work closely together, to share our initial ways in the rehabilitation of 
these patients and to develop together rehabilitation plans and algorithms. To 
reach these goals we need a close collaboration with the other specialists in this 
field to serve best in the search for optimal treatment and interdisciplinary 
approach. A call to all leaders and readers of “Spinal Cord” to join –virtually - and 
to share their early experience in the rehabilitation of these patients – from China 
to the United States of America, from Finland to South Africa! 
With our longstanding tradition of treating and rehabilitating people with 
tetraplegia who are not able to breathe by themselves, we will care for all the 
“Post-COVID-19” patients in long term SCI rehabilitation units to enable these 
individuals to return to a meaningful life in society. 
 
When our first COVID-19-patient was asked at the end of the clinical visit, what 
he wishes most, he simply answered with the help of a speaking valve, 
connected to the ventilator “To eat a Cordon bleu!” For those not familiar with 
this term, it is veal folded and filled with famous Swiss cheese - a lot of proteins 
to support the respiratory muscles. We simply answered: “Not a bad idea!” 




We hope that this letter has increased readers awareness of the respiratory 
therapy with COVID-19 to feel supported during these challenging times. In that 
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In this thesis, three main aspects of the understanding and treatment of 
respiratory complications were assessed in seven projects. These three aspects 
were "pathophysiology and incidence of respiratory complications", 
"predictors/prognostic parameters of pneumonia" and "respiratory muscle 
strength". 
In this general discussion our results will be summarized and compared with the 
current literature and discussed in a comprehensive way. Thoughts regarding 
the generalizability of the results of this thesis will also be discussed in this 
chapter. Finally, there is an outlook into future research. 
 
Pathophysiology and incidence of respiratory complications 
Respiratory complications are still the main cause of morbidity and mortality in 
the acute phase of SCI (1). A recently published study found respiratory 
complications in 53% of all 174 included patients. This new study defined 
respiratory complications broader including acute respiratory failure, respiratory 
infections, atelectasis, non-hemothorax pleural effusion, pulmonary embolism or 
haemoptysis. In our investigation we focused on pneumonia (Chapter 2). As can 
be seen in our systematic review about the incidences of pneumonia in SCI, it is 
challenging to compare different studies because we rely on the quality and 
quantity of available published information (Chapter 2). Due to the diversity of 
the studies under investigation, aiming the same research question, conclusions 
need to be interpreted with caution or, to be on the safe side, seen as 
hypotheses. On the other hand, if conducted properly, systematic reviews and 
meta-analyses offer a number of benefits and are considered to be the highest 
level of evidence and they are extremely useful for making health care decisions 
based on the evidence obtained from multiple studies (2). In our systematic 
review we used random effects Poisson regression to estimate incidence of 
pneumonia per 100 person days and meta-regression to evaluate the influence 
of the clinical setting, the level of injury, the use of mechanical ventilation, the 
presence of tracheostomy, and dysphagia (Chapter 2). The main finding of our 





in the reporting of the incidence rates and we therefore should be cautious with 
interpreting the results (Chapter 2). The limited evidence about the influence of 
dysphagia on pneumonia was striking (Chapter 2) and therefore, in the next 
paragraph we looked at dysphagia in more detail. 
 
Dysphagia may result in pneumonia 
Pneumonia is a harmful consequence of swallowing dysfunction in SCI (1). 
Dysphagia is also a contributor to respiratory deterioration after SCI (3). Shem 
et al. discovered that 75% of spinal cord injured patients with dysphagia 
developed pneumonia compared to 29% without dysphagia (4). Dysphagia 
following cervical SCI may be caused by e.g. peripheral nerve damage, 
prevertebral soft tissue swelling, hypertonicity of the upper esophageal 
sphincter, mechanical obstruction from the bone graft or screw loosening, or side 
effects from medications (5-7). Thus, early and accurate diagnosis of swallowing 
dysfunction should be considered for all patients with cervical SCI to reduce the 
risk of life-threatening complications such as pneumonia (3). Mechanical 
ventilation and prolonged tracheostomy time further increase the risk of 
dysphagia and pneumonia (4, 8). In ICU patients, baseline neurological disease, 
emergency admission and duration of invasive mechanical ventilation appear to 
be prominent risk factors for dysphagia (9). Zuercher et al. stated that the first 
day of mechanical ventilation on ICU increases the risk of dysphagia by 98% 
with the maximum risk on day five (9). We found that the incidence rate of 
pneumonia is almost 5 times as high as in the post-rehabilitation setting (Chapter 
2). Therefore, all ICU patients post mechanical ventilation should be considered 
at risk of dysphagia (9). Dysphagia generally induces a significant burden on 
patients with cervical SCI and plays an essential role in the development of 
pneumonia. Therefore, dysphagia is also an important parameter in our 
RESCOM-project to be able to explain the connection between swallowing 









In December 2019, a cluster of patients with pneumonia of unknown cause was 
in the center of global attention. Since then, public attention has been focused 
on the recently discovered coronavirus responsible for COVID-19 disease. Some 
COVID-19 patients remain asymptomatic, whilst others show mild or moderate 
symptoms of COVID-19 pneumonia (10) of which 10% require mechanical 
ventilation and intensive care unit admission (11). With the onset of the COVID-
19 pandemic during the spring of 2020, we assumed that the increase of 
pneumonia within the SCI population would occur parallel to that of the general 
population (Chapter 8). However, until today, systematically collected data 
regarding the incidence of COVID-19 related pneumonia for the SCI population 
is still not available. At the beginning of July 2020 the total number of cases of 
COVID-19 infected persons was 11.125.245 globally with 203.836 new cases 
every day (WHO). The immediate health priorities have drastically changed 
since then and patients with SCI are among the population with a high risk of 
potentially terminal complications stemming from COVID-19 (12). Chest X-ray, 
ultrasound, and computer tomography are widely used for diagnostic imaging 
tests to diagnose COVID-19 pneumonia. As can be seen in our systematic 
review these tests are identical with those for the diagnosis of pneumonia in SCI 
(Chapter 2). In our RESCOM-project (Chapter 4) we recommend the clinically 
diagnosis of pneumonia using the criteria described in the pneumonia flow 
diagram endorsed by the Center for Disease Control and Prevention (13). 
Accurate diagnosis of pneumonia ensures patients receiving correct treatment 
quickly (10). 
 
Predictors and prognostic parameters of pneumonia 
Clinical prediction models are useful for various reasons including screening of 
high-risk individuals, predicting future events such as disease or death, and 
assisting medical decision-making and health education (14). An important 
aspect of prediction is to consider if a regression model can be used reliably in 





Predictive factors of respiratory complications 
Recently a retrospective study was published which described the predictive 
factors of respiratory complications in 175 patients with acute SCI during initial 
hospitalization (15). Sampol et al. found previous respiratory disease, complete 
lesion and concurrent chest trauma are the strongest predictors for respiratory 
complications (15). The level of injury and gender were not significant in this 
investigation (15). Various studies rejected these findings and concluded that 
patients suffering from tetraplegia or paraplegia affected rates of respiratory 
complications (16-19). As a general rule, the higher the lesion level the higher the 
number of complications. Moreover, the impairment level affected the rates of 
respiratory complications (16-18). In our investigation we could confirm that 
patients with AIS A impairment grade were at highest risk of pneumonia 
compared to AIS B, C, D (Chapter 3). Aarabi et al. presented an even more 
discrete specification: Compared to patients with AIS D, those who suffered from 
AIS A were nearly 10 times as likely to have respiratory complications, while the 
likelihood for AIS B and AIS C patients was 2.6 and 1.7 times respectively (18). 
There are even more predictors for respiratory complications. For example, the 
duration of hospitalization is much longer in patients who develop pneumonia. On 
the other hand, the longer the hospitalization, the higher the risk of respiratory 
complications (16, 18, 20) which in turn prolongs the length of hospitalization even 
further (8).  
 
Predictive value of tracheostomy 
Martin et al. showed that pneumonia is significantly associated with the need for 
a tracheostomy in 67% of patients with pneumonia (16). However, the timing for 
initiation of tracheostomy was discussed controversially in the literature. Some 
authors stated that the timing does not prevent the development of pneumonia 
(21) while others stated that the prevalence of pneumonia is lower in early onset 
of tracheostomy compared to late onset of tracheostomy (22). Moreover, the 
duration of tracheostomy seems to play an essential role and long-term 
tracheostomy places the patients at high risk for complications such as dysphagia 
and pneumonia (4). Regardless of whether patients have SCI or not, patients 





for respiratory complications (4). Poor secretion management is also a risk factor 
for pneumonia and thus, it is most important that dysphagia can be identified and 
interventions are initiated early to prevent respiratory complications (4). 
 
Predictive value of age 
The evidence about the predictive value of age and the risk of pneumonia is 
controversial. Sampol et al. observed only a small effect of age (15), and Martin 
et al. even found that pneumonia was not dependent on age at all (16). McKinley 
et al. showed that the incidence of pneumonia in persons with SCI who were older 
than 60 years was significantly greater than in younger age groups (23). The latter 
findings are in accordance with our own findings; the older the patients are, the 
more prone they are to respiratory complications (Chapter 3). Let’s think outside 
of the box. In the midst of the current pandemic, the question arises whether 
COVID-19 pneumonia is influenced by age. After infection with COVID-19, 
adverse outcomes and even death are more common among the elderly (above 
the age of 65) and those with underlying co-morbidities (50–75% of fatal cases) 
(11, 24). Zhao et al. separated their study sample into two groups; one with mild 
COVID-19 course of illness and one with severe COVID-19 course of illness. 
Severely affected patients were generally older relative to the mild cases (25). 
The severe form was defined as COVID-19 disease accompanied with 
pneumonia, pulmonary edema, acute respiratory distress syndrome, and even 
multiple organ failure. Some studies included only the severe cases of COVID-
19 pneumonia and most of the currently available studies were conducted in Asia, 
because this region was confronted from the beginning of the pandemic on. 
These circumstances may lead to a selection bias and a final consensus about 
age as predictor of COVID-19 pneumonia is not possible at this point in time with 
the currently published data. This is exactly the same with all other predictors for 
COVID-19 pneumonia. 
 
The most important predictor variables? 
How can we select the most important predictor variables for pneumonia? This 





our expertise to determine which variables are the most likely to change. Most 
studies have focused on non-modifiable predictors for respiratory complications 
after SCI. Since certain aspects like demographics or lesion level are immutable, 
it is important to place special emphasis on predictors which address modifiable 
risk factors. In the RESCOM-project a great variety of prognostic parameters for 
pneumonia will be collected with the aim to capture the most accurate predictors 
for pneumonia (Chapter 4). It is important to mention that this project is 
conducted in affluent, first world nations and hence, no generalizability is 
possible. But what about the predictors in low-income countries? Are they 
different? The population in low-income countries often have higher health risks 
due to low levels of access to safe drinking water, sanitation and hygiene, high 
level of air pollution, both indoor and outside. These are all factors which can 
influence the risk of infectious diseases such as pneumonia, but they were not 
of priority for our project in well-developed countries. Thus, the choice of 
predictors also depends on environmental factors. Sometimes the list of 
parameters in a study is not set in stone. The parameter that must be collected 
in any case is the occurrence of a COVID-19 pneumonia since the spring of 
2020. For this reason, we added this new parameter in our RESCOM-project 
(Chapter 4).  
 
Respiratory muscle strength training 
Respiratory muscle strength training, using either pressure threshold or 
resistance loaded breathing devices, is successful in both healthy individuals and 
chronic disease cohorts (26). As shown in Chapter 6 the respiratory muscle 
strength and lung function can be increased also in patients with SCI. Our findings 
are supported by the Cochrane review on respiratory muscle training in cervical 
SCI from 2013 (27). This review with 11 included studies provides an appropriate 
basis for research on optimization of training regimes. The authors of the 
Cochrane review from 2013 stated that longer-term studies are needed to 
ascertain optimal dosage and determine any carryover effects of respiratory 





complications. In order to relate the evidence published since 2013 to the results 
of the above mentioned Cochrane review and this thesis, we searched the 
literature in PubMed with the MEsH terms "spinal cord injuries" AND "respiratory 
muscle training". Table 1 presents an overview of these recently published 
studies and our results after detailed examination (28-32). These new findings 
further encourage the results presented in this thesis (Chapter 6) that respiratory 
muscle training is very valuable in persons with tetraplegia or high paraplegia. 
The advantages lie in improved respiratory function and this may lower the risk of 
excessive decline in respiratory function and respiratory complications (30). The 
meta-analysis in the Cochrane review revealed a statistically significant effect of 
respiratory muscle training for three outcomes, namely the mean difference for 
PImax, for PEmax and for vital capacity. In the evidence published since 2013 the 
mean differences for PImax ranged between 8-30cmH2O, for PEmax ranged 
between 3-16cmH2O and for FVC between 0.1-0.4L (Table 1). In comparison, in 
our investigations the mean difference for all three parameters lie within these 
ranges (Chapter 6). When looking at Table 1 it is obvious that the sample sizes 
of all published studies since 2013 are very low, ranging between 5 and 30. The 
sum of these sample sizes equals the sample size of each of our projects 
(Chapter 6 and 7). Therefore, our results seem to base on more robust data 
compared to the other studies shown in Table 1. The smaller the sample size, the 
more likely outliers are to skew the findings yielding possible unreliable and 
inaccurate results. Using an adequate sample size along with high quality data 
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n.a. n.a. n.a. 7% 7% 
TPI= time post injury; SD= standard deviation; Tetra= tetraplegia; Para= paraplegia; AIS= Spinal Injury Association Impairment Scale;  
FEV1= forced expiratory volume in one second; FVC= forced vital capacity; IQR= interquartile range; PEF= peak expiratory flow;  
PEmax= maximal expiratory pressure; PImax= maximal inspiratory pressure; 
IQR= interquartile range; IMT= inspiratory muscle training; EMT= expiratory muscle training;  
Sample-Size: only the intervention-groups were analyzed; 







The optimal dosage and duration of respiratory muscle training  
The trainings often follow an interval-based, high intensity and high-resistance 
protocol with low repetitions (30, 34). As confirmed in Chapter 7 we are convinced 
that training intensity should be as high as possible. The training intensities used 
in the majority of the recently published studies are at 50-60% of PImax baseline 
value and were comparable with the median training intensities chosen in our 
investigations (33cmH2O and 56cmH2O, respectively). In Table 1 it is obvious that 
the optimum dosages and duration of the training are variable and need to be 
further determined. The training duration in the majority of these new studies is 
about 4-8 weeks with training at 5 days per week (Table 1). In comparison, for 
able-bodied persons the American College of Sports Medicine recommends 1-3 
sets per exercise of 8-12 repetitions with 60-70% of one repetition maximum for 
novice to intermediate trained persons (35). However, some studies with able-
bodied persons have observed increases in muscle strength after only 2 to 4 
weeks (36-39). This early increase in strength is likely caused by neuromuscular 
adaptations such as improved coordination or learning and connective tissue 
adaptations (36, 40). In the Cochrane review of 2013 subgroup analyses were 
performed and only studies with a duration of less than eight weeks of training 
were included (27). They no longer found a significant effect of respiratory muscle 
training but on the other hand only three studies were included in this meta-
analysis (27). But how to define the optimal dosage and duration of training? In a 
very current study about respiratory muscle training in persons with tetraplegia, 
the training intensity, duration and frequency were based on limb muscle 
protocols and protocols used to effectively train respiratory muscles in patients 
with chronic obstructive pulmonary disease and motoneurone disease (41). 
However, there are still many details that need to be researched in respect to the 
optimal individual training, our study clearly showed that the highest possible 
training intensity should be aimed for (Chapter 7). In this way we could provide 
an important guideline for the clinical practice. 
 
The perfect point in time to start with respiratory muscle training 
Another answer is sought regarding the question about the perfect point in time 





respiratory muscle training was not in focus in the above mentioned Cochrane 
review from 2013 (27). In our investigations (Chapter 6 and 7) the respiratory 
muscle training usually started about six weeks after injury. Our argument was 
that a too early start of respiratory muscle training already at the ICU may increase 
the risk of respiratory muscle fatigue (1) and cause respiratory failure – on the 
other hand, it is also important to stop atrophy of respiratory muscles as early as 
possible. Respiratory muscle fatigue is one factor that leads to respiratory 
dysfunction and in turn may cause respiratory complications (1, 42). To our 
knowledge only two studies investigated the use of respiratory muscle strength 
training in the very acute phase of complete SCI. Derrickson et al. started 
inspiratory muscle training between 2-30 days post injury and McDonald et al. 
started training 7-17 days post injury (34, 43). The PImax increased about 
23cmH2O and 8cmH2O, respectively. Both studies provided evidence 
demonstrating that inspiratory muscle strength training is feasible and safe at an 
early stage post injury in patients with stable respiratory conditions. Further 
research is needed to demonstrate the ideal point in time for the start of 
respiratory muscle training in SCI. 
 
The consequence of training discontinuation  
Even though it was not a primary aim of this thesis, an outlook which is worth 
considering is what happens when the respiratory muscle strength training is not 
continued? A practical example of the discontinuation of respiratory muscle 
training is due to the COVID-19 pandemic. All respiratory techniques which 
generate high levels of aerosolized droplets that spread widely and increase the 
risk of transmission of respiratory viruses to other patients or health professionals 
are currently prohibited or only possible under the strictest security measures in 
clinical practice (Chapter 8). Therefore, also the respiratory muscle training in 
group setting is prohibited in our SCI center. Due to the fact that the respiratory 
muscle strength training is one factor in our RESCOM-project (Chapter 4) the 
question arises whether with the loss of these data the values of respiratory 
muscle strength will decrease and thus, the rate of pneumonia will even increase. 
No evidence of carryover beyond the training period was found by Berlowitz et al. 





25%, respectively, following six weeks of respiratory muscle training (32). After 
further six weeks of no respiratory muscle training these improvements could not 
be maintained with a decrease in PImax and in PEmax of 13% and 11%, respectively 
(32). These findings demonstrated that respiratory muscle strength partly 
attenuated with an interruption of the respiratory muscle strength training. 
Generally, strength training over time leads to alterations in strength, mass and 
neural adaptations (36). After exercising, a rapid initial increase in strength 
occurs due to the learning-effect (40). With prolonged strength training, the 
increase slowly reduces and changes in strength after neural adaptations begin 
to plateau (36). At this point, new stimuli are needed to increase strength (36). 
From our point of view, it is much better not to interrupt the respiratory muscle 
training after SCI but to always adapt the training a bit, to set new stimuli and to 
keep the strength of the respiratory muscles as high as possible. As we know 
from our investigation (Chapter 3) a PImax below threshold values may increase 
the risk of pneumonia. Patients with PImax values below the risk threshold values 
are recommended to train their inspiratory muscle strength to prevent pneumonia 
(Chapter 3). Our studies focused on well supervised respiratory muscle training 
in hospital setting. In a study of Postma et al. not one of the 40 participants 
continued respiratory muscle training during the full follow-up time of 1 year after 
discharge from inpatient rehabilitation (30). Boswell et al. found no differences 
between active and sham groups in any outcomes after one year of unsupervised 
respiratory muscle training (41). The participants reported the barriers that 
prevented them from using respiratory muscle training independently were e.g. 
laziness, forgetfulness, lack of time with career, lack of interest, no coach meant 
less motivation, misplaced device or no fun sucking on plastic (41). Additionally, 
patients with restricted hand function need personal assistance for the respiratory 
muscle training and possibly such personal assistance is not available, or the 
patients feel a barrier asking for help (30). Future studies should focus on 
respiratory muscle training in the outpatient setting and on methods how to keep 









Generally, we can summarize that with very strong respiratory muscles patients 
have a distinctively reduced risk of pneumonia (Chapter 3). Well preserved 
inspiratory muscle strength is essential in maintaining gas exchange during quiet 
breathing and during increased respiratory demands such as exercise, 
wheelchair propelling or respiratory complications (44). Hardy et al. speculate 
that respiratory muscle training may improve central haemodynamics and 
exercise capacity in persons with cervical SCI via an enhanced respiratory 
muscle pump and lower operational lung volumes (26). Respiratory 
complications following SCI are common, with a particularly high reported 
prevalence of mucous retention, atelectasis, pneumonia, and respiratory failure 
(27, 45, 46). Thus, Berlowitz et al. summarized that any intervention that 
improves respiratory function and thereby prevents or alleviates these conditions 
would be of great benefit to persons with SCI (27). From our investigations we 
can confirm that training of the respiratory muscles against resistance is an 
effective method of increasing the respiratory muscle strength (Chapter 6 and 7) 
and an intensive training achieves much better effects compared to a moderate 
training (Chapter 7). Fundamentally respiratory muscle training should be an 
addition to the usual inpatient rehabilitation for persons with SCI and impaired 
respiratory function (30).  
 
Generalizability of results 
The principal goal of scientific research is to increase our understanding of the 
world around us (47). Therefore, we as researchers study different populations. 
The SCI population is a very specific group of patients and mostly consists of 
small numbers of participants. The results of our research provide insights into 
respiratory related issues and clinical practice. But how do we know if a study's 
result can be applied to another group or population? 
The Institute for Work & Health perfectly formulates that once researchers have 
collected enough data to support a hypothesis, they can develop a premise to 





(47). Even if study projects were well conducted with a strong design and 
rigorous reporting, the question remains, for which population could these results 
be generalized? Possible questions for the studies in this thesis need to be 
considered for generalizability, e.g.: 
How important is it to transfer the predictors of pneumonia to another population? 
Can the knowledge about predictors of pneumonia in SCI also be applied by an 
unknown clinician? 
Can the respiratory function and following the rate of pneumonia through 
respiratory muscle strength training in SCI also work in a center or country where 
the project is not well known? 
Would the results apply to clinicians of other workplaces that differ from 
specialized SCI-rehabilitation centers? 
Would persons with SCI and younger than 18 years of age respond the same 
way to the respiratory muscle training? 
Generally, the results of our projects are limited to patients with SCI and the 
rigorous pre-defined inclusions criteria. Thus, our results cannot be transferred 
to another clinical disease picture. However, a transfer to other SCI-specific 
centers should be possible and also the transfer into daily clinical SCI practice. 
All projects of this thesis were conducted in industrial nations in selected 
continents, therefore, the results also referring to these conditions.  
The final goal of generalizing should be moving from observations to scientific 
theories or hypothesis (47). Let us think visionary and assume the perfect 
situation. If we had found that respiratory muscle strength training is an effective 
method to decrease respiratory complications. Further assuming other 
researchers are also convinced of this result or possibly come to the same 
conclusion in their investigations, this can initiate many more research studies. 
These studies will be conducted with increasing sample sizes, with different 
groups of participants, with differing training intensities and –duration, with 
differing training devices and in different clinical settings, with alternative 
respiratory muscle strength training methods and so on. We need to generalize 
an existing approach to a new domain. When then the result of the positive effect 
of respiratory muscle training is found to be consistent across person, time and 





respiratory muscle strength training the risk of pneumonia can be reduced after 
SCI." Currently, it is just a vision and we will continue to research. 
 
Future research 
This thesis is one further step into the understanding and treatment of respiratory 
complications in the SCI population. New knowledge could be added in terms of 
incidence of pneumonia, predictors for respiratory complications, lesion specific 
reference values in SCI and optimization in respiratory muscle training regimens. 
The studies in this thesis dealt mainly with respiratory muscle training and proved 
the effectiveness for respiratory muscle strength and lung volumes and provided 
details about the optimal training intensity.  
It is almost needless to say that there is still a big gap of knowledge regarding 
respiratory complications in the SCI population. Thus, some future perspectives 
are summarized in this subchapter to provide more insights into possible 
research projects of the next few years. 
 
Respiratory muscle training in the chronic phase 
In our investigations about respiratory muscle strength we focused on the acute 
phase of SCI (Chapter 6 and 7). There are some recently published studies 
investigating respiratory muscle training in chronic SCI (Table 1). Most of this 
evidence supported the hypothesis that respiratory muscle training in chronic 
SCI increases respiratory capacity and inspiratory muscle strength whereas it 
needs to be mentioned that two studies focused on highly trained athletes with 
cervical SCI (28, 31, 32). Boswell-Ruys et al. did a randomized controlled trial 
and separated the analysis into the effect of inspiratory muscle training in acute 
versus chronic SCI (41). They found an increase in inspiratory muscle strength 
but not in expiratory muscle strength after training in the acute phase (41). After 
comparison of baseline data with that collected after 1 year no significant 
difference showed in any outcomes, but it needs to be mentioned that the 
respiratory muscle training in this chronic phase was unsupervised (41). Still 





a lack of knowledge on long-term effects of respiratory muscle training on 
respiratory muscle strength and lung function. 
Comparison of different respiratory muscle training regimes 
There are some recently published studies which investigated inspiratory muscle 
training, expiratory muscle training (48) or both regimes combined as respiratory 
muscle training (Table 1). Some studies compared respiratory muscle training 
interventions with a control condition (49, 50). To our knowledge only two studies 
compared the effect of inspiratory and expiratory muscle training regimes (41, 
51). One was our own investigation where we compared inspiratory muscle 
training with a combined training of in- and expiratory muscle training (Chapter 
6). Even if the combined respiratory muscle training was performed with more 
repetitions per training and nearly twice as long, the relative improvements of 
respiratory function parameters were comparable with isolated inspiratory 
muscle training (51). The other study, just published in 2020, showed that 
expiratory muscle training did not result in greater increase in PEmax (41). They 
assumed that this result may have been due to the high number of participants 
with complete cervical injuries resulting in complete paralysis of the main 
expiratory muscles (41). In daily clinical practice the degree and severity of 
respiratory paralysis is usually decisive in choosing the respiratory muscle 
training regime (52). More work on the training regimes is necessary to 
determine the potential of the different training regimes dependent on the level 
and the completeness of injury and finally, to provide the optimal respiratory 
training methods for defined subgroups of patients with SCI. 
 
Respiratory muscle training on top of spontaneous recovery  
There is evidence about the partial spontaneous recovery of respiratory muscles 
after SCI (53-55) and on the other hand there are various studies, including our 
investigations (Chapter 6 and 7), which proved the effect of respiratory muscle 
training (Table 1). Mueller et al. found that during inpatient rehabilitation, lung 
function and respiratory muscle strength may increase without specific 
respiratory muscle training (56) but to what extent? The only way to determine 
the absolute increase of respiratory muscle strength and lung function on top of 





The list of predictors for pneumonia 
Respiratory muscle strength and lung function can be best predicted with a 
complete list of accurate predictors. In a next step, predictors such as thoracic 
trauma, previous respiratory diseases, use of physiotherapy techniques or 
assisted coughing techniques need to be evaluated (15). Previous respiratory 
disease such as asthma, chronic obstructive pulmonary disease and sleep 
apnoea was present in 10% of all included patients in the study from Sampol et 
al. and was associated with a very high risk of respiratory complications (15). 
Baseline cardiopulmonary comorbidities can be assessed by using the ISCoS 
Pulmonary function data set which consists of questions on pulmonary 
complications (asthma, chronic obstructive pulmonary disease, sleep apnea and 
others) before and after SCI, smoking history, current utilization of pulmonary 
assistance and lung function measurement (57). The systematic review and 
meta-analysis in this thesis (Chapter 2) highlighted the limited data on the 
incidence of pneumonia caused by dysphagia. Further research should 
concentrate on the predictive influence of dysphagia on pneumonia. Additionally, 
information on breathing during sleep is also of interest for the list of predictors, 
to be able to assess periods of hypoventilation or the coexistence of sleep apnoea 
(15). This is of high clinical relevance since these patients with SCI could benefit 
from early intensive physiotherapy, assisted coughing techniques and 
medications (15). For future research also a prospective approach is essential to 
reduce the potential source of bias and confounding. One very important first step 
is our RESCOM-project (Chapter 4) but taken even further, a randomized 
controlled trial can also be an approach to possibly answer the question as to 
whether the risk of pneumonia can be reduced by respiratory muscle training. 
 
The influence of medication on pneumonia 
To cover the whole spectrum of the treatment of respiratory complications we 
speculate to what extent medication can influence pneumonia. With our 
prospective RESCOM project we will try to answer this question amongst other 
research questions (Chapter 4). A recent systematic review and meta-analysis 
showed that the risk of pneumonia was increased with steroids (58). There are 





in terms of improvements in neurological scores (58). The authors suspected a 
direct association between the use of steroids and risk of gastrointestinal 
bleeding, sepsis and an inverse association with risk of atelectasis and mortality 
(58). Füssenich et al. investigated the usage of medications for spasticity and 
the influence on pneumonia and showed that patients using these medications 
developed significantly more pneumonia (59). The authors speculated that 
spasticity of trunk muscles may have a negative effect on respiratory function by 
decreasing chest wall compliance and increasing intra-abdominal pressure and 
furthermore, the usage of these medications could affect the respiratory center 
in the medulla oblongata (59). Severe spasticity can cause insomnia and pain 
and following the overall tolerance or endurance for weaning from the ventilator 
can be reduced with a higher risk of pneumonia (59). 
Further research is required to answer the question if the benefits of medications 
outweigh the risks of pneumonia in patients with SCI? 
 
Outlook in alternative respiratory muscle training methods 
Although we know that training is effective, in daily clinical practice patients often 
consider respiratory muscle training as cumbersome and boring (60). A problem 
for which new and innovative solutions are required. In our investigation the 
implementation of respiratory muscle training in group setting was a first step to 
motivate the patients to go on with respiratory muscle training (Chapter 6 and 7). 
A further very interesting approach to improve the strength of respiratory muscles 
was investigated by Tamplin et al. (60, 61). They explored the effect of a group 
therapeutic singing intervention for persons with tetraplegia. Generally singing is 
demanding for the respiratory system and requires strong and fast inspirations, 
extended, regulated expirations and recruitment of accessory respiratory muscles 
(27, 60). After singing in a therapeutic group for 1 hour at least three times a week 
for 12 weeks, the PImax measured by a small nasal probe, showed a statistical 
significant increase. Even if it did not show a clear physiological improvement in 
in- and expiratory muscle strength, singing in a group therapy can improve mood 
and quality of life (60). An advantage could be that singing may be better 
incorporated into daily routine than traditional respiratory muscle training and 





choir might be an alternative (60). Furthermore, singing can be effective in 
improving oral conditions and maintaining good oral condition is essential for 
preventing of aspiration pneumonia, especially in the aging society (62). 
Respiratory muscle training by singing is an approach that is worth pursuing in 
future research. 
Sleep disordered breathing has a respiratory related impact for persons with 
tetraplegia (63, 64). Berlowitz et al. showed in a cross-sectional survey that more 
than 90% of persons with complete tetraplegia were affected with obstructive 
sleep apnoea (65). Obstructive sleep apnoea may play a role in the development 
of atelectasis (64). Atelectasis is the most common respiratory complication in 
acute SCI and can lead to pneumonia (66). A highly topical review of Courtney 
investigated singing and playing wind instruments in patients with obstructive 
sleep apnoea and found reduced incidence of sleep apnoea due to e.g. 
improvements in muscle tone of the upper airway and respiratory muscle strength 
(67). Therefore, an important future research question arises; may intensive and 
regular participation in activities that require high levels of breath control, e.g. 
singing or playing wind instruments be helpful to reduce sleep apnoea also in 
persons with SCI? 
A further interesting approach to improve respiratory health in SCI is to examine 
the use of electrical stimulation (68). Expiratory muscle strength plays the most 
basic and important role in producing a functional cough flow to successfully 
clear respiratory secretions (48, 69). Retention of secretion as a consequence of 
ineffective coughing may lead to respiratory complications (1, 70). McBain et al. 
showed that abdominal muscle training through a combination of electrical 
stimulation over the abdominal muscles and voluntary cough had the potential 
to improve cough after SCI. Even if an improvement in cough parameters after 
training suggests an improvement in muscle strength, the abdominal pressure 
did not increase with training. However, lung function such as FVC, FEV1 and 
PEF significantly increased after training. Additionally, the inspiratory capacity 
increased significantly after training and a sufficient inspiratory capacity is 
essential for the inspiratory phase of cough (69). Coughing is most important for 





is unknown whether future, adequately powered studies will improve these 
findings. We conclude that even if it is an interesting approach to improve the 
respiratory muscle strength by electrical stimulation, currently it is still more 
practical to focus on inspiratory muscle strength training by resistance training. 
 
Research potential in the COVID crisis 
In light of the novel COVID-19 pandemic, we need to prepare to detect and treat 
this virus in vulnerable populations, including persons with SCI (72). Therefore, 
also in our RESCOM-project an additional parameter was added to capture 
those patients with SCI and COVID-19 pneumonia (Chapter 4). There are first 
concerns that patients with SCI may not present with the typical COVID-19 
symptoms and therefore, the diagnosis may be delayed (72). Currently we also 
do not know the incidences of pneumonia caused by COVID-19 virus, is the 
number of pneumonia increasing due to COVID-19? We assume that SCI 
induced respiratory dysfunction increases susceptibility to viral pneumonia 
caused by COVID-19 and likely increased morbidity and mortality compared to 
their able-bodied counterparts (72). Generally more and rapid work is needed to 
address these concerns and to standardize best practice protocols throughout 
the SCI community. An enormous spectrum of research questions opens up with 
COVID-19 disease, for the general population and for the SCI-population, 
respectively.  
 
In summary, the overarching aim of future research in respiratory related issues 
in the SCI-population should focus on the reduction of respiratory complications 
and being farsighted to increase the quality of life for the patients and to reduce 
the health care costs. 
Recommendations for respiratory muscle training in hospital and community 
settings need to be developed and implemented in therapeutic practice. Long-
term follow-up studies will assist in determining any carryover effects of 
respiratory muscle strength training. 
Future studies should focus on aspects such as the influence of comorbidities 
and history of respiratory diseases, e.g. previous diagnosis of asthma, chronic 





lung function, the type of bacteria/virus causing pneumonia, the influence of 
dysphagia on respiratory complications and the rate of mortality due to 
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Medicine takes steps forwards in the treatment of persons with spinal cord injury 
(SCI). Nevertheless, respiratory complications are nowadays still the major 
reason for morbidity and mortality in the SCI population. Mainly endangered are 
persons with a tetraplegia because their respiration is limited due to the level of 
lesion and concomitant paralysis of respiratory muscles.  
This thesis provides further insight and is a next step into the understanding and 
treatment of respiratory complications in the SCI population. New knowledge has 
been added in terms of incidence of pneumonia, predictors for respiratory 
complications and lesion-specific reference-values in SCI. Further, the studies in 
this thesis dealt mainly with respiratory muscle training and proved the 
effectiveness of increases in respiratory muscle strength and lung volume and 
provided further knowledge on the optimal training regimen. Finally, this thesis 
also addressed SCI specific issues regarding the COVID-19 crisis. 
The thesis is subdivided into 9 chapters which are presented in the following text. 
 
Chapter 1 provides a general overview of SCI and describes background 
information of respiratory complications in these patients. Furthermore, the 
current knowledge regarding respiratory muscle training specific aspects in SCI 
in comparison with able-bodied persons is summarized. At the end of Chapter 1 
the topics and the contents of each single study are presented. 
In Chapter 2 we systematically assessed the incidence of pneumonia in persons 
with SCI and used systematic and quantitative methods to examine reasons for 
variation in incidence estimates. A systematically collected number of studies on 
pneumonia in persons with SCI was still missing and to our knowledge, this is 
the first systematic review on the incidence of pneumonia in the SCI-population. 
Systematic reviews on prevalence and incidence data are becoming increasingly 
important as decision makers realize their usefulness in informing policy and 
practice. In this systematic review we included 25 studies for the meta-
regression. The incidence rates ranged from 0.03 to 7.21 patients with 
pneumonia per 100 days. In the multivariable meta-regression the incidence rate 
in the acute setting was more than twice as high as in the post-rehabilitation 





post-rehabilitation setting. The main finding of this systematic review and meta-
regression was, that we found large heterogeneity in the reporting of the 
incidence rates and we therefore should be cautious with interpreting the results. 
In the study presented in Chapter 3 we investigated if respiratory function, 
measured at an arbitrary point in time after onset of the SCI, can be used as a 
discriminator for pneumonia risk. Maximal inspiratory pressure was found to be 
the best parameter to discriminate between SCI patients with and those without 
pneumonia independent of injury severity. A PImax threshold value of 115% of the 
lesion specific reference value in motor complete patients and 93.5cmH2O in 
motor incomplete patients were identified. A PImax threshold value of 115% 
means for the daily clinical practice that inspiratory muscle strength needs to be 
15% higher than the lesion-specific reference value (100%). If a patient does not 
succeed in increasing the target value to at least 115% predicted, his risk of 
pneumonia is 4.6 fold higher. In patients with AIS C/D lesions, the expiratory 
parameters FEV1, PEF and PEmax were also excellent discriminators between 
patients with and those without pneumonia. In patients with motor complete 
lesions and PImax values below the threshold values, inspiratory muscle training 
should be promoted in clinical practice to reduce the risk of pneumonia. In 
patients with motor incomplete lesions and accordingly completely or partly 
maintained expiratory muscle innervation, a combination of inspiratory and 
expiratory muscle training is recommended.  
In Chapter 4 we introduce the ongoing RESCOM-project (respiratory 
complications), the first multicenter and multinational study to prospectively 
evaluate predictors of pneumonia from a representative sample of persons with 
SCI receiving inpatient rehabilitation in a high-income setting. To the best of our 
knowledge, there is currently no comprehensive database available for the 
further development of generalizable prognostic models, nor to improve causal 
inference of pneumonia risk in light of impairment in respiratory function. The 
cohort study RESCOM aims to establish such an evidence base in SCI. This 
study will provide insight as to whether the improvement of respiratory muscle 
strength and respiratory function represent promising targets for intervention to 





2016 across 10 SCI rehabilitation centers from Australia, Austria, Germany, the 
Netherlands and Switzerland. In-patients with acute SCI, with complete or 
incomplete cervical or thoracic lesions and not/no more dependent on 24-hour 
mechanical ventilation within the first three months post injury are eligible for 
inclusion. The RESCOM cohort will enroll 500 persons with SCI. The primary 
outcome is pneumonia in relation to respiratory function; secondary outcomes 
include pneumonia related mortality and quality of life. We will use the 
longitudinal data for prognostic models on inpatient pneumonia risk factors. We 
believe RESCOM will improve clinical practice through better selection of 
patients at highest risk for pneumonia and optimal targeting of interventions (i.e. 
respiratory muscle training) during inpatient rehabilitation. 
Prediction of respiratory function is an essential component of understanding 
respiratory status in daily clinical practice, but the prediction of respiratory 
function based on able-bodied values has limitations in persons with SCI. In 2012 
a reference value calculator was developed for persons with SCI to obtain an 
overview of respiratory function status whilst taking into account the spinal cord 
lesion level. It was unclear whether these models are accurate for persons 
several years post injury. Therefore, the aim of this study presented in Chapter 
5 was to test the accuracy of the 2012 models in persons with long-term SCI and 
if necessary develop and validate new prediction models of respiratory function. 
The prediction models published in 2012 showed to be not accurate enough for 
persons with long-term SCI and new models needed to be developed. The 
reason was that the 2012 equations underestimated the actual values in the 
lower range and overestimated them in the upper range for all included 
respiratory function parameters. For clinical practice, comparison of measured 
values with population specific reference values is important in order to prescribe 
preventive treatment. One possible treatment could be the increase of inspiratory 
muscle strength by respiratory muscle training. Using lesion specific relative 
values of respiratory function is much more sensitive in the SCI-population than 
just absolute values or reference values from able-bodied persons. For lung 
function we did not find better models for persons with long-term SCI but the 





differences between measured and predicted values for respiratory muscle 
strength were all around 4.0cmH2O. The predictors included in the new models 
explained 69% of the variance (R2) for both respiratory muscle strength 
parameters. 
A major part of this thesis is dedicated to the training of respiratory muscles. 
Individual respiratory muscle training may be a central aspect of maintaining 
health and quality of life in this group of patients with SCI. In the clinical routine, 
the question about the most effective training regime is often raised. In Chapter 
6 we follow the question if isolated inspiratory muscle training or a combination 
of in- and expiratory muscle training was more effective and evaluated the clinical 
implementation of a respiratory muscle training group during initial rehabilitation 
of patients with SCI. Both in- and combined in- and expiratory muscle training 
increased lung function and respiratory muscle strength on median by 27%. An 
increase of about 30% in the respiratory muscle strength parameters after the 
inspiratory muscle training and in the lung function parameters of about 17% 
could be achieved. The combined in- and expiratory muscle training improved 
the respiratory muscle strength parameters on average by 34% and the lung 
function parameters by about 27%. Even if the combined respiratory muscle 
training was performed with more repetitions per training and nearly twice as 
long, relative improvements of respiratory function parameters were comparable 
with isolated inspiratory muscle training. Thus, both training regimes revealed a 
great effect on improvements in respiratory function parameters and especially 
in respiratory muscle strength. Therefore, from our point of view respiratory 
muscle training should be an integral part of the therapy and the clinical 
implementation of a respiratory muscle training group during initial rehabilitation 
for individuals with SCI seems to be worthwhile. 
In Chapter 7 we devote the training intensity and the training volume to the main 
emphasis of respiratory muscle training. It is important to understand the effect 
of training intensity and volume in SCI that interventions can be targeted at these 
patients to prevent respiratory complications and therefore, to reduce 
hospitalization and to improve recovery. The current practice of respiratory 





aim of the multiple regression analysis was to investigate the effect of training 
intensity and training volume on relative improvements in respiratory muscle 
strength. The training intensity seemed to be more relevant than the training 
volume for a successful improvement of the respiratory muscle strength. Patients 
with motor complete lesions showed a 7% increase in PImax and PEmax per 
10cmH2O increase in training intensity. A training intensity below 30% of PImax 
did not seem to produce a high enough stimulus for an improvement in 
respiratory muscle strength. However, the higher the training intensity, the higher 
the improvements which can be expected in respiratory muscle strength. We 
recommend a regular increase of the training intensity during the inspiratory 
muscle strength training in order to achieve optimal results. 
In December 2019, a cluster of patients with pneumonia of unknown cause was 
in the center of global attention. Since then the world is focusing on the recently 
discovered coronavirus causing COVID-19 disease. Some persons with COVID-
19 remain asymptomatic, whilst in others the infection can cause mild or 
moderate symptoms with COVID-19 pneumonia of which 10% require 
mechanical ventilation and intensive care unit admission. The letter by Torres-
Castro and colleagues has prompted us to provide our perspective and 
experiences from Switzerland. These perspectives summarized in Chapter 8 
aimed to increase readers awareness of the respiratory therapy with COVID-19 
to feel supported during these challenging times. People with tetraplegia or high-
level paraplegia and reduced lung function may be at higher risk of having more 
severe problems with COVID-19. However, we still do not know how much 
greater that risk is. Currently, the treatment for COVID-19 is by symptoms and 
not diagnosis. Therefore, the treatment strategy does not differ from the 
treatment of other respiratory complications but most importantly, hygiene and 
personal safety have to be an absolute priority. Now the therapists need to weigh 
up the pros and cons, the possible positive effect against the hygienic measures. 
It is time to work closely together, to share our initial ways in the rehabilitation of 
these patients and to develop together rehabilitation plans and algorithms. To 





field to serve best in the search for optimal treatment and interdisciplinary 
approach. 
In Chapter 9 the results of this thesis are put in the context of the current state 
of knowledge. It is discussed to what extent the results of the thesis contribute 
to the extension of scientific understanding of respiratory complications in spinal 
cord injury. Further this section deals with the resulting potential and the 
influence on reduction of respiratory complications. The discussion concludes 
with a prospect for various ideas for new research questions and stimulation of 

















De medische wereld maakt veel progressie in de behandeling van personen met 
een dwarslaesie. Desondanks zijn respiratoire complicaties tegenwoordig nog 
altijd de voornaamste oorzaak van morbiditeit en mortaliteit in de populatie van 
personen met een dwarslaesie. Vooral personen met een tetraplegie zijn 
bedreigd, vanwege de restrictie van het respiratoire systeem ten gevolge van 
het niveau van de laesie en de daarmee verbonden paralyse van de respiratoire 
musculatuur. 
Deze thesis biedt interessante inzichten in de thematiek over 
ademhalingscomplicaties na een dwarslaesie en is een volgende relevante stap 
in het beter begrijpen van de behandeling van respiratoire complicaties. Nieuwe 
kennis werd gegenereerd met betrekking tot de incidentie van pneumonieën, 
predictoren voor respiratoire complicaties en laesie-specifieke 
referentiewaarden bij dwarslaesie patiënten. Verder handelden de studies in 
deze thesis voornamelijk over respiratoire spiertraining en onderzochten ze hun 
effectiviteit voor toename van de ademhalingsspierkracht en longvolumes en 
boden zo nieuwe inzichten voor een optimaal trainingsregime. Finaal gaat deze 
thesis ook in op de dwarslaesie specifieke problematiek met betrekking tot de 
COVID-19 pandemie.  
Deze thesis is onderverdeeld in 8 hoofdstukken die gepresenteerd worden in 
onderstaande tekst. 
Hoofdstuk 1 geeft een algemeen overzicht over het thema dwarslaesie en 
respiratoire complicaties. Daarnaast wordt de actuele kennis betreffende 
trainingsspecifieke aspecten bij voetgangers en personen met een dwarslaesie 
samengevat. Aan het einde van hoofdstuk 1 worden de onderwerpen en de 
inhoud van elke afzonderlijke studie gepresenteerd. 
In hoofdstuk 2 onderzochten we met een systematische literatuurstudie de 
incidentie van longontstekingen bij personen met dwarslaesie en werden met 
systematische en kwantitatieve methoden de redenen voor de afwijkingen van 
incidentiecijfers examineert. Een systematisch geregistreerd aantal 
longontstekingen bij personen met dwarslaesie ontbrak nog en voor zover we 
weten is dit de eerste literatuurstudie met betrekking tot dit thema. 





steeds belangrijker, aangezien besluitvormers hun nut inzien voor politieke 
informatie en praktische toepasbaarheid. Vijfentwintig studies werden in der 
systematische review geïncludeerd voor meta-regressie. De incidentie 
van patiënten met een longontsteking varieerde van 0.03 to 7.21 per 100 dagen. 
De multivariabele meta-regressie liet zien dat de incidentie tijdens de acute 
revalidatiefase tweemaal zo hoog was in vergelijking met de post-
revalidatiefase. De belangrijkste conclusie van deze systematische review en 
meta-regressie was dat we een grote variatie in incidentie van longontstekingen 
vonden, een daarom een terughoudende interpretatie van de resultaten op zijn 
plaats is.  
In de studie gepresenteerd in hoofdstuk 3 hebben we onderzocht of de 
ademhalingsfunctie, gemeten op een willekeurig tijdstip na het optreden van de 
dwarslaesie, gebruikt kan worden als een discriminator voor het risico op een 
pneumonie. Maximale inspiratoire druk bleek de beste parameter te zijn om te 
discrimineren tussen mensen met een verhoogd risico op longontstekingen en 
personen met een lager risico, en dat onafhankelijk van de ernst van het letsel. 
De drempelwaarde voor de inademkracht lag bij 115% van de laesie-specifieke 
referentiewaarden bij mensen met een motorische complete dwarslaesie en 
93.5cmH2O bij motorische incomplete patiënten. Een drempelwaarde van 115% 
van de maximale inademkracht betekent voor de klinische praktijk dat de 
inspiratoire spierkracht 15% hoger moet zijn dan de laesie-specifieke 
referentiewaarden (100%). Als een patiënt er niet in slaagt de streefwaarde te 
vermeerderen tot minstens 115% van de voorspelde waarde, stijgt zijn/haar 
risico op een pneumonie met factor 4.6. Bij patiënten met een incomplete 
dwarslaesie (AIS C/D) kunnen daartoe ook de inademkracht, de één seconde 
waarde en de maximale uitademsnelheid gebruikt worden als onderscheidende 
parameters voor het risico op een longontsteking. Bij patiënten met motorisch 
complete laesies en een maximale inademkracht onder de drempelwaarden, 
moet inspiratoire spiertraining gepromoot worden in de klinische praktijk om het 
risico op een pneumonie te verminderen. Bij patiënten met een motorisch 





musculatuur, wordt een combinatie van inspiratoire en expiratoire spiertraining 
aanbevolen. 
In hoofdstuk 4 stellen we het lopende RESCOM-project (respiratoire 
complicaties) voor, de eerste multicenter- en multinationale studie om 
prospectief predictoren van pneumonieën te evalueren door een representatieve 
steekproef van personen met een dwarslaesie, die stationair revalideren in 
geïndustrialiseerde landen met hoge inkomens. In zoverre ons bekent, is er op 
het moment geen uitgebreide database beschikbaar voor de verdere 
ontwikkeling van generaliseerbare prognostische modellen, noch om de causale 
gevolgtrekking te verbeteren met betrekking tot stoornissen van de respiratoire 
functie. De cohortstudie RESCOM beoogt een dergelijk basis van evidentie vast 
te stellen bij dwarslaesie. Deze studie beoogt inzicht te verschaffen of de 
verbetering van respiratoire spierkracht en respiratoire functie veelbelovende 
doelen zijn als interventie ter preventie van pneumonieën bij dwarslaesie. 
RESCOM begon in Oktober 2016 met het rekruteren in 10 revalidatiecentra uit 
Australië, Oostenrijk, Duitsland, Nederland en Zwitserland. Stationaire patiënten 
met acute dwarslaesie, met complete of incomplete cervicale of thoracale 
laesies en niet/niet meer afhankelijk van 24 uur mechanische ventilatie binnen 
de eerste 3 maanden na letsel kwamen in aanmerking voor inclusie. Het 
RESCOM-cohort zal 500 personen met dwarslaesie includeren. De primaire 
uitkomstmaat is pneumonie in relatie tot respiratoire functie; secundaire 
uitkomstmaten zijn pneumonie gerelateerde mortaliteit alsook kwaliteit van 
leven. We zullen de longitudinale data voor prognostische modellen betreffende 
risicofactoren op pneumonieën in stationaire setting gebruiken. Wij geloven dat 
RESCOM de klinische praktijk verbeteren kan door een betere selectie van 
patiënten met een hoog risico op pneumonieën en een optimale targeting van 
interventies (d.w.z. respiratoire spierkrachttraining) tijdens stationaire 
revalidatie. 
De voorspelling van de longfunctie na een dwarslaesie is een essentiële 
component om de respiratoire status van de patiënt in de klinische praktijk te 
begrijpen. Deze predictie van de ademhalingsfunctie die gebaseerd is op 





In 2012 werd er een calculator voor referentiewaarden ontwikkeld voor personen 
met een dwarslaesie, om zo een overzicht te bekomen op de respiratoire status 
met inbegrip van het niveau van de dwarslaesie. Het was onduidelijk of deze 
modellen accuraat waren voor personen enkele jaren na optreden van het letsel. 
Daarom was het doel van deze studie, gepresenteerd in hoofdstuk 5, het testen 
van de accuraatheid van de in 2012 ontwikkelde modellen bij personen met een 
chronische dwarslaesie, en indien nodig, het ontwikkelen en valideren van 
nieuwe predictiemodellen betreffende respiratoire functie. De in 2012 
gepubliceerde predictiemodellen bleken niet accuraat genoeg te zijn voor 
personen met een chronische dwarslaesie en daarom werden nieuwe modellen 
ontwikkeld. De grond was dat de vergelijkingen van 2012 de werkelijke waarden 
in het lagere bereik onderschatten en ze in het hogere bereik overschatten, en 
dit voor alle geïncludeerde parameters van de ademhalingsfunctie. Voor de 
klinisch praktijk is het vergelijken van de daadwerkelijk gemeten waarden met 
populatie-specifieke referentiewaarden belangrijk, om zo preventieve 
behandeling voor te kunnen schrijven. Een mogelijk behandeling is het verhogen 
van de inspiratoire spierkracht door ademhalingsspiertraining. Het gebruik van 
laesiespecifieke referentiewaarden van respiratoire functies is veel sensitiever 
bij de dwarslaesie-populatie dan het gebruik van absolute waarden of 
referentiewaarden bij gezonde personen. Voor longfunctie vonden we geen 
betere modellen voor personen met een chronische dwarslaesie, maar de 
modellen voor respiratorische spierkracht konden geoptimaliseerd worden. Voor 
de nieuwe modellen, lagen de gemiddelde verschillen tussen gemeten en 
voorspelde waarden voor respiratoire spierkracht allen rond 4.0cmH2O. De 
geselecteerde predictoren in de nieuwe modellen verklaarden 69% van de 
variantie (R2) voor beide respiratoire spierkrachtparameters. 
Een groot deel van deze thesis handelt om de training van ademhalingsspieren. 
Individuele respiratoire spiertraining kan een centraal aspect zijn bij het 
behouden van gezondheid en levenskwaliteit bij mensen na een dwarslaesie. In 
de klinische praktijk, wordt vaak gevraagd wat het meest effectieve 
trainingsregime is. In hoofdstuk 6 wordt hier op ingegaan, en wordt er 





expiratoire spiertraining effectiever is en evalueerden we de klinische 
implementatie van ademhalingstraining in groepsetting. Zowel geïsoleerde 
inademtraining als gecombineerde in- en expiratoire training toonden een 
stijging van de longfunctie en respiratoire spierkracht met een mediaan van 27%.  
Na de geïsoleerde inademtraining kon een toename van ongeveer 30% van de 
ademkracht en een stijging van 17% met betrekking tot de longvolumen 
geregistreerd worden. De gecombineerde in- en expiratoire spiertraining 
bewerkstelligde een gemiddelde stijging van de respiratoire 
spierkrachtparameters met 34% en van de longvolumen met ongeveer 27%. 
Zelfs als de gecombineerde ademhalingsspiertraining uitgevoerd werd met meer 
repetities per training en bijna tweemaal zo lang was, waren de relatieve 
verbeteringen van de respiratoire functieparameters vergelijkbaar met 
geïsoleerde inspiratoire spiertraining. Als volgt toonden beide trainingsregimes 
een groot effect op het verbeteren van respiratoire functieparameters en vooral 
in de ademhalingsspierkracht. Vanuit ons standpunt zou respiratoire 
spierkrachttraining een integraal onderdeel van de therapie moeten zijn en wordt 
klinische implementatie van een ademhalingstrainingsgroep tijdens de primaire 
revalidatie als zinvol geacht bij patiënten met een dwarslaesie. 
In hoofdstuk 7 besteden we aandacht aan de trainingsintensiteit en het 
trainingsvolume als verdere focus op respiratoire spiertraining. Het is belangrijk 
om het effect van trainingsintensiteit en -volume bij dwarslaesie te begrijpen, om 
zo met doelgerichte interventies, preventief, respiratoire complicaties te kunnen 
voorkomen en bijgevolg hospitalisaties te verminderen en herstel te verbeteren. 
De huidige ademtherapie is nog steeds voornamelijk gebaseerd op klinische 
ervaring en de meningen van experten. Het doel van de multiple 
regressieanalyse was het effect van de trainingsintensiteit en het 
trainingsvolume op relatieve verbeteringen van de respiratoire spierkracht te 
onderzoeken. De trainingsintensiteit leek relevanter dan het trainingsvolume 
voor een succesvolle verbetering van de respiratoire spierkracht. Patiënten met 
motorisch complete laesies vertoonden een toename van 7% van de in- en 
uitademkracht per 10cmH2O toename in trainingsintensiteit. Een 





stimulus te produceren die hoog genoeg was om de ademhalingsspierkracht te 
verbeteren. Hoe hoger de trainingsintensiteit, hoe hoger de progressie in de 
respiratoire spierkracht te verwachten is. Om een optimaal resultaat te bereiken 
adviseren wij een regelmatige verhoging van de trainingsintensiteit tijdens de 
inspiratoire spierkrachttraining 
In december 2019 stond een plots stijging van patiënten met longontstekingen 
van onbekende oorzaak in het centrum van de wereldwijde belangstelling. 
Sindsdien richt de wereld zich op het recentelijk ontdekte coronavirus, dat de 
COVID-19-ziekte veroorzaakt. Bepaalde personen met COVID-19 blijven 
asymptomatisch, terwijl de infectie bij anderen milde of matige symptomen 
veroorzaakt, waarvan 10% kunstmatige beademing nodig hebben en een 
opname op de intensieve zorgen vereist is. De lezersbrief van Torres-Castro en 
zijn team heeft ons ertoe aangezet om onze perspectieven en ervaringen uit 
Zwitserland te delen. Deze perspectieven, die samengevat zijn in hoofdstuk 8, 
zijn bedoeld om het bewustzijn van lezers betreffende ademhalingstherapie bij 
COVID-19 te verhogen en om zich ondersteund te voelen in deze uitdagende 
tijden. Personen met een tetraplegie, of een hoge paraplegie en verminderde 
longfunctie kunnen een hoger risico hebben op ernstigere problemen bij een 
COVID-19 infectie. We weten echter nog steeds niet hoeveel groter dat risico is. 
Momenteel wordt COVID-19 symptomatisch behandeld en niet op basis van de 
diagnose. Bijgevolg verschilt de behandelingsstrategie fundamenteel niet van de 
behandeling van andere respiratoire complicaties, hygiëne en persoonlijke 
veiligheid hebben echter absolute prioriteit. De therapeuten moeten de voor-en 
nadelen goed afwegen, enerzijds het mogelijke positieve effect van therapie, 
anderzijds de hygiëne maatregels. Het is tijd om nauw met elkaar samen te 
werken, onze ervaringen met betrekking tot de revalidatie van deze patiënten 
delen en samen rehabilitatieplannen en algoritmen ontwikkelen. Om deze 
doelen te bereiken is er nood aan intense coöperatie met de andere specialisten 
op dit gebied, om de zoektocht naar een optimale behandeling en 
interdisciplinaire aanpak te garanderen. 
In hoofdstuk 9 worden de resultaten van deze thesis in de context van de 





van deze thesis bijdragen aan de verbreiding van het wetenschappelijk begrip 
van respiratoire complicaties bij dwarslaesie. Ook wordt erop ingegaan, hoe 
groot het hieruit resulterende potentieel is om het risico op respiratoire 
complicaties te verminderen. De discussie wordt afgesloten met een blik op 
verschillende ideeën voor nieuwe onderzoeksvragen en speculaties, om het 
























Die Medizin macht grosse Fortschritte in der Behandlung von Menschen mit 
einer Querschnittlähmung. Trotzdem zählen Atemwegskomplikationen 
heutzutage immer noch zu den Hauptgründen für eine hohe Morbiditäts- und 
Sterblichkeitsrate in dieser Population. Besonders gefährdet sind Menschen mit 
einer Tetraplegie, da ihre Atmung aufgrund des Lähmungsniveaus 
eingeschränkt ist. 
Diese Thesis bietet einen interessanten Einblick in die Thematik der 
Atemwegskomplikationen nach einer Querschnittlähmung und ist ein weiterer 
relevanter Schritt für ein besseres Verständnis in der Behandlung dieser 
Komplikationen. Neues Wissen konnte generiert werden hinsichtlich der 
Fallzahlen von Lungenentzündungen nach einer Querschnittlähmung, 
Prädiktoren von Atemwegskomplikationen und läsions-spezifischen 
Referenzwerten. Die Studien in dieser Thesis befassten sich grösstenteils mit 
Atemmuskeltraining und überprüften deren Effektivität hinsichtlich der 
Atemmuskelkraft und der Lungenvolumina und lieferten somit neue Erkenntnisse 
für einen optimalen Trainingsplan. Zusätzlich ist diese Thesis auch auf die 
spezifische Problematik einer Querschnittlähmung in Bezug auf die COVID-19 
Pandemie eingegangen. 
Diese Thesis ist in 9 Kapitel unterteilt, welche im folgenden Text vorgestellt 
werden. 
In Kapitel 1 wird ein genereller Überblick zum Thema Querschnittlähmung und 
Atemwegskomplikationen vermittelt. Im Weiteren wird das heutige Wissen zu 
trainingsspezifischen Aspekten bei Fussgängern und Menschen mit einer 
Querschnittlähmung zusammengefasst. Am Ende von Kapitel 1 werden die 
Fragestellungen und Inhalte der einzelnen Studien vorgestellt.  
In Kapitel 2 haben wir in einer systematischen Literatursuche die Fallzahlen von 
Lungenentzündungen nach einer Querschnittlähmung erfasst und mittels 
systematischer und quantitativer Methoden die Gründe für die Abweichungen der 
Fallzahlen geprüft. Bis anhin fehlte diese systematisch erfasste Anzahl an 
Lungenentzündungen bei Menschen mit einer Querschnittlähmung und nach 
unserem Kenntnisstand ist dies somit die erste Literatursuche hinsichtlich dieser 





Erkrankungen werden immer wichtiger und Entscheidungsträger erkennen ihren 
Nutzen für politische Informationen und praktische Anwendbarkeit. In dieser 
Literatursuche konnten wir eine Meta-Regression mit 25 Studien durchführen. Die 
Incidenzrate reichte von 0.03 bis 7.21 Patienten mit einer Lungenentzündung 
während 100 Tagen. Die Incidenzrate im Akut-Setting war dabei mehr als 
zweimal so hoch wie in der Zeit nach der Rehabilitation und die Incidenzrate in 
der Intensivstation war fast 5 mal so hoch wie in der Zeit nach der Rehabilitation. 
Insgesamt wurde ein hohes Mass an Heterogenität innerhalb der einzelnen 
Studien gefunden und aus diesem Grund ist eine zurückhaltende Interpretation 
der Resultate erforderlich. 
In der Studie in Kapitel 3 haben wir untersucht, ob die Lungenfunktion, 
gemessen an einem zufällig gewählten Zeitpunkt nach Lähmungseintritt, als 
Unterscheidungswert für das Risiko einer Lungenentzündung gewählt werden 
kann. Als bester Parameter hat sich die maximale Einatemkraft herausgestellt, 
um zwischen Menschen mit einem erhöhten Risiko für Lungenentzündungen 
und denen mit niedrigem Risiko unterscheiden zu können und das unabhängig 
von der Schwere der Lähmung. Dieser Schwellenwert für die Einatemkraft lag 
bei 115% der läsionsspezifischen Referenzwerte bei Menschen mit einer 
motorisch kompletten Querschnittlähmung und bei 93.5cmH2O bei denen mit 
einer motorisch inkompletten Querschnittlähmung. Ein Schwellenwert von 115% 
der maximalen Einatemkraft bedeutet für den klinischen Alltag, dass die 
Einatemkraft 15% höher sein muss als der läsionsspezifische Wert (100%). 
Wenn ein Patient es nicht schafft seine Einatemkraft um 15% seines Sollwertes 
zu steigern, dann steigt sein Risiko für eine Lungenentzündung um das 4.6-
fache an. Bei Menschen mit einer inkompletten Lähmung (AIS C/D) können 
zusätzlich auch die Ausatemkraft, die Einsekundenkapazität und die maximale 
Ausatemgeschwindigkeit als Unterscheidungsparameter für das Risiko einer 
Lungenentzündung genutzt werden. Bei Patienten mit einer motorisch 
kompletten Querschnittlähmung und einer maximalen Einatemkraft unterhalt des 
Schwellenwertes sollte im klinischen Alltag ein inspiratorisches 
Atemmuskeltraining durchgeführt werden, um das Risiko einer 





inkompletten Querschnittlähmung und demzufolge einer vollständig oder 
teilweise erhaltenen Innervation der exspiratorischen Muskulatur ist eine 
Kombination aus Ein- und Ausatemtraining empfehlenswert um das Risiko einer 
Lungenentzündung zu reduzieren. 
In Kapitel 4 stellen wir das laufende RESCOM-Projekt (Respiratory 
Complications) vor, ein multizentrisches und multinationales Projekt mit einem 
repräsentativen Patientenkollektiv, das als erste prospektive Studie Prädiktoren 
von Lungenentzündungen während der Erstrehabilitation in industrialisierten 
Ländern mit hohem Einkommen untersucht. Nach unserem Wissensstand ist 
gegenwärtig keine vergleichbare Datenbank vorhanden für die weitere 
Entwicklung von generalisierbaren, prognostischen Modellen, um eine kausale 
Schlussfolgerung für das Risiko einer Lungenentzündung in Abhängigkeit einer 
eingeschränkten Lungenfunktion ziehen zu können. RESCOM als 
Kohortenstudie zielt darauf ab eine dementsprechende Forschungsgrundlage 
etablieren zu können. RESCOM soll Einblicke ermöglichen, ob die 
Verbesserung der Atemmuskelkraft und der Lungenvolumina vielversprechende 
Behandlungsziele darstellen, um das Risiko einer Lungenentzündung nach einer 
Querschnittlähmung zu reduzieren. Die Rekrutierung für RESCOM begann im 
Oktober 2016 in 10 Rehabilitationszentren in Australien, Österreich, 
Deutschland, den Niederlanden und in der Schweiz. Stationäre Patienten mit 
einer akuten, kompletten oder inkompletten Querschnittlähmung im Hals- oder 
Brustwirbelbereich und ohne Abhängigkeit von einer 24-stündigen künstlichen 
Beatmung innerhalb der ersten drei Monate nach Lähmungseintritt werden in die 
Studie eingeschlossen. Die RESCOM Kohorte wird insgesamt 500 Personen mit 
Querschnittlähmung aufnehmen. Der erste Outcome-Parameter ist die 
Lungenentzündung in Relation zur Lungenfunktion, die sekundären Outcomes 
beinhalten die aufgrund einer Lungenentzündung folgenden Sterblichkeitsrate 
und Lebensqualität. Wir verwenden longitudinale Daten für diese prognostischen 
Modelle für Risikofaktoren von Lungenentzündungen im stationären Setting. Wir 
gehen davon aus, dass RESCOM die klinische Praxis verbessern wird indem 





selektiert werden und Interventionen wie z.B. Atemmuskeltraining optimal 
angewendet werden können. 
Die Vorhersage der Lungenfunktion nach einer Querschnittlähmung ist eine 
essentielle Komponente um die Atemsituation dieser Patienten im klinischen 
Alltag zu verstehen. Diese Vorhersage der Lungenfunktion basierend auf den 
Werten von Fussgängern hat Limitationen für Menschen mit einer 
Querschnittlähmung. Im Jahr 2012 wurde ein Kalkulator für Referenzwerte 
entwickelt für Menschen mit einer Querschnittlähmung, um einen Überblick über 
den Status der Lungenfunktion zu erhalten und dies unter Berücksichtigung der 
jeweiligen Läsionshöhe. Es war unklar, ob diese Modelle auch präzise für 
Menschen viele Jahre nach einer Querschnittlähmung sind. Aus diesem Grund 
war das Ziel der Studie in Kapitel 5 die Genauigkeit der 2012 entwickelten 
Modelle für Menschen mit einer chronischen Querschnittlähmung zu testen und 
falls nötig neue Modelle für die Vorhersage der Lungenfunktion zu entwickeln 
und zu validieren. Die Modelle, die 2012 entwickelt wurden, sind nicht präzise 
genug für Menschen mit einer chronischen Querschnittlähmung und neue 
Modelle wurden entwickelt. Der Grund dafür war, dass die Modelle von 2012 die 
aktuellen Lungenfunktionswerte im unteren Bereich unterschätzten und im 
oberen Bereich überschätzten und das für alle untersuchten 
Lungenfunktionsparameter. Für den klinischen Alltag ist ein Vergleich zwischen 
den tatsächlich gemessenen Werten und den spezifischen Referenzwerten 
wichtig, um die geeignete präventive Therapie anzuordnen. Eine mögliche 
Behandlungsform könnte das Training der Einatemkraft mittels 
Atemmuskeltraining sein. Die Verwendung von läsions-spezifischen 
Referenzwerten ist deutlich sensitiver für Menschen mit einer 
Querschnittlähmung als die Verwendung von absoluten Werten oder die 
Referenzwerte von Fussgängern. Für die Lungenvolumina konnten wir keine 
besseren Modelle entwickeln für Menschen mit einer chronischen 
Querschnittlähmung, aber die Modelle für die Atemkraft konnten verbessert 
werden. Für die neuen Modelle der mittlere Unterschied zwischen den 





cmH2O. Die ausgewählten Prädiktoren in den neuen Modellen konnten 69% der 
Varianz (R2) für Ein- und Ausatemkraft erklären. 
Ein grosser Teil dieser wissenschaftlichen Arbeit widmet sich dem 
Atemmuskeltraining. Individuelles Atemmuskeltraining kann eine zentrale Rolle 
einnehmen bei der Erhaltung der Gesundheit und der Lebensqualität bei 
Menschen nach einer Querschnittlähmung. Im klinischen Alltag kommt häufig 
die Frage nach dem effektivsten Atemmuskeltraining auf. In Kapitel 6 folgen wir 
der Frage, ob isoliertes Einatemtraining oder die Kombination aus Ein- und 
Ausatemtraining effektiver war und evaluierten die klinische Implementierung 
eines Atemmuskeltrainings im Gruppensetting. Sowohl das isolierte 
Einatemtraining, als auch das kombinierte Training aus Ein- und 
Ausatemtraining konnten die Atemmuskelkraft im Median um 27% steigern. 
Nach dem isolierten Einatemtraining konnte ein Anstieg von etwa 30% der 
Atemkraft und von etwa 17% der Lungenvolumina erzielt werden. Nach dem 
kombinierten Ein- und Ausatemtraining konnte die Atemkraft um durchschnittlich 
34% und die Lungenvolumina um etwa 27% gesteigert werden. Auch wenn das 
kombinierten Training mit mehr Wiederholungen pro Training durchgeführt 
wurde und fast zweimal so lang war, waren die relativen Anstiege der Atemkraft 
und Lungenvolumunia vergleichbar mit dem isolierten Einatemtraining. Das 
bedeutet, dass beide Trainingsformen einen grossen Effekt auf die 
Verbesserung der Atemparameter und v.a. auf die Atemkraft erzielten. Aus 
unserer Sicht sollte das Atemmuskeltraining einen wesentlichen Bestandteil im 
Therapiealltag einnehmen und die klinische Implementierung einer 
Atemtrainingsgruppe während der Primärrehabilitation ist durchaus sinnvoll für 
Menschen mit einer Querschnittlähmung. 
In Kapitel 7 fokusieren wir uns auf die Trainingsintensität und den 
Trainingsumfang als weiteren Schwerpunkt zum Thema Atemmuskeltraining. Es 
ist wichtig den Effekt von Trainingsintensität und –umfang auf die 
Lungenfunktion nach einer Querschnittlähmung zu verstehen, um mit 
zielgerichteten Interventionen präventiv vor Atemwegskomplikationen 
vorzubeugen und somit die Hospitalisationsrate zu reduzieren und die Erholung 





Expertenmeinungen. Das Ziel der multiplen Regressionsanalyse war es, den 
Effekt von Trainingsintensität und -umfang auf die relativen Verbesserungen der 
Atemmuskelkraft zu untersuchen. Für eine erfolgreiche Steigerung der 
Atemmuskelkraft scheint die Trainingsintensität eine relevantere Rolle zu spielen 
als das Trainingsvolumen. Patienten mit einer motorisch kompletten 
Querschnittlähmung zeigten eine 7% Zunahme der Ein- und Ausatemkraft pro 
10cmH2O Erhöhung der Trainingsintensität. Eine Trainingsintensität unterhalb 
30% der Einatemkraft kann keinen ausreichend hohen Reiz für eine 
Verbesserung der Atemmuskelkraft erzeugen. Je höher die Trainingsintensität 
umso höher ist jedoch die zu erwartende Zunahme der Atemmuskelkraft. Wir 
empfehlen eine regelmässige Steigerung der Trainingsintensität während des 
inspiratorischen Atemmuskeltraining, um das optimale Resultat zu erzielen. 
Im Dezember 2019 war plötzlich eine Anhäufung an Patienten mit 
Lungenentzündungen unbekannter Ursache im Zentrum der globalen 
Aufmerksamkeit. Seitdem fokusiert sich die Welt auf das neu entdeckte Corona-
Virus, der die COVID-19 Erkrankung verursacht. Einige Menschen mit COVID-
19 bleiben asymptomatisch, während bei anderen die Infektion milde bis 
moderate Symptome verursachen kann mit einer COVID-19 Lungenentzündung, 
von denen etwa 10% einer künstlichen Beatmung und Behandlung auf der 
Intensivstation bedürfen. Der Leserbrief von Torres-Castro und seinem Team 
hat uns dazu bewogen, unsere Perspektiven und Erfahrungen in der Schweiz 
darzustellen. Diese Perspektiven sind im Kapitel 8 zusammengefasst, um das 
Bewusstsein der Leser hinsichtlich der Atemtherapie bei COVID-19 zu erhöhen 
und Unterstützung in dieser herausfordernden Zeit zu erfahren. 
Menschen mit einer Tetraplegie oder einer hohen Paraplegie und reduzierter 
Lungenfunktion könnten einem höheren Risiko für schwerwiegendere COVID-
19 Verläufen unterliegen. Zum aktuellen Zeitpunkt wissen wir allerdings noch 
nicht, wie viel grösser dieses Risiko ist. Die Therapie bei COVID-19 erfolgt nach 
Symptomen und nicht nach der Diagnose. Das bedeutet, dass sich die 
Behandlungsstrategien grundsätzlich nicht von der Behandlung anderer 
Atemwegskomplikationen unterscheiden, allerdings haben Hygiene und die 





Nachteile genau abwägen, d.h. den möglichen positiven Therapieeffekt gegen 
die Hygienemassnahmen. Es ist an der Zeit, dass wir eng zusammenarbeiten, 
unsere Erfahrungen in der Rehabilitation dieser Patienten teilen und gemeinsam 
Rehabilitationspläne und Algorithmen entwickeln. 
Um diese Ziele zu erreichen, benötigen wir eine enge Kollaboration mit den 
anderen Experten in diesem Bereich, um die Suche nach der optimalen 
Behandlung und einem interdisziplinären Ansatz bestmöglich zu gewähren. 
In Kapitel 9 werden die Ergebnisse dieser Thesis in den Kontext des aktuellen 
Wissensstandes eingeordnet. Es wird diskutiert inwieweit die Resultate dieser 
Thesis zur Erweiterung der wissenschaftlichen Erkenntnisse hinsichtlich 
Atemwegskomplikationen nach einer Querschnittlähmung beitragen. 
Ausserdem wird darauf eingegangen, wie gross das daraus resultierende 
Potential ist, die Rate der Atemwegskomplikationen zu reduzieren. Die 
Diskussion wird mit einem Ausblick abgeschlossen, in dem Ideen für neue 
Forschungsfragen und Spekulationen angeregt werden, um das Thema rund um 
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